Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,ligand-gated ion channel activity (GO:0015276),-0.726605756051957,-2.4199979711157793,0.0,0.0,0.0,14/30,10.62%,GRIK2;GRID2;GRIA4;GABRB1;GRIA1;GRIN2B;GRIN2A;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;CHRNA4;GRIK1
prerank,ligand-gated channel activity (GO:0022834),-0.7266123830237735,-2.3994004669724593,0.0,0.0,0.0,14/29,10.62%,GRIK2;GRID2;GRIA4;GABRB1;GRIA1;GRIN2B;GRIN2A;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;CHRNA4;GRIK1
prerank,glutamate receptor activity (GO:0008066),-0.7923437551798055,-2.2757598564595787,0.0,0.0006922670622478451,0.002,12/19,10.62%,GRM7;GRIK2;GRID2;GRIA4;GRM8;GRM5;GRIA1;GRM1;GRIA2;GRIK4;GRIN2D;GRIK1
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6762229839609925,-2.1830728310861076,0.0,0.0010384005933717676,0.004,16/29,12.75%,GRIK2;GRID2;GRIA4;GABRB1;GRIA2;GABRA3;GABRG3;GABRG1;GABRA2;GRIK4;GABRG2;GRIN2D;GABRB3;GRIK1;GLRA2;GABRA5
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.738390924738961,-2.1264988865073966,0.0,0.0035305620174640104,0.014,11/17,10.62%,GRIK2;GRIA4;GRIA1;GRIN2B;GRIN2A;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;GRIK1
prerank,microtubule minus-end binding (GO:0051011),0.8024230169561442,2.0220254916498868,0.0,0.029133598722077134,0.027,6/13,7.69%,CAMSAP1;NUMA1;TUBGCP5;MACF1;HAUS7;CAMSAP2
prerank,cAMP binding (GO:0030552),-0.7835190699499106,-1.9286660668899422,0.0,0.035651753705764025,0.17,7/11,13.66%,PDE4B;PDE4D;HCN1;RAPGEF2;PDE10A;PDE4A;PDE2A
prerank,triglyceride lipase activity (GO:0004806),0.6772743388775107,1.9005512152871054,0.0018018018018018018,0.10973655518649052,0.187,6/20,8.30%,LIPC;LIPH;DAGLB;PLA2G15;PNPLA1;LCAT
prerank,cyclic nucleotide binding (GO:0030551),-0.6442651715041948,-1.8937698992137606,0.0022624434389140274,0.04776642729510131,0.257,9/21,13.66%,PDE4B;PDE4D;HCN1;PDE11A;KCNH1;RAPGEF2;PDE10A;PDE4A;PDE2A
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6490108941868333,-1.8692156860834386,0.0021413276231263384,0.053867030781160445,0.319,11/19,15.92%,GRIK2;GRID2;GABRA3;GABRG3;GABRG1;GABRA2;GRIK4;GABRG2;GRIK1;GABRA5;GRIK3
prerank,R-SMAD binding (GO:0070412),0.6716800963420416,1.8587795543772527,0.0,0.1323960208592172,0.316,8/18,7.65%,LDLRAD4;SMAD3;PMEPA1;DDX5;SMURF1;PAX6;RANBP3;JUN
prerank,glycine binding (GO:0016594),-0.7199869903578648,-1.832378459797925,0.00423728813559322,0.07395719781681145,0.445,7/11,17.04%,GRIN2B;GLRA1;GRIN3A;SRR;GLRA2;GNMT;GLDC
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6679324394437784,-1.8311963066822667,0.00631578947368421,0.06791139880651362,0.451,7/15,7.20%,HS6ST3;HS3ST5;NDST4;HS3ST2;HS6ST2;HS3ST4;HS3ST1
prerank,BMP binding (GO:0036122),0.7308205726526984,1.8132146432266623,0.00375234521575985,0.182813331981034,0.495,2/11,12.68%,GREM1;ENG
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5789040092226263,-1.812780724063424,0.0,0.07580324331613904,0.519,11/28,12.75%,GRIK2;GRID2;GABRA3;GABRG3;GABRG1;GABRA2;GRIK4;GABRG2;CHRNA4;GRIK1;GABRA5
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.5150464500483022,-1.8083053274566159,0.0,0.07363990874661452,0.543,11/42,6.08%,LRRC4C;PDLIM5;CD47;TMOD3;CNTN6;EMB;NPTN;PALLD;S100A11;PDLIM1;STXBP6
prerank,syntaxin-1 binding (GO:0017075),-0.5861792174054148,-1.8014818047860286,0.013729977116704805,0.0720490257862565,0.561,9/22,7.38%,LRRK2;SYT1;UNC13C;SNPH;SYNPR;STXBP5;SNAP25;CPLX2;DAPK1
prerank,I-SMAD binding (GO:0070411),0.7110076583132431,1.7947591885817307,0.0035971223021582736,0.18237632800020287,0.558,5/13,2.62%,TGFBR1;SMAD3;SMAD7;TGFB1I1;SMURF1
prerank,ligand-gated anion channel activity (GO:0099095),-0.6347914206982714,-1.7740994994954427,0.010638297872340425,0.08974747985570278,0.681,11/17,15.40%,GABRB1;GLRA1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GLRA2;GABRA5;CFTR
prerank,GTPase activator activity (GO:0005096),0.3891605568020129,1.7633738704421,0.0,0.2193112570467473,0.693,80/313,11.62%,DOCK4;SRGAP2;RAPGEF5;ELMO1;CHN2;DOCK8;TBC1D16;FGD2;HPS4;ARHGAP22;ARHGAP45;SIPA1L2;OPHN1;ARHGAP39;RASGRP3;ASAP1;CYTH4;ARHGEF2;PREB;SMAP2;HERC2;PREX1;VAV2;DENND4A;TBC1D17;DENND6B;ARHGAP27;RAP1GDS1;ASAP3;RAB3IL1;TBC1D9B;RCBTB2;ARFGAP3;TBC1D10B;RGS10;ARAP3;TBC1D7;CDC42EP2;ARHGAP25;RGL2;RANBP2;TBCK;TBC1D8;GARNL3;DENND2C;TBC1D15;RP2;FLCN;ARHGAP30;EIF2B3;ARHGAP28;HACD3;ACAP2;ARHGAP17;CCZ1;RASA4;SIPA1;PSD;RAB3GAP1;SGSM2;RAB3GAP2;RANBP3;LAMTOR2;JUN;FRMD7;ARHGAP8;RALGPS1;DOCK10;AKAP13;CYTH3;EEF1B2;NCKAP1L;RGS14;EIF2B4;FGD3;TBC1D9;LAMTOR5;RUNDC1;RAPGEF3;SPATA13
prerank,GABA receptor activity (GO:0016917),-0.5863449557502554,-1.737113091599254,0.0022026431718061676,0.12135441601204724,0.799,11/21,15.69%,GABRB1;GABBR1;GABBR2;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GABRA5;GABRQ
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.5157905177644272,-1.6725240821326197,0.006818181818181818,0.21417012238292704,0.937,16/29,22.21%,SLC25A30;SLC1A6;SLC1A5;SLC13A3;SLC26A7;SLC46A1;SLC25A12;SLC26A2;SLC25A18;SLC13A5;SLC1A1;SLC1A4;ABCC2;SLC26A8;SLC26A3;SLC26A4
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.5611260740123368,-1.6699671364134068,0.011286681715575621,0.2058476470389916,0.941,11/21,13.66%,PDE7B;PDE4B;PDE4D;PDE1C;PDE9A;PDE7A;PDE11A;PDE8A;PDE10A;PDE4A;PDE2A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5438292249105174,-1.6692312187917786,0.013422818791946308,0.19556544508501625,0.941,11/23,13.66%,PDE7B;PDE4B;PDE4D;PDE1C;PDE9A;PDE7A;PDE11A;PDE8A;PDE10A;PDE4A;PDE2A
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6916058428356493,1.666131002573648,0.010948905109489052,0.5219076113926389,0.946,6/11,18.10%,PRMT2;PRMT8;PRMT1;PRMT6;FBXO11;CARM1
prerank,MHC class II protein complex binding (GO:0023026),-0.6599205157428633,-1.6614364683917597,0.025806451612903226,0.19855312398524377,0.954,6/11,25.19%,CD74;YWHAE;HSPA8;MS4A1;CD4;HSP90AB1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.5970951581679627,-1.6593247422558175,0.01348314606741573,0.19189642965510267,0.957,5/18,6.08%,PDLIM5;TMOD3;S100A11;PDLIM1;STXBP6
prerank,voltage-gated ion channel activity (GO:0005244),-0.6115497619623917,-1.6564214987951007,0.012711864406779662,0.18770326916377286,0.963,5/14,8.52%,KCND2;CACNA1E;HCN1;PKD2;ANO6
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6131940684698117,1.6562764465146331,0.010619469026548672,0.4987914881208955,0.957,4/18,1.07%,TGFBR1;TGFBR2;SMAD3;SMAD7
prerank,muscle alpha-actinin binding (GO:0051371),-0.5884974180424289,-1.655899903037881,0.013761467889908258,0.1800681028960588,0.963,5/15,12.71%,PDLIM5;PALLD;PDLIM1;PKD2;PDLIM4
prerank,ion channel activity (GO:0005216),-0.4072627985794697,-1.6553449538022227,0.0026246719160104987,0.1729162727223422,0.963,20/80,10.62%,GRIK2;GRID2;GRIA4;UNC80;GABRB1;GRIA1;GRIN2B;GRIN2A;NALCN;TRPM3;GRIA2;GRIA3;MCUB;GRIK4;PKD2;GRIN3A;GRIN2D;CHRNA4;CALHM6;GRIK1
prerank,myosin V binding (GO:0031489),-0.6130567717824221,-1.6527509763208688,0.018404907975460124,0.16925929671959813,0.964,6/15,15.90%,RAB3C;RAB6A;RAB3D;RAB8A;RAB3A;RAB27B
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5352559787738193,1.6499348737813506,0.008928571428571428,0.47271961482007374,0.969,13/29,21.36%,GANAB;GUSB;NEU3;HPSE2;ACER3;CHIT1;HEXD;ACER2;PARG;CTBS;PGGHG;MGAM;GAA
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.6927668692084794,-1.64988255701436,0.00823045267489712,0.16709942348538487,0.966,6/10,17.28%,B3GALT1;B4GALT5;B4GALT6;B3GALT4;B3GALT2;B4GALT7
prerank,metalloaminopeptidase activity (GO:0070006),-0.6035847227126734,-1.6488458011759617,0.0021598272138228943,0.1617908001441935,0.967,10/16,18.64%,MMP16;NPEPPS;XPNPEP3;TRHDE;ENPEP;RNPEPL1;MMP15;ANPEP;MMP14;LNPEP
prerank,lipase activity (GO:0016298),0.4956058860396637,1.6380042210983865,0.0017452006980802793,0.47303253125079237,0.981,12/43,13.24%,LIPC;LIPH;ABHD12;DAGLB;PLA2G15;PNPLA1;PLB1;LCAT;SMPD2;ABHD15;ABHD6;PLBD2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.652698131474861,1.6229632348794898,0.01967799642218247,0.48829677130851096,0.99,4/12,12.88%,SLC25A42;ENTPD1;NUDT15;ENTPD7
prerank,GTPase regulator activity (GO:0030695),0.3716829223816088,1.617244036162561,0.0,0.4700220593828444,0.991,47/212,7.65%,SRGAP2;CHN2;TBC1D16;ARHGAP22;ARHGAP45;SIRPA;SIPA1L2;OPHN1;ARHGAP39;RASGRP3;ASAP1;PREB;SMAP2;PREX1;TBC1D17;ARHGAP27;RAP1GDS1;ASAP3;TBC1D9B;ARFGAP3;TBC1D10B;RGS10;ARAP3;TBC1D7;CDC42EP2;ARHGAP25;GPS2;RANBP2;TBCK;TBC1D8;GARNL3;TBC1D15;RP2;FLCN;ARHGAP30;ARHGAP28;RHOH;HACD3;ACAP2;ARHGAP17;RASA4;SIPA1;RAB3GAP1;SGSM2;RAB3GAP2;RANBP3;JUN
prerank,O-acyltransferase activity (GO:0008374),0.5164979188278733,1.6126469871478137,0.02079722703639515,0.45164548172738034,0.991,10/30,12.14%,LPCAT2;MBOAT2;LPCAT4;DGAT1;PLA2G4A;PLA2G15;MOGAT1;LCAT;MOGAT2;MBOAT1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3873427576965215,1.608345011307598,0.0,0.43277267244533146,0.993,35/147,11.62%,DOCK4;RAPGEF5;ELMO1;DOCK8;FGD2;HPS4;CYTH4;ARHGEF2;PREB;HERC2;PREX1;VAV2;DENND4A;DENND6B;RAB3IL1;RCBTB2;RGL2;DENND2C;EIF2B3;CCZ1;PSD;RAB3GAP1;RAB3GAP2;LAMTOR2;FRMD7;RALGPS1;DOCK10;AKAP13;CYTH3;EEF1B2;EIF2B4;FGD3;LAMTOR5;RAPGEF3;SPATA13
prerank,anion channel activity (GO:0005253),-0.41903585350479733,-1.5958224149283988,0.0047169811320754715,0.23490928978943543,0.997,20/61,15.69%,LRRC8C;GABRB1;GLRA1;CLCN5;GABRA3;GABRG3;GABRG1;ANO3;GABRA2;LRRC8B;GABRG2;ANO6;GABRB3;SLC26A7;ANO5;GLRA2;GABRA5;CLCC1;CFTR;GABRQ
prerank,GABA-A receptor activity (GO:0004890),-0.5584087691058538,-1.5954298332919556,0.01991150442477876,0.2272984727419844,0.997,9/18,15.69%,GABRB1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GABRA5;GABRQ
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6533060457302835,1.5929180400111524,0.028142589118198873,0.45953396384289663,0.997,3/12,3.56%,TGFBR1;TGFBR2;LTBP4
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.5230705875383657,-1.5923608247238945,0.01939655172413793,0.22508228034258382,0.998,5/23,4.92%,HIP1;CLVS2;SESTD1;SNX14;PLEKHA5
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6289941991591177,-1.5840382953905014,0.0457516339869281,0.23177101244057852,0.998,8/12,12.75%,GABRB1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRB3;GABRA5
prerank,semaphorin receptor activity (GO:0017154),-0.6315354980957258,-1.5698258582176254,0.04484304932735426,0.2493501295825625,0.999,5/11,14.18%,PLXNC1;PLXND1;PLXNA2;PLXNB2;PLXNB1
prerank,water transmembrane transporter activity (GO:0005372),-0.6386241047141481,-1.5661558221063439,0.032397408207343416,0.24795059168605238,0.999,5/11,31.58%,AQP4;AQP11;AQP1;SLC5A1;SLC4A11
prerank,sequence-specific mRNA binding (GO:1990825),0.676924223828399,1.5655928949913573,0.048417132216014895,0.5367258614569335,0.999,6/10,19.75%,SSB;ETF1;DHX9;RBM24;SHFL;TYMS
prerank,voltage-gated cation channel activity (GO:0022843),-0.3752862129374602,-1.5652864371599318,0.0,0.24163267140914557,0.999,22/97,8.74%,KCND2;KCNB2;CACNA2D3;CACNA1E;HCN1;KCNC2;GRIN2B;GRIN2A;KCNQ5;KCNH1;CACNG2;KCND3;KCNA6;CACNA1C;KCNQ3;PKD2;KCNH7;GRIN3A;OPRM1;KCNH5;CACHD1;GRIN2D
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6008196661188663,-1.5530808402169312,0.05010438413361169,0.25633224059321313,0.999,8/13,12.75%,GLRA1;GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GLRA2;GABRA5
prerank,calcium channel regulator activity (GO:0005246),-0.4561605127287444,-1.5482981727194438,0.02849740932642487,0.2578200330400189,1.0,7/37,7.86%,NRXN1;PRKG1;ITPR1;YWHAE;CALM1;MCUB;STIM2
prerank,potassium channel activity (GO:0005267),-0.3745836559950941,-1.5467648520412982,0.005263157894736842,0.2535716560092003,1.0,24/89,13.76%,GRIK2;KCND2;KCNT2;KCNB2;KCNK10;KCNN2;HCN1;KCNC2;KCNQ5;KCNMB2;KCNH1;KCND3;KCNA6;KCNQ3;GRIK4;PKD2;KCNH7;KCNH5;TMEM38B;GRIK1;TMEM38A;KCNMB4;KCNQ1;HCN2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.5565992807210883,-1.5423658544486871,0.03938730853391685,0.2552781566840432,1.0,9/16,18.05%,SLC25A30;SLC1A6;SLC1A5;SLC13A3;SLC25A12;SLC25A18;SLC13A5;SLC1A1;SLC1A4
prerank,alpha-actinin binding (GO:0051393),-0.49087447412802293,-1.5409086643746503,0.02891566265060241,0.25126561726456326,1.0,10/24,15.51%,PDLIM5;PPARG;KCNN2;PALLD;CACNA1C;PDLIM1;PKD2;RARA;PDLIM4;DAG1
prerank,vinculin binding (GO:0017166),-0.6286502089017488,-1.5318746422820246,0.04516129032258064,0.26039891803015097,1.0,4/11,5.41%,DMD;CTNNA1;UTRN;SYNM
prerank,calcium channel inhibitor activity (GO:0019855),-0.6174281663187058,-1.5263109101746748,0.04740406320541761,0.2632345504197431,1.0,3/11,6.10%,ITPR1;CALM1;MCUB
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.5110559182984522,-1.523987309428817,0.032679738562091505,0.2608918173737214,1.0,4/21,9.92%,GRM5;GRIA1;GRM1;CHRNA4
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5553632641696499,-1.5238489866100096,0.051224944320712694,0.254927345672769,1.0,10/16,22.21%,SLC12A5;SLC26A7;SLC4A8;SLC26A2;CFTR;SLC1A1;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5470051428547203,1.5229321532470004,0.037300177619893425,0.7060613337350458,1.0,3/18,3.56%,TGFBR1;TGFBR2;LTBP4
prerank,sodium channel activity (GO:0005272),-0.44076290930239337,-1.519651169475741,0.026378896882494004,0.2562917557547575,1.0,14/37,22.61%,GRIK2;HCN1;SCN2A;SCN3A;GRIK4;PKD2;GRIK1;HCN2;GRIK3;ASIC3;SCN9A;CACNA1G;SCN1A;HCN4
prerank,lysophospholipase activity (GO:0004622),0.5395345634617332,1.5111825023206786,0.04212454212454213,0.727584652529504,1.0,6/20,8.19%,ABHD12;PNPLA7;PLA2G4A;PLA2G6;PLA2G4B;PLB1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4027915938200809,1.5104238674997663,0.008064516129032258,0.6929196453950871,1.0,20/78,14.82%,USP35;CAPN3;CFLAR;UCHL1;USP8;USP12;CAPN9;CASP1;CTSS;LGMN;CAPN5;USP28;USP25;PIGK;USP36;USP5;CTSF;USP9Y;PDIA3;PYCARD
prerank,3'-5' DNA helicase activity (GO:0043138),0.5634294851120157,1.5071937133548512,0.0466786355475763,0.6741029184309947,1.0,4/16,6.85%,NAV2;FANCM;MCM2;DHX9
prerank,myosin binding (GO:0017022),-0.40734622344772065,-1.5031521435009,0.01639344262295082,0.2794241596709484,1.0,12/55,9.03%,DMD;STXBP5L;GSN;RAB3C;SPATA6;RAB6A;STXBP5;GIPC1;RAB3D;SHROOM1;RAB8A;RAB3A
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5021847293323769,-1.4988733155061227,0.034934497816593885,0.26918878360939613,1.0,9/22,17.07%,HRH1;HTR2C;HTR2B;CHRM2;CHRM3;HTR1D;HTR4;HTR6;HTR1F
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5021847293323769,-1.4988733155061227,0.034934497816593885,0.26918878360939613,1.0,9/22,17.07%,HRH1;HTR2C;HTR2B;CHRM2;CHRM3;HTR1D;HTR4;HTR6;HTR1F
prerank,serotonin receptor activity (GO:0099589),-0.5021847293323769,-1.4988733155061227,0.034934497816593885,0.26918878360939613,1.0,9/22,17.07%,HRH1;HTR2C;HTR2B;CHRM2;CHRM3;HTR1D;HTR4;HTR6;HTR1F
prerank,carboxylic acid binding (GO:0031406),-0.4256575087614559,-1.4934858951037875,0.023504273504273504,0.27338058955081307,1.0,10/38,13.02%,GRM7;EPDR1;GRIN2B;GLRA1;GRIN3A;PADI4;SRR;GLRA2;GNMT;SHMT1
prerank,phospholipase activity (GO:0004620),0.402905883037031,1.491706850088826,0.018612521150592216,0.716640284755602,1.0,15/67,13.47%,LIPC;LIPH;ABHD12;PLCL1;PNPLA7;PLA2G4A;PLA2G6;PLA2G15;PLA2G4B;PLB1;SMPD2;PLD4;ABHD6;PLBD2;PDIA3
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5104973457987331,-1.4898196535609727,0.04487179487179487,0.2746463610224104,1.0,5/19,2.52%,ITPR1;GRIN2B;GRIN2A;RYR3;RYR2
prerank,ligand-gated cation channel activity (GO:0099094),-0.37236028423735945,-1.483052570814905,0.01240694789081886,0.28130272074441187,1.0,14/75,10.62%,GRIK2;GRIA4;KCNN2;GRIA1;GRIN2B;GRIN2A;KCNJ3;GRIA2;GRIA3;GRIK4;GRIN3A;GRIN2D;CHRNA4;GRIK1
prerank,solute:anion antiporter activity (GO:0140323),-0.5548066729524763,-1.4821658227922596,0.06236559139784946,0.2774158447978497,1.0,7/14,22.21%,SLC26A7;SLC26A2;SLC7A11;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5400696775238969,-1.47019312286147,0.07158836689038031,0.29248949021377463,1.0,7/16,9.84%,MSR1;CD36;STAB1;LDLR;PLTP;SCARF1;CDH13
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.4521115124696486,1.4683064755343929,0.041025641025641026,0.79799575408744,1.0,15/37,21.59%,KARS1;AARS2;CARS2;NARS1;SARS2;SARS1;RARS1;FARSA;IARS1;DARS2;EPRS1;QARS1;WARS2;IARS2;MARS2
prerank,insulin-like growth factor I binding (GO:0031994),0.5792681501074932,1.4644426305539366,0.05565217391304348,0.784496035153903,1.0,4/13,3.66%,ITGA6;IGFBP3;IGF1R;ITGAV
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.5215396414640218,-1.4618826112701522,0.05439330543933055,0.30266438427183145,1.0,5/17,17.74%,DPYD;DECR2;LBR;SRD5A3;DHCR7
prerank,cell adhesion mediator activity (GO:0098631),-0.4717351406865929,-1.4554945746900783,0.04212860310421286,0.3087703394031569,1.0,9/24,14.16%,LRRC4C;CD47;CNTN6;EMB;NPTN;PALLD;NINJ1;JAM3;NTNG1
prerank,amyloid-beta binding (GO:0001540),-0.3663123146124044,-1.4544003747156118,0.007575757575757576,0.3052897744512997,1.0,16/79,5.12%,NLGN1;CD74;GRIA4;MSR1;CD36;GRIA1;GRIN2B;LILRB3;LILRB1;GRIN2A;IAPP;LDLR;GRIA2;APOE;APBA2;GRIA3
prerank,chloride channel activity (GO:0005254),-0.3864152050355418,-1.4543415101795518,0.02112676056338028,0.29998651427800815,1.0,18/59,15.69%,GABRB1;GLRA1;CLCN5;GABRA3;GABRG3;GABRG1;ANO3;GABRA2;GABRG2;ANO6;GABRB3;SLC26A7;ANO5;GLRA2;GABRA5;CLCC1;CFTR;GABRQ
prerank,amino acid binding (GO:0016597),-0.437319866003693,-1.4515956550417493,0.045064377682403435,0.30002490126736214,1.0,12/31,19.23%,GRM7;GRIN2B;GLRA1;GRIN3A;PADI4;SRR;GLRA2;GNMT;SHMT1;DDAH2;GLDC;AARS1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5965955173894961,-1.4510139440699228,0.09799554565701558,0.29571142415037044,1.0,3/10,1.64%,DPP6;DPP10;DPP4
prerank,FMN binding (GO:0010181),0.5980111428437608,1.4508903585910342,0.06839186691312385,0.8242380638454323,1.0,6/11,23.08%,PPCDC;NOS2;HAO1;NOS1;POR;PNPO
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.6257462438401521,1.4500052502643193,0.06998158379373849,0.7954249347092979,1.0,4/10,6.32%,SIRPA;DSP;CXADR;DSG2
prerank,MAP kinase kinase activity (GO:0004708),-0.5251642730361189,-1.444335807797206,0.07472527472527472,0.3024033728019273,1.0,7/15,20.04%,LRRK2;MAPK10;PAK3;MAPKAPK5;MAP2K6;SBK2;MAP2K5
prerank,potassium channel regulator activity (GO:0015459),-0.3967741099387521,-1.4409509759602837,0.03529411764705882,0.3033341200004495,1.0,9/49,6.99%,KCNIP4;DPP6;DPP10;KCNIP1;KCNMB2;YWHAE;NEDD4L;KCNAB2;SGK2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5709279663610008,-1.4386133062264643,0.07352941176470588,0.3023788481977493,1.0,7/11,16.72%,KCND2;KCNT2;KCND3;PKD2;KCNQ1;KCNIP2;KCNT1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5300292666151416,-1.4385877103024702,0.06941431670281996,0.2975185183976787,1.0,8/15,22.21%,SLC26A7;SLC4A8;SLC26A2;CFTR;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,voltage-gated potassium channel activity (GO:0005249),-0.35400564028243486,-1.4332390175405476,0.03258145363408521,0.3021416075729821,1.0,15/80,8.04%,KCND2;KCNT2;KCNB2;KCNN2;HCN1;KCNC2;KCNQ5;KCNJ3;KCNH1;KCND3;KCNA6;KCNQ3;PKD2;KCNH7;KCNH5
prerank,carboxylic ester hydrolase activity (GO:0052689),0.37745468007178107,1.4322006461327947,0.026272577996715927,0.8583579900410956,1.0,17/85,11.28%,LIPC;ABHD12;DAGLB;PNPLA7;AARS2;PLA2G4A;PLA2G6;PLA2G15;PLA2G4B;PNPLA1;PLB1;LCAT;PTRH1;ABHD15;ABHD6;PAFAH2;PON2
prerank,cysteine-type peptidase activity (GO:0008234),0.38603856060117897,1.4320788467058387,0.0256,0.8273582363011608,1.0,18/73,14.71%,USP35;CAPN3;UCHL1;USP8;OTULIN;USP12;CASP1;CTSS;LGMN;USP28;USP25;OTULINL;USP36;USP5;CTSF;USP9Y;PDIA3;ATG4C
prerank,hexosaminidase activity (GO:0015929),0.5874910272302989,1.426924965987905,0.07984790874524715,0.8252091838028347,1.0,3/12,9.35%,HEXB;HEXA;HEXD
prerank,acylglycerol lipase activity (GO:0047372),0.5859337923235314,1.4244903353576823,0.0875,0.8089094376212588,1.0,4/11,16.11%,ABHD12;ABHD15;ABHD6;LIPE
prerank,actinin binding (GO:0042805),-0.46033753470825634,-1.4212990291095529,0.0730593607305936,0.3191297073598327,1.0,8/21,15.51%,PDLIM5;PPARG;KCNN2;CACNA1C;PKD2;RARA;PDLIM4;DAG1
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.5115102582246833,-1.4156102286268064,0.07888631090487239,0.3193711158311138,1.0,4/16,1.57%,PTPRG;PTPRD;PTPRN2;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.5115102582246833,-1.4156102286268064,0.07888631090487239,0.3193711158311138,1.0,4/16,1.57%,PTPRG;PTPRD;PTPRN2;PTPRT
prerank,tRNA binding (GO:0000049),0.42280633780428295,1.4077612205702477,0.038525963149078725,0.8658505540201323,1.0,15/43,18.00%,KARS1;TRNT1;XPOT;SSB;AARS2;EIF2A;SARS2;SARS1;NSUN6;PSTK;TRMT10B;HSD17B10;DARS2;NEMF;TYW5
prerank,sodium:proton antiporter activity (GO:0015385),0.5916392566851378,1.39700441508658,0.0940959409594096,0.894996683322305,1.0,2/11,3.05%,SLC9A9;SLC9A8
prerank,deubiquitinase activity (GO:0101005),0.3618626886288952,1.389914597984103,0.036334913112164295,0.902079397930982,1.0,21/88,13.05%,USP35;UCHL5;UCHL1;USP8;OTULIN;USP12;OTUD6B;OTUD5;ZRANB1;MYSM1;JOSD2;USP28;USP25;USP19;STAMBPL1;UFD1;USP36;USP5;MINDY2;OTUB2;USP9Y
prerank,glutamate receptor binding (GO:0035254),-0.4978921269431125,-1.3882955933387855,0.0918580375782881,0.3673303352761831,1.0,5/17,8.13%,HIP1;SHISA6;SHANK3;HOMER1;SYNDIG1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.5415186566647858,1.3880726064671125,0.09411764705882353,0.8848079927037303,1.0,3/14,6.05%,CAPN3;CAPN9;CAPN5
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.562470574547745,-1.383658830850127,0.10559006211180125,0.37092280019117996,1.0,4/11,8.54%,ITPR1;TRPC5;TRPC4;TRPC3
prerank,GTPase inhibitor activity (GO:0005095),-0.5196965355774756,-1.3813587690501195,0.10482180293501048,0.3701220897592066,1.0,3/13,1.55%,IQGAP2;IQGAP1;SLIT2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.36534158691922364,1.3765893408989804,0.03745928338762215,0.9179654209106244,1.0,20/83,13.05%,USP35;UCHL5;UCHL1;USP8;OTULIN;USP12;OTUD6B;OTUD5;ZRANB1;MYSM1;JOSD2;USP28;USP25;USP19;STAMBPL1;UFD1;USP36;USP5;OTUB2;USP9Y
prerank,insulin-like growth factor binding (GO:0005520),0.5290499732917279,1.3764134586100567,0.10526315789473684,0.8922650168614823,1.0,4/15,3.66%,ITGA6;IGFBP3;IGF1R;ITGAV
prerank,lipoprotein particle binding (GO:0071813),-0.48196866461246624,-1.3748631491027916,0.09692671394799054,0.3781261589292337,1.0,7/20,9.84%,MSR1;CD36;STAB1;LDLR;PLTP;SCARF1;CDH13
prerank,potassium:proton antiporter activity (GO:0015386),0.5957402207063873,1.3734202817979086,0.10946196660482375,0.8819387746477684,1.0,2/10,3.05%,SLC9A9;SLC9A8
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.5185069982066554,-1.3703115881023167,0.10176991150442478,0.3817950350699999,1.0,3/14,18.63%,RDH10;DHRS9;RDH12
prerank,transforming growth factor beta binding (GO:0050431),0.46879574964089077,1.3645998840792015,0.10260869565217391,0.9029053420163743,1.0,4/23,3.66%,TGFBR1;TGFBR2;LTBP4;ITGAV
prerank,aspartic-type peptidase activity (GO:0070001),0.5787692787412255,1.3634775216704347,0.11610486891385768,0.8849202832889166,1.0,2/10,15.27%,CTSD;CTSE
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.40371805660123716,-1.3578094968174625,0.08584686774941995,0.4036638084428112,1.0,6/32,5.47%,KCNB2;KCNC2;KCNQ5;KCNH1;KCNA6;KCNQ3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5349314580397444,-1.3557087101119938,0.13541666666666666,0.40241579159571655,1.0,7/12,13.66%,PDE7B;PDE4B;PDE4D;PDE7A;PDE8A;PDE4A;PDE2A
prerank,metalloexopeptidase activity (GO:0008235),-0.36667294832163266,-1.354860766524867,0.05741626794258373,0.39868969809295485,1.0,21/51,25.49%,AGBL4;CPQ;MMP16;NPEPPS;AGBL1;XPNPEP3;TRHDE;ENPEP;RNPEPL1;MMP15;ANPEP;AEBP1;VASH2;MMP14;LNPEP;AGBL2;ACE;CPXM2;XPNPEP1;CPA2;PEPD
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5694000916140681,-1.3544629286013774,0.14935064935064934,0.39412148387894314,1.0,2/10,1.60%,ADARB2;GDA
prerank,receptor tyrosine kinase binding (GO:0030971),0.38244506802006784,1.3537932322878157,0.056666666666666664,0.9098148975275677,1.0,14/56,15.18%,DOCK4;BLNK;PIK3R1;GAB2;PCNA;RNF41;FIZ1;TRADD;FRS2;TOB1;PTPN1;LRP4;PITPNM1;ACP4
prerank,store-operated calcium channel activity (GO:0015279),-0.5591854610281894,-1.3533271317283275,0.12605042016806722,0.39140870787264515,1.0,4/10,8.54%,TRPC5;TRPC4;STIM2;TRPC3
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.5512722574478237,-1.3521561484765219,0.11825726141078838,0.3888338221907555,1.0,3/11,5.22%,RPS3;NEIL3;APEX2
prerank,cGMP binding (GO:0030553),-0.5488668403234019,-1.3512555764091045,0.1375,0.3853664355940072,1.0,4/11,13.66%,PDE11A;RAPGEF2;PDE10A;PDE2A
prerank,microtubule motor activity (GO:0003777),-0.37052708750872865,-1.3503576510163773,0.06175771971496437,0.38239430458698054,1.0,24/51,20.34%,KIF5C;KIF1B;DYNC1I2;KIF23;KIF26B;DNAH8;KIF22;DNAH2;KIF14;CENPE;KIF5B;DYNLRB1;KIF11;APPBP2;KIF6;KIF20A;DNAH3;KIF18B;KIF21A;KIF4A;DNAH17;KIF24;KIF3C;KIFC1
prerank,poly(A) binding (GO:0008143),-0.45862619582299347,-1.3460427509827773,0.10855949895615867,0.3868172010384006,1.0,6/21,9.08%,RBMS1;KHDRBS2;RBMS3;PABPC1;EIF4A3;ELAVL4
prerank,signaling receptor complex adaptor activity (GO:0030159),-0.39073978060112163,-1.3452287229837518,0.078125,0.3839646440997261,1.0,9/38,4.59%,MAGI2;SORBS1;LRRK2;STAP1;NCK2;IRS1;DEDD2;GRIP1;SHANK3
prerank,hyaluronic acid binding (GO:0005540),-0.5481692166662703,-1.343985687078801,0.1504237288135593,0.38191614018901393,1.0,2/10,1.40%,LYVE1;CD44
prerank,syntaxin binding (GO:0019905),-0.3500065174364954,-1.3432651628550047,0.05970149253731343,0.3786283802144961,1.0,14/61,7.84%,STXBP5L;LRRK2;NAPB;SYT1;UNC13C;SNPH;SYT10;SYNPR;STXBP5;SNAP25;CPLX2;SCFD1;DAPK1;PTPN2
prerank,phospholipase inhibitor activity (GO:0004859),-0.5450836835195877,-1.3431693038021189,0.12155963302752294,0.37438049964599984,1.0,6/10,25.44%,ANXA4;SNCA;ANXA2;ANGPTL3;ANXA1;ANXA5
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.5403091561137989,-1.3386889753476383,0.11894273127753303,0.3782954444041195,1.0,7/11,33.87%,KCNJ3;KCND3;KCNQ1;KCNE3;KCNJ8;KCNE2;KCNH2
prerank,methyl-CpG binding (GO:0008327),0.46406225983293886,1.3384701521193003,0.12142857142857143,0.9671140875782855,1.0,6/22,12.56%,ZBTB21;TET3;PRMT1;MBD1;CXXC5;ERH
prerank,omega peptidase activity (GO:0008242),0.3472610298177199,1.3304587612733594,0.045813586097946286,0.983389229059511,1.0,20/89,13.05%,USP35;UCHL5;UCHL1;USP8;OTULIN;USP12;OTUD6B;OTUD5;ZRANB1;MYSM1;JOSD2;USP28;USP25;USP19;STAMBPL1;UFD1;USP36;USP5;OTUB2;USP9Y
prerank,Wnt-activated receptor activity (GO:0042813),0.5018382371127651,1.3303581009854708,0.14365671641791045,0.9604838816786381,1.0,10/15,26.53%,LRP5;RYK;FZD2;FZD6;FZD1;TSPAN12;FZD5;FZD9;FZD3;FZD10
prerank,SH2 domain binding (GO:0042169),0.42662610522695615,1.330245842378633,0.1125,0.9389600778830068,1.0,6/31,6.29%,PAG1;ARHGAP5;BLNK;LAT2;SRC;AFAP1L2
prerank,fatty acid synthase activity (GO:0004312),-0.5431610771302594,-1.3301458798990378,0.1503267973856209,0.39039032540576735,1.0,4/10,20.37%,ELOVL7;ELOVL5;CBR4;MCAT
prerank,tropomyosin binding (GO:0005523),-0.4824693616905642,-1.327797850688567,0.1258426966292135,0.390629593331853,1.0,11/16,36.39%,TMOD3;NEBL;SMTNL2;LMOD3;LMOD1;TNNT2;TMOD4;TNNT1;TNNT3;CALD1;TMOD1
prerank,pre-mRNA binding (GO:0036002),0.43393669211405955,1.3266452854263169,0.09407665505226481,0.9354312989680266,1.0,8/28,14.26%,DDX5;U2AF2;SNRPC;CELF2;RBM24;TRA2B;U2AF1L4;SLU7
prerank,myosin II binding (GO:0045159),-0.5591867748301866,-1.323601711851327,0.1400862068965517,0.39437982535990024,1.0,4/10,8.72%,STXBP5L;GSN;STXBP5;SHROOM1
prerank,ribosomal small subunit binding (GO:0043024),0.48602209473154,1.320295994908782,0.15245009074410162,0.9466693149195241,1.0,10/17,25.79%,ABCE1;EIF4H;NME1;MTIF2;EIF1B;EIF1;DHX29;DDX3X;LARP1;CPEB2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5594982226155312,-1.320092073229319,0.14925373134328357,0.39677403346959217,1.0,6/10,12.75%,GABRA3;GABRG3;GABRG1;GABRA2;GABRG2;GABRA5
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5355996037579536,1.3188760332736886,0.16176470588235295,0.9335629486151977,1.0,8/11,34.46%,MAP4K2;MAP3K11;TCF3;DUSP19;PPEF2;TRAF6;STK38;SASH1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.47616206281359263,-1.3179724234442856,0.1447084233261339,0.3967151778054985,1.0,4/16,4.79%,CD38;MACROD2;RPS3;NEIL3
prerank,adenylate cyclase binding (GO:0008179),-0.5551531860486667,-1.3172374252322343,0.14757709251101322,0.39362229086108924,1.0,4/10,6.83%,AKAP6;ADCY2;CALM1;ADCY5
prerank,tubulin binding (GO:0015631),-0.2703011987375419,-1.3172100718428987,0.01020408163265306,0.38941150947738434,1.0,68/295,13.14%,DNM3;UNC5C;LRRK2;KIF5C;CCDC88C;AGBL4;TTLL11;HTT;REEP3;MAP1B;TPPP;MTUS2;KIF1B;MACO1;SYBU;GAS2L3;APC2;RPS3;VAPA;SGIP1;SNPH;EML5;KIF23;MAP2;MID2;TTLL7;RACGAP1;KIF26B;DNM1L;NCALD;STMN4;ARL4C;CDK5RAP2;EML1;AGBL1;RMDN3;KIF22;TOGARAM2;DNM1;TPX2;SAXO2;BIRC5;TTLL5;PRKN;KIF14;CCDC69;CENPE;NUSAP1;KIF5B;CCSAP;MTCL1;CCDC88A;DLGAP5;MAP9;PRC1;SPAG5;KIF6;TBCA;TTLL12;KIF20A;STMN2;REEP4;NEFH;IFT81;KIF18B;RAD51D;KIF21A;FAM83D
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5273734908723285,1.3095028667505224,0.14476190476190476,0.9613880957017922,1.0,5/12,9.52%,BLNK;PIK3R1;GAB2;TRADD;FRS2
prerank,potassium ion antiporter activity (GO:0022821),0.5032689127835621,1.307967542070761,0.16785714285714284,0.9488246617138705,1.0,3/15,3.27%,SLC9A9;SLC9A8;SLC24A3
prerank,leucine zipper domain binding (GO:0043522),0.564738305205276,1.306906203371366,0.15818181818181817,0.9350497875561898,1.0,2/10,4.32%,DDIT3;AATF
prerank,actin binding (GO:0003779),-0.28495766414229123,-1.305404242210903,0.03278688524590164,0.40886185944179987,1.0,44/170,18.18%,IQGAP2;EPS8;PDLIM5;DMD;MTSS1;SORBS1;LRRK2;UTRN;MAP1B;GSN;ABLIM1;SYNE2;GAS2L3;SYNE1;PHACTR2;FXYD5;NCALD;PDLIM1;MICAL3;PRKN;GIPC1;PAWR;MSRB1;FHL3;CCDC88A;SPTBN4;PHACTR1;ADCY8;ALKBH4;KLHL2;PDLIM4;MYO6;VASH2;SNCA;DAG1;TMSB10;PARVG;ITGB1;ADD2;PRKCE;HPCA;VPS16;MYRIP;EPS8L2
prerank,damaged DNA binding (GO:0003684),0.38400066083992446,1.3024315262397776,0.08089500860585198,0.9376357412713303,1.0,16/44,18.32%,PCNA;CRY2;DDB2;NBN;MPG;ERCC2;CUL4B;FANCG;APTX;DCLRE1B;RAD1;ERCC4;DCLRE1C;DCLRE1A;HMGB2;NTHL1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.499807308980575,-1.2992502377264554,0.15711252653927812,0.417160868164873,1.0,4/14,9.12%,CYBB;NCF2;KMO;CYBA
prerank,translation initiation factor activity (GO:0003743),0.40221971229396675,1.2961736260404906,0.13485113835376533,0.948688990543351,1.0,16/36,24.81%,EIF4A2;EIF4G1;EIF2B3;EIF2S1;EIF2A;EIF3K;EIF2B4;EIF2S2;EIF3D;EIF2D;EIF1B;EIF1;EIF5;EIF4G2;EIF2B2;EIF3G
prerank,epidermal growth factor receptor binding (GO:0005154),-0.41381953433020374,-1.2961276393073657,0.1320754716981132,0.4190328962894746,1.0,10/25,26.31%,HIP1;LINGO1;ERBB4;CCDC88A;FER;FAM83B;ATXN2;SNX2;CNOT9;PLSCR1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4908375029498517,1.2947640330491972,0.16308243727598568,0.9378217480939404,1.0,7/15,15.73%,PI4KB;PIK3CG;ATM;PIK3C3;PIK3CD;PIK3CB;PIK3R3
prerank,galactosyltransferase activity (GO:0008378),-0.52519508653737,-1.294695452547953,0.1738241308793456,0.417739905375184,1.0,4/11,17.28%,B4GALT5;B4GALT6;B4GALT2;B4GALT7
prerank,aminopeptidase activity (GO:0004177),-0.4151879845088685,-1.2930346945709927,0.11547344110854503,0.4169553063014121,1.0,8/26,9.99%,MMP16;NPEPPS;XPNPEP3;TRHDE;ENPEP;RNPEPL1;MMP15;ANPEP
prerank,retinoid binding (GO:0005501),-0.42299438589331806,-1.2917380651126593,0.1258426966292135,0.415550963988306,1.0,10/22,25.03%,RARA;RBP4;ABCA4;CYP26C1;RBP1;CRABP1;UGT1A7;UGT1A4;UGT1A8;UGT1A1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.523569191052021,1.2912681094582106,0.1713221601489758,0.9369108826767107,1.0,5/11,18.08%,SLC25A42;SLC25A25;LRRC8A;SLC17A9;SLC19A1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.5328933484583807,-1.2911051207942799,0.16875,0.41266459136389344,1.0,3/10,9.12%,CYBB;NCF2;CYBA
prerank,anion transmembrane transporter activity (GO:0008509),0.5161160021198106,1.2887347321025047,0.15555555555555556,0.9314119413665547,1.0,2/12,8.71%,SLCO2B1;SLC22A6
prerank,hormone activity (GO:0005179),0.3664571493892419,1.280351121777048,0.10362694300518134,0.9535338578103354,1.0,18/54,26.26%,NPY;HCRT;GNRH1;PPY;EDN3;EDN2;INHA;METRN;NPFF;VIP;NMB;AGT;PENK;PTHLH;CCL25;NPPC;CHGB;AMH
prerank,carboxy-lyase activity (GO:0016831),0.44259138858000135,1.2773321235650386,0.16333938294010888,0.9507958040083601,1.0,7/23,12.62%,PPCDC;CSAD;GAD1;PISD;FAHD1;BCKDHA;UROD
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3570372256035417,1.2757845861066637,0.12664473684210525,0.9414922801056752,1.0,22/57,27.09%,NDUFB2;NDUFB8;NDUFB10;COX7A2L;COX8A;NDUFS4;NDUFS3;NDUFB3;COX5A;NDUFA13;CYB561A3;CYB561D2;NDUFS5;NDUFV3;NDUFV2;NDUFA9;COX6B1;NDUFC2;COX6A2;NDUFV1;NDUFB4;UQCRC1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.41405258734301326,-1.2752333051384248,0.15192743764172337,0.4419329085330906,1.0,9/22,22.61%,HCN1;SCN2A;SCN3A;PKD2;HCN2;SCN9A;CACNA1G;SCN1A;HCN4
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.43078364214960096,1.2742947600109567,0.14210526315789473,0.9323588763441754,1.0,9/24,19.09%,CAMKK1;MKNK1;CAMK1D;PTK2B;EEF2K;PHKG2;CAMK1;CAMK1G;PHKA2
prerank,snoRNA binding (GO:0030515),0.4121355135264971,1.273818963473867,0.14821428571428572,0.9191732695116811,1.0,10/30,21.40%,UTP6;TBL3;NOP14;IMP4;NHP2;ISG20;WDR3;NOP56;NUDT16;BYSL
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.50266984549214,1.2732574984106457,0.17586206896551723,0.906103476254469,1.0,5/13,14.90%,HSD3B2;DDT;ECI1;ECH1;IDI1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.4842848391660315,1.2713410397007938,0.18363636363636363,0.8998779605275464,1.0,3/15,9.13%,PLA2G4A;PLA2G4B;PLA2G5
prerank,monocarboxylic acid binding (GO:0033293),-0.4362738709729759,-1.2702728342749425,0.17467248908296942,0.4482806205167902,1.0,9/18,29.83%,NAPEPLD;RARA;CYP26C1;NR1H4;UGT1A7;UGT1A4;UGT1A8;UGT1A1;AKR1C1
prerank,histone methyltransferase binding (GO:1990226),-0.5231234599725532,-1.2694190557823766,0.19162995594713655,0.4457181841078699,1.0,7/11,25.19%,LCORL;WIZ;LCOR;CBX3;CBX1;CTNNB1;HSP90AB1
prerank,O-methyltransferase activity (GO:0008171),0.5462245596545175,1.2687433635702507,0.18864468864468864,0.8969232600119907,1.0,4/10,16.50%,COMT;ASMT;BCDIN3D;FTSJ3
prerank,NAD binding (GO:0051287),0.4163879436279601,1.2657208158085949,0.16283185840707964,0.8964362082975639,1.0,7/26,14.69%,QDPR;SIRT2;HPGD;ALDH1B1;SORD;NNT;CRYL1
prerank,protein serine/threonine kinase activity (GO:0004674),0.2791369824223051,1.262659778472153,0.030598052851182198,0.896085766943888,1.0,93/334,20.67%,TGFBR1;NUAK1;TGFBR2;BMP2K;ULK2;CAMKK1;CSNK1E;CDKL3;PIM2;MAP4K4;IRAK2;CLK1;RIPK2;RPS6KA1;PRKCA;PRKACA;CHEK2;CDK9;NEK6;CSNK2A2;CSNK2A1;ATM;MKNK1;PRKCD;MAP4K3;NEK3;CAMK1D;RPS6KA5;NEK8;ULK3;PTK2B;PDPK1;NRBP1;PKN3;CLK4;VRK3;TSSK6;TSSK4;MAP3K8;ARAF;MTOR;WNK1;PRKCB;NUAK2;GRK2;TRIO;MAP4K2;TAF1;PINK1;PHKG2;MAP3K2;MAP3K11;PRKD3;NEK7;UHMK1;CDK11B;MARK2;MAP3K10;TAOK2;MAPK8;MAST3;PLK3;LATS2;AKT1;MAPK14;DYRK4;DYRK1A;STK39;PASK;MAP2K1;EIF2AK2;AURKA;CDC42BPB;ACVR2B;STK35;MASTL;ULK1;RPS6KA4;MAPK7;VRK2;ROCK2;MAP4K5;MAP3K14;CAMK1;CAMK1G;MAP3K15;MARK4;CSNK1G2;EIF2AK3;WNK3;WNK2;PRKCH;CDK8
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.477921357600936,-1.261456752100401,0.19027484143763213,0.45831776092498966,1.0,8/14,31.74%,SPOCK1;SPOCK3;TIMP3;BST2;COL4A3;TIMP4;RARRES1;NGF
prerank,kinase binding (GO:0019900),-0.2518711554478997,-1.2607951931605172,0.0199203187250996,0.4553087063302498,1.0,104/434,16.47%,DLG2;IQGAP1;UNC5C;FRMD5;ANK2;CNTLN;ATF2;CADPS;UTRN;SYN1;STAP1;POLA1;BICD1;EGFR;HTT;GSN;SHC3;ATG13;AP2A2;PTPN22;RND3;SNAP91;LATS1;PRKAG2;NBEA;ACSL3;RPS3;FAF1;JAK2;TAX1BP1;RPS7;USF1;CD226;DLG3;SP100;TRIP6;RACGAP1;EXOC2;CNKSR2;CCND2;GSK3B;CALM1;CDK5RAP2;BARD1;CDC42;SKAP1;SLC12A4;DNM1;TPX2;PRKN;KIF14;PDE8A;TRAP1;TNS2;AXIN1;PTPN2;IRGM;MOB1B;ACTB;SMCR8;AURKB;ABI2;BCAR1;DNAJC3;SIK1;PRC1;CACUL1;KIF11;EEF1A2;ADRA2A;BECN1;LRBA;KIF20A;SRCIN1;CSPG4;FBXO7;ARHGAP33;CEBPA;MAP3K13;NEFH;FAM83D;WWC1;CDKN2A;MAP2K6;CDKN1A;THY1;INKA2;PKD1;ERCC6L2;TRIP4;ACVRL1;TEX14;PER1;FAM83B;CDC25C;RGCC;TIAM1;LAX1;FAM83H;PPP1R12A;RCC2;VRK1;NR3C1;CD3E
prerank,nuclear receptor coactivator activity (GO:0030374),0.36656096992484527,1.260427216411407,0.1254180602006689,0.8915329418166713,1.0,17/52,18.46%,BRD8;ETS1;ELK1;TACC1;CALCOCO1;RBM14;PRKCB;CCDC62;MED4;NCOA3;ZMIZ2;ZMIZ1;CCAR1;KDM1A;RNF4;CARM1;PPRC1
prerank,chemokine receptor binding (GO:0042379),0.40213193713000195,1.2601621091096322,0.14664310954063603,0.8791725541630457,1.0,4/35,8.89%,CX3CR1;ITCH;CCL3;CXCL1
prerank,GTPase activity (GO:0003924),-0.27346093336391925,-1.2601578969419418,0.03735632183908046,0.4524360832968095,1.0,41/192,12.26%,DNM3;RIT2;LRRK2;RAB3C;GFM2;TPPP;SEPTIN9;RND3;RAB22A;GNAO1;RAB6A;GBP3;DNM1L;ATL2;RAB1B;RRAGB;RAB5C;CDC42;DNM1;GPN2;DNAJC27;RAN;GFM1;IRGM;SAR1B;RAB28;AGAP3;RAB8A;RAB3A;GBP4;RASL12;RHOT2;EEF1A2;TBCC;HBS1L;GNAI1;RERG;RHOU;GBP2;TRIM23;IFT22
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.43738360277286226,1.2594369776791468,0.16370106761565836,0.8692393278416356,1.0,8/21,11.18%,PJA2;AKAP8;PRKACA;AKAP8L;AKAP5;AKAP14;ACBD3;PRRC1
prerank,calcium ion binding (GO:0005509),-0.26006496081409386,-1.259254264355278,0.02857142857142857,0.45033278563490714,1.0,68/323,15.00%,KCNIP4;NRXN1;IQGAP1;ADGRL3;KCNIP1;ITPR1;AOAH;SPOCK1;PAM;SLIT2;MCTP2;CDH8;GSN;ANXA4;SYT1;RYR3;RYR2;ASTN2;ITSN1;RAPGEF2;ATP2A2;SPARCL1;SYT10;TPT1;S100A11;PCLO;LETM1;CALM1;CDH22;RCN3;EML1;CDH4;FBN1;PKD2;CDH7;CDH20;RET;RASGRP2;EFCAB11;MICU2;STIM2;CDH10;SLC25A24;PADI4;MMP12;CDH11;CDH13;MICU3;SRR;PLSCR4;PLSCR2;DYSF;CDHR3;TESC;MCTP1;CDH5;ENPP2;CLEC6A;CDH1;GJB2;CHP2;MELK;HSPA5;KCNIP2;S100A1;SYT3;SNCA;SLC25A12
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.513413400869595,-1.256740230064873,0.21413721413721415,0.45163632536761983,1.0,3/11,2.52%,ITPR1;RYR3;RYR2
prerank,protein kinase C binding (GO:0005080),0.3733860338965245,1.255356658318031,0.14711033274956217,0.8748648322129633,1.0,14/43,15.26%,TWF2;PRKCSH;DSP;PLEK;ITGAV;ADCY4;PRKCB;TOP2B;ADCY6;ABL1;TRPV4;HDAC5;DACT3;PICK1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.46493173218950923,1.2546897418463314,0.18629173989455183,0.8527543077374463,1.0,6/16,17.01%,ATP6V0B;ATP6V1D;ATP6V0A2;TCIRG1;ATP6V0A4;ATP6V0E2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.46493173218950923,1.2546897418463314,0.18629173989455183,0.8527543077374463,1.0,6/16,17.01%,ATP6V0B;ATP6V1D;ATP6V0A2;TCIRG1;ATP6V0A4;ATP6V0E2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.48434854832335944,-1.2536773145741265,0.1670061099796334,0.45414642247520437,1.0,6/12,24.57%,TENT5A;PAPOLA;TENT2;TUT1;PAPOLG;PAPOLB
prerank,phospholipase A2 activity (GO:0004623),0.4210091931293462,1.2532625905641679,0.15480427046263345,0.8467208586338896,1.0,6/26,9.13%,PLA2G4A;PLA2G6;PLA2G15;PLA2G4B;PLB1;PLA2G5
prerank,1-phosphatidylinositol binding (GO:0005545),-0.46500365722016157,-1.2484179176847046,0.2054176072234763,0.46102128362421974,1.0,6/15,12.43%,SNAP91;SESTD1;EEA1;SNX9;FRMPD2;EPB41
prerank,SUMO binding (GO:0032183),0.493649354126516,1.2464368619877466,0.19378427787934185,0.86390561654989,1.0,5/13,17.91%,HERC2;UBA2;USP25;SIMC1;RNF4
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.4116780812389713,-1.2454077242863217,0.18518518518518517,0.4632021846869626,1.0,6/21,30.49%,GRIK2;CHRNA4;P2RX1;CHRNB2;CHRNA9;CHRNB4
prerank,ubiquitin-specific protease binding (GO:1990381),0.45289491375521157,1.2451333488843892,0.17805755395683454,0.8575122253995853,1.0,3/19,6.44%,BAG6;SUMO1;SART3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4935560952445013,1.2450491535523251,0.19962686567164178,0.8462654266630026,1.0,5/12,18.08%,SLC25A42;SLC25A25;LRRC8A;SLC17A9;SLC19A1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3654697224071386,1.2406635193909452,0.1423670668953688,0.8531224084451093,1.0,12/46,11.17%,HEXB;LARGE1;MGAT4A;B3GNT2;POMGNT1;HEXA;GCNT2;RFNG;B3GNT4;MGAT2;MGAT5;MGAT1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.4189323839379165,1.2351490434875079,0.17555938037865748,0.8651784367864565,1.0,9/25,16.80%,ADAP2;DAPP1;GAB2;ARAP3;PLEK;PLEKHA4;HIP1R;AKT1;FCHSD2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.37260663768808505,-1.2326959647492075,0.16461916461916462,0.48613986698339895,1.0,13/31,24.00%,KCNK10;HCN1;SLC12A8;SLC12A4;PKD2;SLC12A5;TMEM38B;TMEM38A;SLC12A1;KCNK5;AQP1;SLC12A3;KCNA1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5133461078158504,-1.2265807976666958,0.221505376344086,0.495076025757729,1.0,6/10,33.06%,SLC10A6;SLC6A1;SLC6A12;SLC6A13;SLC10A2;SLC10A1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.2850424740310495,1.2263798790809972,0.08064516129032258,0.8911854341555906,1.0,32/188,11.49%,ETV5;BASP1;SMAD3;ETS1;NFE2L2;MEF2C;DDIT3;FLI1;KMT2D;KLF11;CRY2;EGR1;PAX6;ELK1;ATMIN;ZNF568;TFE3;CREB3L2;CALCOCO1;FOXK2;ATF3;BCOR;DHX9;EGR2;JUN;BRCA1;SOX17;CHD3;NFYA;PAX2;RUNX1;SMARCA2
prerank,clathrin adaptor activity (GO:0035615),-0.4499562100642206,-1.2205369340496843,0.2,0.5045248475919484,1.0,6/15,15.23%,DAB2;HIP1;AP2A2;AP1M1;AP2B1;AP1G2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.40529118800928843,-1.2185454014689672,0.18403547671840353,0.5047993200357017,1.0,8/23,15.96%,PLCB1;CCR1;PLCH1;CHRM3;PLCB4;PLCH2;CCL5;PLCD1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.45960929811649937,1.2143629874920385,0.22413793103448276,0.9320884052685062,1.0,4/16,8.82%,SLC7A8;SLC25A42;SLC22A2;SLC29A4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3483115457577093,1.211213985954832,0.1832191780821918,0.9343526182558485,1.0,16/54,18.72%,TGM2;SIRT2;HDAC10;SUDS3;ACER3;VNN1;ACER2;ASAH1;AMDHD2;NIT2;PM20D2;HDAC5;NTAN1;ASPG;HDAC8;MIER3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5138325456584114,1.2093429779378195,0.21787709497206703,0.9309155911661047,1.0,2/10,4.91%,CFLAR;CASP1
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4464745272627647,-1.2058878111363234,0.23387096774193547,0.5287716412856583,1.0,6/14,22.21%,SLC25A30;SLC26A7;SLC26A2;SLC26A8;SLC26A3;SLC26A4
prerank,lipoprotein particle receptor binding (GO:0070325),0.3985801495770077,1.2042067647871875,0.20825852782764812,0.9407274994764535,1.0,7/27,13.28%,PICALM;AP2A1;CLU;MESD;LRP1;ANKRA2;LDLRAP1
prerank,microtubule binding (GO:0008017),-0.25714040942501004,-1.2027790711285444,0.06930693069306931,0.5314462623042681,1.0,53/222,13.14%,DNM3;LRRK2;KIF5C;CCDC88C;REEP3;MAP1B;TPPP;MTUS2;KIF1B;MACO1;SYBU;GAS2L3;APC2;RPS3;VAPA;SGIP1;SNPH;EML5;KIF23;MAP2;MID2;RACGAP1;KIF26B;DNM1L;CDK5RAP2;EML1;RMDN3;KIF22;TOGARAM2;DNM1;TPX2;SAXO2;BIRC5;KIF14;CCDC69;CENPE;NUSAP1;KIF5B;CCSAP;MTCL1;CCDC88A;DLGAP5;MAP9;PRC1;SPAG5;KIF6;KIF20A;REEP4;CLIP4;NEFH;KIF18B;KIF21A;FAM83D
prerank,kinase activity (GO:0016301),0.3073365313276668,1.2023182396832792,0.15016501650165018,0.9371426018197909,1.0,31/109,16.73%,PI4KB;MAP4K4;LYN;CSNK2A1;PIK3CG;DGKK;CCL3;PANK4;PIK3C3;DGKD;PGK1;GK5;CHKB;CKB;PIK3CD;MTOR;PSTK;PIK3CB;CERK;PANK2;TAF1;PINK1;PRKD3;ABL1;PAPSS1;FCSK;NADK2;AKT1;STK39;DCAKD;MASTL
prerank,DNA binding (GO:0003677),0.25074627253878906,1.2018010406472261,0.03647798742138365,0.9279226696588325,1.0,193/694,24.39%,IKZF1;ARID3B;ETV5;MLXIPL;SMAD3;DNMT3A;DENND4A;ETS1;QRICH1;NFE2L2;GTF3C2;DDIT3;CEBPZ;LYL1;SOX8;FLI1;COLEC11;POLR2H;SRRT;PCNA;PPARD;FOXE1;KMT2D;CDK9;RAD51AP2;CRY2;DDB2;MAU2;FAM111A;NKX2-8;NBN;ZCCHC3;EGR1;POLR2D;ERF;PAX6;REXO4;CUX1;MEIS3;CTC1;CHD8;WDR48;ZBTB21;MPG;SLPI;MYCL;CALCOCO1;RNF138;MLX;TAF12;JRK;FOXK2;ZBTB18;RAD51B;KDM5B;ILF2;TAF6L;PCBP2;MCM2;TAF6;ERCC2;DHX9;SWSAP1;THAP1;CGAS;EGR2;SLTM;ZMYND11;NLRP3;CUL4B;CHTF18;JUN;BRCA1;CNBP;TAL2;ALX4;ZBTB32;TIGD3;POU4F1;KLF12;CHD3;PATZ1;HMGN1;MEF2A;NR2F1;MBD1;C1D;CXXC5;E2F2;NUP35;SMARCA5;FANCG;NFYA;PAX2;APTX;IMPDH1;SMARCA2;TBX6;LIN9;DCLRE1B;SSBP1;TAF1;TARDBP;GTF3C6;EXO1;ARNT;RAD1;ERCC4;RLF;BLM;CEBPG;DCLRE1C;TERF1;ABL1;TAF4;HP1BP3;ZNF3;SAFB;PRDM2;ZNF292;CSRNP2;PROX1;SPTY2D1;POU2F2;TCF7L1;TCF3;RNF11;IRF3;POLG2;DNASE2;AIM2;NABP1;POU2F1;GATA3;RNF4;DCLRE1A;HMGB2;RFC1;CUX2;ARID1A;NTHL1;FBH1;KHDRBS1;IRF2;TOP3A;E2F3;MCM3;NR1H2;PALB2;REPIN1;TSG101;XRCC6;PARP4;PRDM9;TSNAX;SAP30L;KDM5A;TSN;MAPT;TOPORS;GZF1;MCMDC2;ZNF513;PLAGL2;DDX3X;DNTTIP1;IRX1;ZC3H12A;HDGF;RPA3;TFAP4;RC3H2;ZFPL1;SMARCA4;SAFB2;ZBTB6;GLYR1;KDM2B;PARK7;HDGFL2;SCRT1;RTF2;MBD6;TP53;SYCP2;SPRTN;YY1;MTERF2;RAD23B;RAD51C;OTP;SOX9;HNRNPA1
prerank,metal ion binding (GO:0046872),-0.23817658957364687,-1.2017834550172883,0.021367521367521368,0.5289275364323407,1.0,96/477,15.00%,KCNIP4;NRXN1;IQGAP1;ADGRL3;KCNIP1;ITPR1;LRRK2;AOAH;SPOCK1;NLRC4;PAM;SLIT2;MCTP2;CDH8;GSN;ANXA4;TPPP;ADCY2;PAPOLA;SYT1;RYR3;RYR2;GSS;ASTN2;ITSN1;ERN1;LATS1;RAPGEF2;TOP2A;PPA1;ATP2A2;SPARCL1;ACVR1C;APOE;SIK3;STK26;SYT10;TPT1;S100A11;PCLO;LETM1;CALM1;CDH22;RCN3;EML1;CDH4;FBN1;PKD2;CDH7;CDH20;RET;HMGCLL1;RAN;POSTN;RASGRP2;EFCAB11;YDJC;MICU2;STIM2;CDH10;CDC42BPA;SLC25A24;NLK;PADI4;MMP12;SIK1;CDH11;CDH13;NUDT3;GNAI1;MICU3;SRR;PLSCR4;PLSCR2;DYSF;CDHR3;TESC;MCTP1;CDH5;ENPP2;GEN1;CLEC6A;CDH1;FIGNL1;PDE2A;GJB2;CHP2;CDC42BPG;MELK;HSPA5;KCNIP2;EYA2;S100A1;SYT3;SNCA;SLC25A12
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.4907918958236748,1.2006068469674425,0.22882882882882882,0.9214772300563014,1.0,2/12,3.05%,SLC9A9;SLC9A8
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.32236487725469065,-1.199807744644501,0.14824120603015076,0.5288363021921726,1.0,21/49,28.25%,MCTP2;ANXA4;SYT1;SYT10;PCLO;CPNE8;CPNE4;DYSF;MCTP1;SYT3;ANXA2;CPNE2;CPNE6;DOC2B;ANXA1;SYT5;ANXA8;ANXA5;C2CD5;SYT8;PLA2G4C
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4960061240674946,1.199161830470877,0.24080882352941177,0.9164287663897934,1.0,8/11,32.64%,CTC1;TERF1;HNRNPA2B1;HNRNPA1;STN1;RPA1;TERF2;RPA2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.41071428319423525,-1.1983600012403424,0.20823798627002288,0.528083421089686,1.0,6/19,13.88%,NRG3;GRM5;ERCC6;ERBB3;EFNA5;CCL5
prerank,ubiquitin-protein transferase activity (GO:0004842),0.26489870622167455,1.1960329764734312,0.08062418725617686,0.9189053215533909,1.0,91/346,21.94%,HERC2;RNF38;RNF216;TRIM69;SEL1L;PJA2;FBXO22;SMURF1;ITCH;TRIM11;TRIM5;DDB2;NEURL1B;NEURL3;UBA7;FBXO24;TRAF5;RNF41;TRIM36;UBE2H;RNF138;TRIM44;RFFL;HLTF;BCOR;RNF141;AKTIP;MAEA;TRIM72;TRIM45;CDC34;CUL4B;DTX4;ZFP91;ASB4;BRCA1;RNF31;RNF8;RNF103;BFAR;MSL2;RNF20;RNF166;AREL1;MYLIP;RNF25;DTX1;MIB2;TAF1;UHRF2;RNFT2;TRIM62;UBE2U;RNF187;ZNRF3;FBXO21;WWP2;UBE3A;RNF144B;DTX3;MKRN3;RNF7;FBXL22;ANKRD39;RNF11;UBE2A;FBXO11;PELI2;ANAPC11;XIAP;DTX3L;TNFAIP1;RNF4;RNF214;TRIM47;STUB1;CUL4A;MGRN1;RNF2;RNF123;RNF182;TRAF7;TRIM3;UBE2T;TOPORS;SYVN1;RNF121;RNF34;UBE2R2;GID4;RFWD3
prerank,motor activity (GO:0003774),-0.31361739062134664,-1.1893585375702946,0.1828978622327791,0.5449526314015036,1.0,20/60,13.35%,KIF5C;KIF1B;DYNC1I2;KIF23;KIF26B;DNAH8;KIF22;DNAH2;KIF14;CENPE;KIF5B;DYNLRB1;KIF11;APPBP2;KIF6;KIF20A;DNAH3;KIF18B;KIF21A;MYO6
prerank,peptide hormone receptor binding (GO:0051428),0.4940983873899205,1.1866836301948873,0.25321100917431194,0.9483935179396787,1.0,3/11,22.83%,GNRH1;VIP;PTHLH
prerank,nucleotidyltransferase activity (GO:0016779),-0.4094531641400597,-1.1857270607756167,0.22747747747747749,0.549073622847265,1.0,7/19,19.48%,CRPPA;PAPSS2;TUT4;TENT2;TUT1;DNTT;TERT
prerank,cytochrome-c oxidase activity (GO:0004129),0.4552762279940444,1.1801266859845594,0.24029574861367836,0.9654808403771993,1.0,8/15,35.18%,COX7A2L;COX8A;COX5A;COX6B1;COX6A2;COX6A1;CYB5A;COX10
prerank,cadherin binding (GO:0045296),-0.24166673436238928,-1.1793952183326077,0.05204460966542751,0.5601064708805126,1.0,48/315,8.63%,CTNND2;AHNAK;PDLIM5;ANK3;CTNNA2;CTNNA3;IQGAP1;SPTBN1;CTNNA1;PTPRT;CDH8;EGFR;DIAPH3;SEPTIN9;CTTN;SLK;TRPC4;LRRFIP1;TMOD3;PRDX1;VAPA;YWHAE;EHD1;PUF60;FXYD5;RPS2;AFDN;S100A11;CDH22;PDLIM1;RPL7A;CAST;STXBP6;TBC1D2;RTN4;CDH4;CDH7;CDH20;CNN2;GIPC1;RAN;BAG3;PKP4;EIF3E;SPTBN2;SNX9;KIF5B;CDH10
prerank,RNA polymerase binding (GO:0070063),0.4295247202738575,1.177954726473652,0.24285714285714285,0.9635692269472612,1.0,5/18,10.33%,BIN1;PHRF1;DHX9;BRCA1;PABPN1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.4949178808021328,1.1718983336755568,0.2669172932330827,0.979622652140718,1.0,2/10,8.71%,SLCO2B1;SLC22A6
prerank,ATPase activator activity (GO:0001671),-0.39660166886984627,-1.1718452832316366,0.24532710280373832,0.5745901039469584,1.0,6/20,14.00%,DNAJA2;DNAJC15;DNAJB4;ATP1B3;TOR1AIP2;MYBPC3
prerank,retinoid X receptor binding (GO:0046965),-0.4684289959743043,-1.170403376647697,0.2702702702702703,0.5733897341028895,1.0,4/11,9.66%,PPARG;NR4A2;RARG;NSD1
prerank,ribonuclease activity (GO:0004540),0.3324061247088026,1.1691484745537533,0.20473773265651438,0.9814287692580753,1.0,20/56,23.84%,RNASE1;YBEY;INTS11;DIS3L2;PIWIL1;RCL1;KHNYN;RNASE6;ZC3H12C;EXOSC5;EXOSC10;ZC3H12B;ELAC2;EXOSC8;TSNAX;SND1;RNASEH1;ZC3H12A;EXOG;AGO1
prerank,dynactin binding (GO:0034452),-0.46434989093129886,-1.1677907113040777,0.2665198237885463,0.5750911702235258,1.0,3/12,5.28%,BICD1;HTT;GSK3B
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4213590921526711,1.166235615525556,0.26654740608228983,0.9831850673081269,1.0,5/18,19.50%,PIK3R1;SOCS6;AGAP2;PIK3R3;WDR81
prerank,P-type ion transporter activity (GO:0015662),-0.46413873149240736,-1.165740665933565,0.2689075630252101,0.5759414719665554,1.0,4/12,10.17%,ATP2B1;ATP2A2;ATP7A;ATP2A3
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.49370759938178344,1.1648404219060624,0.2672727272727273,0.9785025575088465,1.0,6/10,15.73%,PIK3CG;ATM;PIK3C3;PIK3CD;PIK3CB;PIK3R3
prerank,small GTPase binding (GO:0031267),0.2758436092098307,1.1639629136741598,0.15372670807453417,0.9717811454586749,1.0,43/169,17.94%,DOCK4;SRGAP2;FGD2;HPS4;ARHGEF2;KIF3B;PICALM;MLPH;TBC1D7;CDC42EP2;CYRIB;GOLGA5;RANBP2;PIH1D2;RNF41;RHOH;ARFIP2;RAB3GAP1;SGSM2;RAB3GAP2;PPP6R1;GOLGA4;AKAP13;RABGGTA;RAB34;FGD3;CYFIP1;MYO5B;IFT20;OPTN;GCC1;TBC1D30;SOD1;PDE6D;CIB1;RABGEF1;KIF3A;TNPO3;ULK1;GGA3;SGSM3;TNFAIP1;LZTR1
prerank,single-stranded DNA binding (GO:0003697),0.30056074742050043,1.1620123567170204,0.2144026186579378,0.9696172770474324,1.0,37/93,26.60%,POLR2H;RAD51AP2;CRY2;FAM111A;POLR2D;REXO4;CTC1;WDR48;RNF138;RAD51B;PCBP2;MCM2;DHX9;SWSAP1;POU4F1;NUP35;APTX;SSBP1;ERCC4;BLM;NABP1;HMGB2;FBH1;TOP3A;MCM3;MAPT;MCMDC2;RPA3;PARK7;SPRTN;RAD23B;HNRNPA1;STN1;LONP1;RADX;MCM6;TDP1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3540766627433818,-1.1615080958292505,0.23261390887290168,0.5816269780275645,1.0,12/27,28.28%,DCUN1D2;ZMYM2;RNF19A;PRKN;DCUN1D3;RNF19B;RNF217;SIAH2;ANKIB1;PPARA;UBE3D;RNF14
prerank,estrogen receptor binding (GO:0030331),0.3660503271403486,1.1614331617708633,0.23734729493891799,0.9616717694836754,1.0,10/32,15.79%,PRMT2;CNOT1;PHB2;TACC1;PADI2;PPID;MMS19;CCDC62;DDX54;NRIP1
prerank,retinoic acid binding (GO:0001972),-0.45568031583608715,-1.1608936581498084,0.2740899357601713,0.5785594931054245,1.0,6/12,25.03%,RARA;CYP26C1;UGT1A7;UGT1A4;UGT1A8;UGT1A1
prerank,cation channel activity (GO:0005261),-0.2806786503626205,-1.1606786598957313,0.14722222222222223,0.5744448181766625,1.0,27/94,20.49%,KCNK10;CACNA1E;UNC80;HCN1;MCU;TMEM63C;TRPC5;RYR2;NALCN;TRPM3;SLC24A2;PKD2;ANO6;TRPC3;CALHM6;TMEM38B;TMEM38A;PANX1;ANO10;PKD1;ANXA2;ASIC3;TRPV6;TRPV3;PIEZO2;KCNK5;TRPM7
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.40428362853092586,1.1597188360585922,0.26334519572953735,0.9585254325941955,1.0,6/22,13.28%,PICALM;AP2A1;CLU;MESD;ANKRA2;LDLRAP1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.41505176363051177,1.1594746649034284,0.2705061082024433,0.9496859526284714,1.0,4/20,9.77%,SENP2;OTUD5;USP25;OTULINL
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3658811481399303,-1.1588546929953123,0.24839400428265523,0.5744831467376224,1.0,12/27,24.97%,SLC25A30;GET3;SLC26A7;XPR1;SLC26A2;SLC22A8;SLC26A8;SLC26A3;SLC4A1;SLC26A4;SLC5A5;ANO1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.4792708654253798,1.1577367006226698,0.28073394495412846,0.9470970000724811,1.0,4/11,21.77%,CFLAR;CASP1;PYCARD;CASP12
prerank,receptor antagonist activity (GO:0048019),0.42689000977583524,1.156728475765925,0.2834507042253521,0.9415784882983848,1.0,6/17,24.47%,AGTR2;IL18BP;FST;DKK3;PXDN;LRPAP1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.39147296272377785,-1.1545161911324975,0.2610619469026549,0.5809415350200265,1.0,10/21,31.64%,FGF10;NPTN;FGF7;FGF9;FGF5;KL;FGF16;FGF23;KLB;FGF22
prerank,ephrin receptor binding (GO:0046875),0.4171820738094128,1.153709868660808,0.2818181818181818,0.9447362627182875,1.0,9/21,24.43%,LYN;SRC;PIK3CG;PTPN1;ABL1;EFNB1;EFNA1;EFNA3;EFNA2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3627136418564623,1.1519214639345614,0.24156305506216696,0.9334442743949917,1.0,14/34,26.62%,NDUFB2;NDUFB8;NDUFB10;NDUFS4;NDUFS3;NDUFB3;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;NDUFC2;NDUFV1;NDUFB4
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3627136418564623,1.1519214639345614,0.24156305506216696,0.9334442743949917,1.0,14/34,26.62%,NDUFB2;NDUFB8;NDUFB10;NDUFS4;NDUFS3;NDUFB3;NDUFA13;NDUFS5;NDUFV3;NDUFV2;NDUFA9;NDUFC2;NDUFV1;NDUFB4
prerank,microtubule plus-end binding (GO:0051010),0.40719964089998534,1.1489808999204967,0.2426470588235294,0.9366358612228816,1.0,6/20,22.05%,DST;NUMA1;CLIP3;MAPRE1;CLIP2;TTBK2
prerank,poly-purine tract binding (GO:0070717),-0.3623167651743009,-1.1489263673007966,0.23956043956043957,0.590409404043469,1.0,6/27,9.08%,RBMS1;KHDRBS2;RBMS3;PABPC1;EIF4A3;ELAVL4
prerank,voltage-gated calcium channel activity (GO:0005245),-0.3339163712035021,-1.1477755569638408,0.23232323232323232,0.5889449019534778,1.0,7/37,8.41%,CACNA2D3;CACNA1E;CACNG2;CACNA1C;PKD2;OPRM1;CACHD1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.31162929565497655,1.1454336643521488,0.23076923076923078,0.9418846223040043,1.0,14/70,12.61%,HEXB;LARGE1;MGAT4A;XXYLT1;B3GNT2;POMGNT1;HEXA;GCNT2;RFNG;B3GNT4;CHPF;CHPF2;B4GALNT1;GXYLT2
prerank,sulfotransferase activity (GO:0008146),0.3590940814407697,1.143316670085047,0.24686940966010734,0.9412809224850224,1.0,7/33,10.61%,CHST11;GAL3ST4;TPST2;CHST1;SULT2A1;HS3ST3A1;CHST7
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.24564411732111457,1.1411970131878288,0.11409395973154363,0.941459957208257,1.0,100/431,18.97%,TGFBR1;DNM2;TWF2;ABCD2;TUBA4A;MYO1B;RAC1;GUK1;MAP4K4;RND1;MYO1F;TRNT1;TGM2;ABCF3;UBA2;TBCK;ARL5C;PFKL;NEK6;RHOQ;MYH9;MKNK1;RHOB;MAP4K3;AARS2;RHOBTB1;TAP2;EIF4G1;CHD8;FICD;CARS2;TUBB;TUBB1;RPS6KA5;KSR1;RND2;TUBG1;RHOH;ARFIP2;RAB4A;ABCB8;DHX9;HSPA4;ABCE1;PGK1;SARS2;TSSK6;TSSK4;RRAS2;RAB39A;WNK1;PDK2;NUAK2;SMARCA5;TUBA8;GBP6;PEX6;MAP4K2;PINK1;TUBA1A;RAB35;RRAD;NMUR2;UHMK1;CDK11B;MARK2;BLM;AGAP2;PRPS1;PRPS1L1;ABL1;DIRAS2;PXK;ABCF1;LATS2;SCG5;NDUFA13;RRAGA;AKT1;RAB32;NVL;ARL3;CDC42BPB;HSPA13;DARS2;GBP5;RAB27A;MRAS;RPS6KA4;ATP5F1D;TRIB1;RAB13;NME1;ARL11;GNL1;GBP7;MAP4K5;VPS4A;P2RX5;PEX1
prerank,exonuclease activity (GO:0004527),0.3337026754627248,1.1392506130260298,0.2532588454376164,0.940053110617146,1.0,16/46,23.55%,REXO5;DXO;REXO4;REXO2;DCLRE1B;EXO1;RAD1;ISG20L2;DCLRE1C;EXOSC5;EXOSC10;ISG20;EXOSC8;RAD9A;ZC3H12A;EXOG
prerank,peptidase inhibitor activity (GO:0030414),0.3602385848404257,1.1384354146298952,0.2683333333333333,0.9351083347620097,1.0,4/33,5.05%,CST3;UCHL5;PROS1;SLPI
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.4289961531022838,1.135969433351585,0.2851782363977486,0.9363891763805555,1.0,2/16,3.00%,ALOXE3;BCO2
prerank,neurexin family protein binding (GO:0042043),-0.4743512327688395,-1.1347281753829292,0.2984189723320158,0.6165774747180454,1.0,1/10,0.13%,NLGN1
prerank,GTPase binding (GO:0051020),0.26396669366776204,1.1336844187147037,0.18597560975609756,0.9370870147512557,1.0,49/194,18.20%,DOCK4;SRGAP2;FGD2;HPS4;ARHGEF2;KIF3B;PICALM;MLPH;TBC1D7;CDC42EP2;CYRIB;GOLGA5;RANBP2;ATG14;PIH1D2;RNF41;RHOH;ARFIP2;RAB3GAP1;SGSM2;RAB3GAP2;PPP6R1;GOLGA4;AKAP13;RABGGTA;RAB34;FGD3;CYFIP1;RASIP1;MYO5B;IFT20;OPTN;GCC1;TBC1D30;SOD1;GNB2;PDE6D;CIB1;RABGEF1;KIF3A;TNPO3;IARS1;ULK1;EPRS1;GGA3;SGSM3;TNFAIP1;LZTR1;GNB1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3898363611990918,1.13312871189486,0.28,0.9307837963147427,1.0,6/22,11.69%,ATP6V0B;ATP2C1;ATP6V1D;ATP6V0A2;TCIRG1;ATP6V0A4
prerank,thioesterase binding (GO:0031996),0.4699751896220453,1.1315443518562793,0.3162878787878788,0.9283391153853146,1.0,3/11,7.42%,RAC1;TRAF5;HAUS7
prerank,neuropeptide hormone activity (GO:0005184),0.3930707884525878,1.1308595212356893,0.2851985559566787,0.9229643335499681,1.0,7/22,19.64%,NPY;HCRT;PPY;NPFF;VIP;NMB;PENK
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.3586213206347657,1.1284925204617662,0.2767402376910017,0.9246413117891471,1.0,11/32,20.02%,PHYHD1;EGLN1;PHYH;TET3;JMJD7;KDM4A;ALKBH5;KDM8;TYW5;KDM7A;KDM2A
prerank,ATP binding (GO:0005524),0.2530180577838876,1.128024377084644,0.1659634317862166,0.9183613541995451,1.0,64/266,18.97%,TGFBR1;TWF2;ABCD2;MYO1B;GUK1;MAP4K4;MYO1F;TRNT1;ABCF3;UBA2;TBCK;PFKL;NEK6;MYH9;MKNK1;MAP4K3;AARS2;TAP2;EIF4G1;CHD8;FICD;CARS2;RPS6KA5;KSR1;ABCB8;DHX9;HSPA4;ABCE1;PGK1;SARS2;TSSK6;TSSK4;WNK1;PDK2;NUAK2;SMARCA5;PEX6;MAP4K2;PINK1;UHMK1;CDK11B;MARK2;BLM;AGAP2;PRPS1;PRPS1L1;ABL1;PXK;ABCF1;LATS2;NDUFA13;AKT1;NVL;CDC42BPB;HSPA13;DARS2;RPS6KA4;ATP5F1D;TRIB1;NME1;MAP4K5;VPS4A;P2RX5;PEX1
prerank,insulin-like growth factor receptor binding (GO:0005159),0.45901567347391836,1.1271466558457455,0.29038112522686027,0.9138653807686998,1.0,4/12,17.39%,YWHAH;PIK3R1;GNAS;ARRB1
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3969593787865703,1.126658383733716,0.2825278810408922,0.9077831845875695,1.0,4/20,12.80%,SLC30A5;SLC30A10;SLC30A8;SLC39A2
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.2377698660288074,-1.1245937268554875,0.15588235294117647,0.6376779584614789,1.0,50/248,13.35%,DNM3;RIT2;LRRK2;RAB3C;GFM2;ATP2B1;TPPP;SEPTIN9;RND3;ATAD1;RAB22A;GNAO1;CLPX;RAB6A;GBP3;VWA8;DNM1L;ATL2;RAB1B;RRAGB;RAB5C;CDC42;DNM1;GPN2;TOR1A;DNAJC27;KIF14;RAN;GFM1;IRGM;SAR1B;RAB28;AGAP3;RAB8A;RAB3A;GBP4;RASL12;RHOT2;EEF1A2;TBCC;HBS1L;GNAI1;RERG;RHOU;GBP2;TRIM23;IFT22;KIF18B;GNB5;MYO6
prerank,kinase activator activity (GO:0019209),0.3581015067940271,1.124590607979758,0.2773972602739726,0.9082664623444652,1.0,8/30,13.19%,FGF13;STRADA;GPRC5A;RPTOR;NCKAP1L;WNK1;MARK2;AGAP2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.47188202228542664,1.1243900843555878,0.3204633204633205,0.9013368957968847,1.0,4/11,17.78%,SLC5A11;SLC5A3;SLC23A2;SLC23A1
prerank,PDZ domain binding (GO:0030165),-0.2969128948990093,-1.124028436977729,0.2459396751740139,0.63446276255015,1.0,10/61,7.17%,NLGN1;GRID2;CCDC88C;GRIA1;ATP2B1;PLEKHA1;RAPGEF2;KIDINS220;PRKN;KIF14
prerank,receptor ligand activity (GO:0048018),0.2572597026416556,1.1203805383327365,0.1994261119081779,0.9090324864069818,1.0,42/245,15.99%,IL18;GREM1;SLURP1;SEMA3B;OSGIN2;SEMA4C;ARTN;CCL3;NPY;SEMA4G;TNFSF13B;VEGFB;WNT2B;GNRH1;PDGFB;SHH;PPY;EDN3;WNT10B;CNTF;AMBN;LEFTY1;EDN2;GDNF;IL12B;SEMA3G;CTF1;CXCL1;INHA;JAG2;WNT7B;CSPG5;IL33;OSGIN1;METRN;SEMA4D;IL34;CSF1;VIP;GPNMB;NMB;OSM
prerank,snRNA binding (GO:0017069),0.33525602972507484,1.1199970384380211,0.2869718309859155,0.9031176803854387,1.0,7/42,6.67%,SNRNP70;SNRPA;CDK9;SNRPC;COIL;SART3;SNRPA1
prerank,exopeptidase activity (GO:0008238),-0.30507090219037686,-1.119462426444146,0.2661498708010336,0.6415799753762529,1.0,9/50,9.99%,DPP6;DPP10;DPP4;NPEPPS;MME;XPNPEP3;TRHDE;ENPEP;ANPEP
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.43313932156883095,1.1181667022564443,0.315018315018315,0.9022257074164342,1.0,6/14,18.42%,QDPR;CRYM;ALDH4A1;MTHFD1;PYCR2;PYCR1
prerank,steroid hydroxylase activity (GO:0008395),0.4173835522874587,1.117910530419677,0.30864197530864196,0.8958659923164314,1.0,5/16,18.56%,CH25H;CYP46A1;CYP7B1;CYP2R1;CYP2A6
prerank,pentosyltransferase activity (GO:0016763),0.3423987560498929,1.1178901604253264,0.2862190812720848,0.8888000608534697,1.0,6/36,8.40%,LARGE1;QTRT1;SIRT2;ART4;PNP;UPP1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.3963990764525137,1.1157003461536021,0.28401360544217685,0.8899158314407181,1.0,5/20,9.06%,LPCAT2;DGAT1;PLA2G15;MOGAT1;MOGAT2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4259964187091605,1.114344487878146,0.29853479853479853,0.8877565733427062,1.0,8/15,28.37%,KMT2D;CXXC1;SETD4;PRDM9;SETD3;KMT2B;WDR5;KMT2A
prerank,translation elongation factor activity (GO:0003746),-0.4232917832899439,-1.112913022200215,0.30752688172043013,0.6535603038978134,1.0,5/14,13.86%,GFM2;GFM1;EEF1A2;EIF5AL1;EIF5A
prerank,adrenergic receptor binding (GO:0031690),-0.39639593693566194,-1.1128060638837358,0.31756756756756754,0.6491273694910764,1.0,5/16,10.43%,MAGI2;PDE4D;RAPGEF2;ARRDC3;ADRA2A
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.4453245953326934,1.1124074806276074,0.2885662431941924,0.8879374635513071,1.0,6/12,15.73%,PIK3CG;ATM;PIK3C3;PIK3CD;PIK3CB;PIK3R3
prerank,metal ion:proton antiporter activity (GO:0051139),0.44613368274645615,1.111681274118088,0.32065217391304346,0.8838847785934161,1.0,2/13,3.05%,SLC9A9;SLC9A8
prerank,NF-kappaB binding (GO:0051059),-0.35776988247365094,-1.1108461638511045,0.29772727272727273,0.6495344054482317,1.0,10/24,23.09%,ANXA4;FAF1;GSK3B;NFKBIA;TAF4B;CDKN2A;NPM1;FOXP3;CDK5RAP3;HDAC1
prerank,alanine transmembrane transporter activity (GO:0022858),0.45122301134007736,1.1102447031677734,0.32015065913371,0.8823147723748653,1.0,2/12,2.43%,SLC7A8;SLC36A1
prerank,GABA receptor binding (GO:0050811),0.45930513276765905,1.1083009547122296,0.33457943925233646,0.8825849524311291,1.0,4/11,14.25%,TRAK1;AKAP5;PLCL2;GABARAPL1
prerank,protease binding (GO:0002020),0.2867202096786131,1.1059923924838702,0.26373626373626374,0.884741779979362,1.0,19/99,15.21%,BIN1;BAG6;CST3;SUMO1;CFLAR;CRADD;RIPK2;ITGAV;UBC;RFFL;SART3;NFRKB;BFAR;ADAMTS4;SERPINE1;PINK1;INSL3;PYCARD;ANXA9
prerank,calcium channel activity (GO:0005262),-0.2760498724373064,-1.1050697455202183,0.24641833810888253,0.6599882693347354,1.0,14/84,8.54%,CACNA2D3;CACNA1E;MCU;TRPC5;RYR2;TRPC4;SLC24A2;CACNG2;CACNA1C;PKD2;OPRM1;STIM2;CACHD1;TRPC3
prerank,ubiquitin protein ligase binding (GO:0031625),0.24608582379037494,1.1001075615212064,0.24246575342465754,0.8988919978640278,1.0,62/254,21.35%,BAG6;SMAD3;HERC2;SUMO1;SMAD7;FHIT;UCHL1;ARRB2;SKI;SNCAIP;PRKACA;CHEK2;NEK6;TRAF5;CLU;TUBB;RPS27A;UBC;MID1;RFFL;HLTF;PCBP2;ARRDC1;USP25;EGR2;CUL4B;ASB4;JUN;BRCA1;CKB;RNF31;PATZ1;RNF8;RNF20;DTX1;LAPTM4B;AUP1;ANKRA2;PINK1;FZD6;KDM4A;GABARAPL1;TMBIM6;LRPPRC;BAG4;RRAGA;UBE2A;DET1;TRIB1;ARRB1;SPOPL;STUB1;CUL4A;TSG101;SLF2;SYT11;UBE2T;TNFRSF14;TNK2;UBXN7;DBT;RNF34
prerank,protein kinase binding (GO:0019901),-0.21722432410012563,-1.1001053131913903,0.12133891213389121,0.6685983538871881,1.0,128/479,20.69%,PDLIM5;NEDD9;IQGAP1;UNC5C;FRMD5;ANK2;CNTLN;BANK1;ATF2;CADPS;GRM5;GRK5;UTRN;SYN1;STAP1;POLA1;BICD1;SHC3;IRS1;ATG13;RYR2;AP2A2;RND3;SNAP91;PKIA;LATS1;PRKAG2;NBEA;ACSL3;TOP2A;RPS3;FAF1;JAK2;RPS7;USF1;CD226;RACGAP1;EXOC2;CNKSR2;CCND2;GSK3B;CALM1;CDK5RAP2;CDC42;SKAP1;SLC12A4;DNM1;HINT1;TPX2;PRKN;KIF14;TRAP1;MAPKAPK5;SIRT1;AXIN1;PTPN2;IRGM;ACTB;SMCR8;DUSP10;BCAR1;CCDC88A;DNAJC3;SIK1;PRC1;CACUL1;RARA;KIF11;EEF1A2;ADRA2A;BECN1;LRBA;KIF20A;SRCIN1;CSPG4;FBXO7;ARHGAP33;MAP3K13;CDH5;NEFH;DUSP16;FAM83D;KCNQ1;CDKN2A;MAP2K6;CDKN1A;THY1;INKA2;PKD1;ERCC6L2;TRIP4;ACVRL1;DACT2;TEX14;FAM83B;CDC25C;RGCC;LAX1;FAM83H;PPP1R12A;RCC2;VRK1;NR3C1;CD3E;ITGB1;ADD2;TFRC;NPM1;CCNB1;SPDYA;GSTP1;DUSP2;IRAK3;SMAD1;MSN;CKS2;DOK7;PIH1D1;TPRKB;RPS6;CAMK2N2;RPS19;PTPRK;CDK5RAP3;EPHA4;ACE;CD247;NOX4
prerank,protein heterodimerization activity (GO:0046982),-0.2443155434018789,-1.1000654794252342,0.2310126582278481,0.6640027178916629,1.0,32/178,11.60%,HIP1;KCNB2;TENM3;CYBB;ADRA1A;EXT1;NPAS3;TENM2;TOP2A;GABBR2;VAPA;YWHAE;USF1;TAF7;MIGA1;NR4A2;BARD1;SDCBP;PSMF1;UBA3;RAN;MICU2;ERBB3;CYBA;TENM4;BAK1;ADRA2A;PPP2R1A;ADCY8;ATP1A1;FBXO7;AHR
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.33227763851430864,1.0998477465291017,0.2967032967032967,0.8930607554534435,1.0,9/34,16.65%,CNOT1;DIS3L2;REXO2;EXOSC5;EXOSC10;PAN3;ERI3;DIS3;ISG20
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.34405106230011606,1.0994072836157276,0.32372881355932204,0.8879777020865792,1.0,11/35,18.14%,CLK1;LYN;SRC;PTK2B;CSK;PKDCC;ABL1;BMX;DYRK1A;TEC;FES
prerank,AMP binding (GO:0016208),-0.43554688260212115,-1.0990730698894788,0.3538135593220339,0.6620020116201971,1.0,4/11,13.29%,MPPED2;PRKAG2;APRT;PFKP
prerank,DNA polymerase activity (GO:0034061),-0.3664980624890932,-1.0961793432813556,0.3420479302832244,0.6647697371098005,1.0,10/22,25.68%,POLA1;POLL;POLE2;POLG;POLD1;TERT;POLD3;POLH;POLQ;POLM
prerank,hydro-lyase activity (GO:0016836),0.3290000346114087,1.0916616871958928,0.2902097902097902,0.9103392730098454,1.0,9/41,15.92%,TBXAS1;ECHS1;HACD3;ACO2;FAHD2A;ECI1;ECHDC2;NAXD;HADHB
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.29299694816308186,-1.090922142950582,0.2951219512195122,0.6742562647413489,1.0,16/55,17.77%,ITPR1;MCU;TRPC5;ATP2B1;RYR2;ATP2A2;SLC24A2;PKD2;TMEM165;TRPC3;ATP2A3;PANX1;PKD1;ANXA2;TRPV6;TRPV3
prerank,sodium channel regulator activity (GO:0017080),-0.32314159365943634,-1.089391592764226,0.3185011709601874,0.6736323631640715,1.0,7/37,8.44%,FGF14;FGF12;NEDD4L;FXYD5;PTPN3;SGK2;FGF11
prerank,histone acetyltransferase binding (GO:0035035),0.37590091392291297,1.0840643433550687,0.32809773123909247,0.9311197390111644,1.0,5/21,9.92%,SIRT2;PCNA;EGR1;PAX6;MEF2A
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.44886000727770237,-1.0830530826204199,0.3592436974789916,0.6862354515940032,1.0,6/11,38.64%,PPP1R14C;PABIR1;PPP1R17;PPP1R14A;PPP1R8;PPP1R11
prerank,GTP binding (GO:0005525),0.254654736008642,1.0796745470234859,0.27105666156202146,0.9401637494850789,1.0,62/172,28.17%,DNM2;TUBA4A;RAC1;RND1;TGM2;ARL5C;RHOQ;RHOB;RHOBTB1;TUBB;TUBB1;RND2;TUBG1;RHOH;ARFIP2;RAB4A;RRAS2;RAB39A;TUBA8;GBP6;TUBA1A;RAB35;RRAD;NMUR2;AGAP2;DIRAS2;SCG5;RRAGA;RAB32;ARL3;GBP5;RAB27A;MRAS;RAB13;NME1;ARL11;GNL1;GBP7;NUDT16;TUBD1;RAC3;ARHGEF5;ARF1;NRAS;ARF4;RAB9A;RALB;TUBB3;SEPHS1;EIF2B2;RHOC;RAP2B;RAP1B;ARL6;NOA1;ANXA6;ARL8B;RANBP17;RRAS;MMAA;RAB2A;PIP4K2B
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3366894931096571,1.0792300470985867,0.3269230769230769,0.9350907083354844,1.0,5/34,2.60%,ADAP2;MYO1B;DAPP1;GAB2;ARAP3
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.24131879755134228,1.07874608325346,0.2724795640326976,0.9302219340536743,1.0,65/269,21.35%,BAG6;SMAD3;HERC2;SUMO1;SMAD7;FHIT;UCHL1;ARRB2;SKI;SNCAIP;ITCH;PRKACA;CHEK2;NEK6;TRAF5;CLU;TUBB;RPS27A;UBC;MID1;RFFL;HLTF;PCBP2;ARRDC1;USP25;EGR2;CUL4B;ASB4;JUN;BRCA1;CKB;RNF31;PATZ1;RNF8;RNF20;DTX1;LAPTM4B;AUP1;ANKRA2;PINK1;FZD6;KDM4A;GABARAPL1;TMBIM6;LRPPRC;BAG4;RRAGA;UBE2A;DET1;DTX3L;TRIB1;ARRB1;SPOPL;STUB1;CUL4A;TSG101;SLF2;SYT11;UBE2T;HGS;TNFRSF14;TNK2;UBXN7;DBT;RNF34
prerank,death receptor activity (GO:0005035),0.4437570649093595,1.07831925748159,0.362453531598513,0.9250985137475073,1.0,4/11,20.98%,TNFRSF25;EDA2R;TNFRSF19;TNFRSF14
prerank,endoribonuclease activity (GO:0004521),0.33615078157981976,1.0776556441553098,0.3587521663778163,0.9209910187563678,1.0,13/32,23.84%,YBEY;INTS11;PIWIL1;RCL1;KHNYN;ZC3H12C;ZC3H12B;RIDA;TSNAX;SND1;ZC3H12A;EXOG;AGO1
prerank,single-stranded DNA helicase activity (GO:0017116),0.3878879168003186,1.0768388697081464,0.3597122302158273,0.9175997029669791,1.0,4/19,7.43%,RFC2;MCM2;DHX9;CHTF18
prerank,androgen receptor binding (GO:0050681),0.3651586940567488,1.0765896753712143,0.3392226148409894,0.912124419990365,1.0,5/25,10.51%,PRMT2;DDX5;TGFB1I1;KDM3A;PRKCB
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3518754661429607,1.076311957616015,0.3486394557823129,0.9067246581582558,1.0,9/27,23.17%,POLR2J;PRIMPOL;POLR2D;POLR3H;POLR1D;POLR1C;POLR2E;POLR2I;MED20
prerank,ubiquitin binding (GO:0043130),0.2934543848312424,1.0744018531149777,0.3222591362126246,0.9075648122451629,1.0,23/73,24.08%,MVB12B;SMAD3;NBR1;UCHL1;SIRT2;WDR48;USP25;CKS1B;RNF31;OTULINL;USP5;AUP1;OTUB2;VPS36;UBXN2A;GGA3;NUP62;TSG101;MARK4;UBXN7;SPRTN;UBXN1;RAD23B
prerank,histone methyltransferase activity (GO:0042054),0.3376570559765563,1.0742796411379478,0.33620689655172414,0.9018335212580938,1.0,15/32,24.09%,PRMT2;EHMT2;PRMT8;PRMT1;SETD2;PRMT6;EZH2;EED;CARM1;PRDM9;SETD7;FBL;SMYD1;KMT5A;SETDB1
prerank,ion channel inhibitor activity (GO:0008200),-0.3137010925140316,-1.0738644599676224,0.37122969837587005,0.7066629648812339,1.0,5/35,6.10%,ITPR1;KCNMB2;NEDD4L;CALM1;MCUB
prerank,iron ion binding (GO:0005506),0.3186323698792442,1.0738397137888407,0.3436426116838488,0.8973870184746474,1.0,16/48,19.13%,AGMO;FECH;EGLN1;PHYH;ISCU;ACO2;JMJD6;ABCE1;KDM3A;FDX1;CYP2R1;SCD5;TYW5;SCD;DNAJC24;KDM7A
prerank,phospholipase binding (GO:0043274),0.4276159402264853,1.0723895279877498,0.36891385767790263,0.8961547107579779,1.0,4/13,7.86%,BLNK;SRC;PDPK1;SELE
prerank,LRR domain binding (GO:0030275),0.4220669109945136,1.0676943795868659,0.3891992551210428,0.9065599026344481,1.0,3/14,4.32%,DDIT3;POLR2J;AATF
prerank,neuropeptide receptor activity (GO:0008188),-0.3215947867132285,-1.0668140023881616,0.31277533039647576,0.7218199431352056,1.0,12/29,37.25%,SORCS1;OPRM1;HCRTR2;GALR1;NTSR1;GAL;NMUR1;GPR143;NPY2R;NPSR1;GPR37;SORCS3
prerank,transition metal ion binding (GO:0046914),0.23344367006427816,1.0653366677953453,0.29226736566186107,0.9090776115147391,1.0,95/397,20.61%,LARGE1;ARHGEF2;SLC30A5;SMAD3;XXYLT1;AGMO;SKI;SIRT2;PRIMPOL;HPF1;HDAC10;EGR1;POMGNT1;PLA2G15;LOXL3;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;PLSCR3;SNRPC;ATAD3A;PITRM1;MDM4;KDM5B;TET3;ISCU;ACO2;SHH;JMJD6;THAP1;GALNT1;ZMYND11;ABCE1;ACER3;SLC30A8;ZBTB32;PAPPA2;MGAT2;MT2A;TAB2;LIMS1;TIMM8B;CHD3;RNF8;MGAT5;KDM3A;DPEP1;MBD1;CXXC5;MGAT1;PTPN1;RNPEP;BAZ1B;SORD;KDM4A;GALNT3;BLM;ABL1;ZNF3;SLU7;SOD1;UBA5;IMPA1;PRDM2;RNF7;FDX1;RBSN;RNF11;ZEB1;CYP2R1;CCS;EPRS1;SCD5;TYW5;CHMP1A;SCD;CZIB;DNAJC24;KDM7A;RNF2;DUSP12;NUDT16;TRAF7;KDM2A;SAP30L;KDM5A;PCK2;IL1A;NOS1;GALNT2
prerank,nuclease activity (GO:0004518),0.29991301241371054,1.0638330019980096,0.33843537414965985,0.9084763312030171,1.0,15/52,23.55%,RNASE1;REXO5;REXO4;DIS3L2;EXO1;RNASE6;ISG20L2;DIS3;ISG20;NME1;NTHL1;SND1;RNASEH1;ZC3H12A;EXOG
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4125486044764712,1.0631339295663238,0.4117647058823529,0.9052805631663824,1.0,9/14,34.82%,NME4;CMPK1;NME6;NME1;AK8;DTYMK;AK1;AK7;CMPK2
prerank,cytokine receptor activity (GO:0004896),0.278829840191001,1.0629433053927557,0.3521594684385382,0.9000894690896972,1.0,20/83,17.93%,CX3CR1;CSF3R;IL1RL2;EBI3;IL6ST;IL12B;IL6R;IL12RB2;IL10RB;GFRA4;IL10RA;CCR5;IFNGR2;GHR;IL4R;IL1RL1;IL1R2;CSF2RA;IL7R;IL20RA
prerank,endopeptidase regulator activity (GO:0061135),0.3229468216431874,1.0627476621927814,0.358843537414966,0.8949841527422094,1.0,5/40,5.05%,CST3;UCHL5;VSIR;PROS1;SLPI
prerank,active ion transmembrane transporter activity (GO:0022853),0.3264762018237487,1.0606662366950919,0.34804753820033957,0.8964744483691466,1.0,6/37,12.97%,SLCO2B1;COX7A2L;COX8A;SLC22A6;SLC16A7;COX5A
prerank,GDP binding (GO:0019003),-0.276491725839921,-1.0586180457400398,0.3246445497630332,0.7396919405619036,1.0,15/63,19.40%,RIT2;RAB22A;RAB5C;RAN;RAB28;RAB8A;RASL12;GNAI1;RERG;TRIM23;RAB27B;NME2;RHEBL1;RAB9B;RAB5A
prerank,DNA-binding transcription factor binding (GO:0140297),0.24734432650357585,1.0569153939951514,0.32554744525547447,0.9040384546125654,1.0,38/189,15.88%,SMAD3;NFE2L2;MEF2C;DDIT3;SKI;PPARD;MTA1;NEK6;NBN;MEF2D;ELK1;NFATC1;RBL2;FIZ1;DHX9;MTDH;SIN3A;EGR2;NLRP3;JUN;TLE6;ANKRD2;MEF2A;CXXC5;CRTC1;TBX6;BBS2;TAF1;MAP3K10;DDX20;WWP2;HDAC5;PIAS3;RERE;TAL1;GTF2I;PIAS2;TCF3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.39866317446737165,1.0555644027133821,0.381651376146789,0.9031169750690138,1.0,1/15,0.04%,CX3CR1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.4465438157056517,1.055313133820859,0.3931947069943289,0.8981271611074885,1.0,3/11,10.41%,GATA2;EHMT2;SRRM2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.24359796532606467,1.0546822322184195,0.30344827586206896,0.8946685387560537,1.0,45/232,16.81%,HERC2;RNF38;RNF216;TRIM69;SMURF1;ITCH;TRIM11;TRIM5;NEURL1B;NEURL3;RNF41;RNF138;TRIM44;RFFL;HLTF;TRIM72;EGR2;DTX4;RNF8;BFAR;MSL2;RNF166;AREL1;MYLIP;RNF25;DTX1;UHRF2;RNFT2;TRIM62;RNF187;ZNRF3;WWP2;PIAS3;UBE3A;RNF144B;DTX3;MKRN3;RNF7;FBXL22;PIAS2;RNF11;PELI2;ANAPC11;XIAP;DTX3L
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.43548002293759036,-1.0527073037737391,0.4028056112224449,0.751972819172438,1.0,4/11,22.61%,HCN1;HCN2;AQP1;HCN4
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.25929234496897324,-1.0515170225222352,0.3359173126614987,0.7503292653608874,1.0,13/91,6.56%,HIP1;PLCB1;CLVS2;GSN;FRMPD4;SNAP91;SESTD1;KCNH1;SNX14;PLEKHA5;MYO1G;STXBP6;SDCBP
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.30365110873756357,1.0506608653798803,0.38078902229845624,0.9035095002440281,1.0,8/48,6.36%,CALHM2;SLC12A6;TRPV2;TRPM4;MCOLN1;TRPM2;TRPM6;ABCC9
prerank,phospholipid transfer activity (GO:0120014),0.36755611150649187,1.0503213209435387,0.4007421150278293,0.8990832380932704,1.0,8/21,24.53%,PITPNC1;CPTP;C2CD2L;PITPNM1;MTTP;PRELID2;PITPNM2;PITPNB
prerank,RNA binding (GO:0003723),0.21200965399675986,1.0490551752010602,0.2575928008998875,0.8979106197549465,1.0,377/1321,25.00%,SRRM1;SNRNP70;TLR7;UTP6;SON;FBRSL1;CCDC59;TWF2;PRPF38B;SUMO1;UBFD1;UCHL5;FAM98B;ADAT1;GDI2;CSNK1E;SECISBP2;CEBPZ;NCBP1;RBM18;WDR46;KARS1;DDX5;QKI;SNRPA;DSP;EIF4A2;POP1;TRNT1;AKAP8;FUS;SRRT;XPOT;CNOT1;AKAP8L;EMG1;SRP72;CSTF2;SSB;HNRNPDL;PNISR;MYH9;TRMT6;ZCCHC3;POLR2D;ATXN2L;HNRNPA3;STXBP1;ETF1;AARS2;RBM19;DXO;AATF;SF3B2;SF3B1;BUD23;ZRANB2;MRPS24;GANAB;REXO4;EIF4G1;TBL3;PRKRIP1;FSCN1;THUMPD1;MRPL2;MRPL37;SLPI;CCDC124;MAGOHB;MAGOH;RPS27A;UBC;U2AF2;EIF2S1;EIF2A;NSUN5;HNRNPC;SNRPC;RRBP1;RBM14;EWSR1;HLTF;MOV10;ZCCHC9;CELF2;SART3;PES1;NUP42;SNRPF;MRPL43;ILF2;SNRPA1;PCBP2;HNRNPH1;NTPCR;DHX9;RBM39;JMJD6;MTDH;MACF1;RNMT;SLTM;C1QBP;DHX38;TIAL1;ZFP36L1;JUN;BRCA1;CNBP;BOP1;SARS2;SARS1;ZFP36L2;NANOS2;PKP3;PIWIL1;PTRH1;RPUSD2;NSUN6;CHD3;DUT;KRR1;MRPL9;PRMT1;HNRNPR;DDX17;SRP9;TNPO1;SRSF5;PSTK;EIF4H;C1D;LRP1;MAP4;ANP32A;PABPN1;RPL15;USP36;SRRM2;G3BP1;ESRP1;NIP7;MRPS5;TOP3B;RPL10;APTX;RBM8A;PTPN1;TRMT10B;SSBP1;PEBP1;ZYX;TRA2B;SNUPN;CSDC2;KHNYN;TARDBP;RPP21;DCP1B;NOP14;ERH;RPS8;DDX54;RPS27L;MRPS21;CDK11B;MARK2;IMP4;ZC3H12C;HDLBP;GNL3L;ISG20L2;KCTD12;CHCHD1;PDIA3;PRPF31;LUC7L3;GSPT2;GCN1;DDX20;CCT3;LSM5;ABCF1;FARSA;NSRP1;EXOSC10;SF3A1;LRPPRC;RPS24;MYEF2;FIP1L1;EIF2S2;MRPL13;IGF2BP2;SAFB;PSMC1;BUD13;BAG4;ALYREF;ZC3H12B;CFAP20;NOM1;SHFL;MAPRE1;TRA2A;MKRN3;NELFE;SREK1;MRPS11;NVL;HNRNPUL2;R3HDM2;SLC4A1AP;SLC25A11;ALKBH5;ERI3;HADHB;HSD17B10;RSRC2;EIF2AK2;NHP2;DARS2;NEMF;LUC7L;ANXA7;FTSJ3;WDR6;BRIX1;RIDA;METTL14;DUSP11;TRMT2A;EPRS1;CCAR1;PRPF3;EIF3D;IBA57;DQX1;PDIA4;API5;KDM1A;ELAC2;MRPS28;MRPS35;ROCK2;FXR2;NME1;PCF11;NQO1;TYW5;HMGB2;FASTKD3;MTO1;DUS3L;WDR3;PPRC1;SRP14;KHDRBS1;MTIF2;ZCCHC8;EIF1B;RPL9;ZCCHC7;NOP56;METAP2;EIF1AX;EIF1;PCDH20;SBDS;EIF5;DDX43;REPIN1;UBTF;LSM7;NDUFV3;RPL39;RBMX;SNRNP40;CAPRIN1;XRCC6;TDRD7;NUDT16;TNRC6B;PDCD11;CRKL;PSMD4;MEX3A;TSNAX;RTCB;MRPL11;SND1;TSN;NANOS1;HNRNPA2B1;MAPT;SRSF9;MRPL41;MRPL27;PRRC2B;HNRNPH3;MRPL54;FAM133B;MYO18A;DHX29;RNASEH1;TFB1M;WBP4;FBL;FASTKD2;RBM38;ARF1;SNIP1;BYSL;DDX19B;TASOR;DDX39B;DDX3X;ZC3H12A;RPL28;HDGF;ACAA2;ZNFX1;LARP1;RC3H2;PTCD1;TUFM;ELAVL1;DEK;SAFB2;HNRNPUL1;DDX47;CLK3;DAZAP1;DAP3;RBPMS;MPHOSPH10;RBM34;RBM25;RPL34;PARK7;RPL31;TDRD3;EIF4G2;CCDC86;POLR1G;NGRN;DDX56;LSM8;DDX46;TRMT1L;IPO5;YY1;AGO1;NOVA2;CCDC9B;LSM14B;HNRNPLL;ELP1;XPO5;PTBP3;TES;HNRNPA1;RBM7;FKBP4;DHX30;HABP4;RRP36;FAM120A;DDX31;PCID2;EIF3G;SYF2;AIMP1;PNN;DDX49;RRP8
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.4303881188651043,1.048072223322087,0.42727272727272725,0.8958403963144072,1.0,4/12,14.82%,CASP1;APAF1;RPS27L;PYCARD
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3869858065041832,1.0477429496631172,0.4104882459312839,0.8914528074425638,1.0,8/17,24.07%,PLA2G6;THEM4;PPT1;ACAA2;ABCD1;ACOT1;ACOT8;ACOT4
prerank,poly-pyrimidine tract binding (GO:0008187),0.35642737860346946,1.0474066134404145,0.41304347826086957,0.8872935846940081,1.0,5/23,6.79%,SSB;U2AF2;HNRNPC;DIS3L2;HNRNPH1
prerank,voltage-gated chloride channel activity (GO:0005247),-0.4298089619083538,-1.0467553404660035,0.3737166324435318,0.7592798624456357,1.0,2/10,8.52%,CLCN5;ANO6
prerank,protein tyrosine kinase binding (GO:1990782),0.28128996998011396,1.0458633824658503,0.3853658536585366,0.8870279471989867,1.0,14/71,15.18%,DOCK4;BLNK;SIRPA;PCNA;RNF41;FIZ1;CEACAM1;TOB1;PTPN1;PTPN11;LRP4;TJP2;PITPNM1;ACP4
prerank,5'-3' exonuclease activity (GO:0008409),0.3923112326613468,1.0458630863204228,0.4014466546112116,0.8817480189418498,1.0,6/14,23.55%,DXO;DCLRE1B;EXO1;DCLRE1C;DCLRE1A;EXOG
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.40110435068803685,1.0432422650196458,0.38764044943820225,0.8855924458878973,1.0,3/15,15.73%,PIK3R1;SOCS6;PIK3R3
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.30537335116642667,-1.042805778687844,0.3741496598639456,0.765743394987009,1.0,10/35,17.65%,MPPED2;PDE11A;APEX2;NAPEPLD;PLCB4;GDPD1;ENPP2;FAM83B;PLCXD2;GPCPD1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.34121827940438076,1.0418049832476446,0.3826530612244898,0.8852158284648071,1.0,10/29,20.48%,NBR1;NFATC1;PRMT1;DUSP5;ABL1;MAPK14;DUSP6;MAPK7;PTPRJ;TNIP1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.4175969575925233,1.0417002183433333,0.4175627240143369,0.880430983134959,1.0,6/12,30.52%,CNOT1;PAN3;CNOT2;PARN;PNLDC1;CNOT8
prerank,leak channel activity (GO:0022840),-0.3621590832392836,-1.0408318968319545,0.3955773955773956,0.7664727661895661,1.0,8/18,28.33%,KCNK10;NALCN;PANX1;KCNK12;KCNK5;KCNK2;RHAG;KCNK7
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.2148966099925338,1.0390516158287453,0.3108935128518972,0.883809497976563,1.0,145/732,20.15%,ZFHX3;SALL1;IKZF1;ZSCAN26;MLXIPL;RREB1;SALL3;SMAD3;ZNF697;DNMT3A;BACH2;ETS1;NFE2L2;HEYL;HIVEP3;HOXD9;MEF2C;DDIT3;LYL1;SOX8;SKI;FOXJ2;UBP1;PPARD;MLXIP;FOXE1;MTA1;KLF11;ZNF83;NKX2-8;EGR1;MEF2D;PAX6;ELK1;KLF3;SKIL;ZNF568;HBP1;MEIS3;TFE3;NFATC1;ZIM3;ELK3;MYCL;CALCOCO1;MLX;GTF2IRD1;FOXK2;ATF3;ZBTB18;EGR3;ZBTB24;DHX9;THAP1;EGR2;ZNF569;FOXN3;JUN;SARS1;PKNOX1;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BHLHE22;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;POU4F1;ZNF319;KLF12;PATZ1;RXRB;MEF2A;NR2F1;PRDM1;IRF8;E2F2;ZSCAN21;NFE2L1;NRF1;NFYA;PAX2;RUNX1;MYNN;TBX6;ZNF367;TEF;ARNT;SMAD9;E4F1;CEBPG;MXI1;RELB;SP9;ZIC1;HDAC5;ZBTB48;OLIG2;SAFB;TAL1;PROX1;MXD1;NRIP1;POU2F2;ZBTB39;TCF7L1;TCF3;IRF3;ZEB1;TGIF1;STAT6;MYPOP;MAFG;ZBTB2;CCAR1;HES6;ZFP62;POU2F1;GATA3;IRF9;HMGB2;PROX2;ZBTB11;MITF;IRF2;ZNF740;ZNF260;ZKSCAN1;ZSCAN22;E2F3;NR1H2;DMTF1;RBMX;ZFP82;ZNF585B;ZNF585A;KCNIP3;MGA
prerank,hexose transmembrane transporter activity (GO:0015149),-0.41056599313385356,-1.0387770201302469,0.4026258205689278,0.7674970907990656,1.0,7/12,35.01%,SLC2A8;SLC2A2;SLC2A4;SLC5A1;SLC2A3;MFSD4A;SLC2A6
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3891908996672542,-1.0355617573592375,0.3858447488584475,0.7719719753040583,1.0,7/13,23.00%,GPAT3;AGPAT4;AGPAT1;ABHD5;AGPAT3;PNPLA3;GPAT2
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.24386381282905545,1.034507245114226,0.3808095952023988,0.8934135205798902,1.0,52/173,23.81%,ZFHX3;HEYL;HOXD9;SKI;PPARD;ZFP90;DEAF1;ERF;SKIL;ZBTB21;ELK3;MLX;GTF2IRD1;FOXK2;ATF3;ZBTB18;THAP1;JUN;OVOL2;BCL6B;ZBTB32;KLF12;PATZ1;NR2F1;PRDM1;IRF8;E4F1;MXI1;ZNF3;PRDM2;PROX1;MXD1;ZBTB39;TCF3;ZEB1;TGIF1;MYPOP;ZBTB2;GATA3;MITF;KCNIP3;ZNF692;GZF1;IRX1;ZBTB45;ZBTB6;ZBTB1;FOXP4;SCRT1;MNT;BATF3;YY1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.33359296239697384,1.0342028659160813,0.38669064748201437,0.8893617030577994,1.0,6/30,12.80%,SLC30A5;SLC30A10;SLC40A1;SLC25A37;SLC30A8;SLC39A2
prerank,double-stranded RNA binding (GO:0003725),-0.2657380395705148,-1.032931188808514,0.40463917525773196,0.7746664351193645,1.0,24/70,25.79%,ADARB2;OAS2;STAU2;LRRFIP1;VIM;DDX60;AGO4;DHX15;ZFR;STRBP;OAS3;DROSHA;TLR8;DUS2;TFRC;EIF4B;MSN;IFIH1;SIDT1;DHX33;RFTN1;OASL;HSP90AB1;ADAR
prerank,pyrophosphatase activity (GO:0016462),0.30048786912277575,1.0320314626538962,0.40559440559440557,0.8912772491333814,1.0,16/50,22.59%,ENTPD1;DXO;TRPM2;DHX9;NUDT15;PLPP1;NUDT14;DCPS;ENTPD7;BNIP2;NUDT6;ATCAY;NUDT16;DHX29;DDX3X;ENTPD6
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.21332959556516776,1.0318633688475425,0.3313106796116505,0.8867428756491613,1.0,144/731,20.15%,ZFHX3;SALL1;IKZF1;ZSCAN26;MLXIPL;RREB1;SALL3;SMAD3;ZNF697;DNMT3A;BACH2;ETS1;NFE2L2;HEYL;HIVEP3;HOXD9;MEF2C;DDIT3;LYL1;SOX8;SKI;FOXJ2;UBP1;PPARD;MLXIP;FOXE1;MTA1;KLF11;ZNF83;NKX2-8;EGR1;MEF2D;PAX6;ELK1;KLF3;SKIL;ZNF568;HBP1;MEIS3;TFE3;NFATC1;ZIM3;CREB3L2;ELK3;MYCL;CALCOCO1;MLX;GTF2IRD1;FOXK2;ATF3;ZBTB18;EGR3;ZBTB24;DHX9;THAP1;EGR2;ZNF569;JUN;SARS1;PKNOX1;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BHLHE22;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;POU4F1;ZNF319;KLF12;PATZ1;RXRB;MEF2A;NR2F1;PRDM1;IRF8;E2F2;ZSCAN21;NFE2L1;NRF1;NFYA;PAX2;RUNX1;MYNN;TBX6;ZNF367;TEF;ARNT;SMAD9;E4F1;CEBPG;MXI1;RELB;SP9;ZIC1;HDAC5;ZBTB48;OLIG2;SAFB;TAL1;PROX1;MXD1;NRIP1;POU2F2;ZBTB39;TCF7L1;TCF3;IRF3;ZEB1;TGIF1;STAT6;MYPOP;MAFG;ZBTB2;CCAR1;HES6;ZFP62;POU2F1;GATA3;IRF9;PROX2;ZBTB11;MITF;IRF2;ZNF740;ZNF260;ZKSCAN1;ZSCAN22;E2F3;NR1H2;DMTF1;RBMX;ZFP82;ZNF585B;ZNF585A;KCNIP3;MGA
prerank,channel activity (GO:0015267),-0.28842437148316463,-1.031797104304293,0.4,0.7730697717541554,1.0,11/41,22.27%,AQP4;MCUB;SLC14A1;PANX2;AQP11;PANX1;BCL2;TRPV6;TRPV3;TMEM266;AQP1
prerank,rRNA binding (GO:0019843),-0.2919706088627425,-1.030776941438579,0.3976470588235294,0.7708931212556966,1.0,14/42,20.62%,RPS3;MRPL18;TST;MRPL16;RPS14;PPAN;ERI1;MRPS7;RPS9;MDM2;RPLP0;RRS1;RPS5;CAVIN1
prerank,histone deacetylase activity (GO:0004407),0.37171039468119155,1.026422323423641,0.40850277264325324,0.8995149485660685,1.0,10/19,30.33%,SIRT2;HDAC10;SUDS3;HDAC5;HDAC8;MIER3;HDAC6;HDAC11;SIRT3;SIRT7
prerank,growth factor activity (GO:0008083),0.2777092419974546,1.0261494197060348,0.40836012861736337,0.8953453220746816,1.0,16/74,17.12%,OSGIN2;ARTN;VEGFB;PDGFB;CNTF;AMBN;GDNF;IL12B;CXCL1;INHA;JAG2;CSPG5;OSGIN1;CSF1;OSM;AGT
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.4343895644793658,1.0260843636041515,0.4280373831775701,0.8905170009381577,1.0,4/12,17.85%,CBR1;DHRS4;CRYZL1;NQO1
prerank,solute:proton symporter activity (GO:0015295),0.37502707868463137,1.0254414098672942,0.42447418738049714,0.8876575921746945,1.0,5/16,22.26%,SLC36A1;SLC15A4;SLC15A2;SLC25A3;CTNS
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.34842664485764724,-1.0246928736917944,0.40987124463519314,0.7835629860218827,1.0,9/21,25.68%,POLA1;POLL;POLE2;POLG;POLD1;POLD3;POLH;POLQ;POLM
prerank,protein kinase C activity (GO:0004697),0.40016731919883675,1.0226090802576393,0.42934782608695654,0.8920246512587661,1.0,5/14,12.85%,PRKCA;PRKCD;CCL3;PRKCB;PRKD3
prerank,mRNA binding (GO:0003729),0.23382478783570837,1.0222407144139858,0.4031339031339031,0.8883346489459728,1.0,102/249,29.09%,SNRNP70;SECISBP2;NCBP1;DDX5;QKI;CSTF2;SSB;ETF1;DXO;SF3B1;EIF4G1;SLPI;EIF2A;HNRNPC;RBM14;CELF2;PCBP2;DHX9;C1QBP;ZFP36L1;CNBP;NANOS2;PIWIL1;RBM24;HNRNPR;SRSF5;RNF20;SRRM2;G3BP1;ESRP1;RBM8A;TRA2B;CSDC2;KHNYN;TARDBP;DCP1B;ZC3H12C;HDLBP;LUC7L3;NSRP1;MYEF2;EIF2S2;MRPL13;IGF2BP2;ZC3H12B;SHFL;MRPS11;SLC4A1AP;LUC7L;RIDA;METTL14;EIF3D;FXR2;PCF11;KHDRBS1;RBMX;TYMS;TDRD7;NUDT16;NANOS1;HNRNPA2B1;BOLL;SNIP1;DDX3X;ZC3H12A;CPEB1;LARP1;RC3H2;ELAVL1;DAZAP1;RBPMS;RBM25;PARK7;EIF4G2;TP53;NOVA2;LSM14B;HNRNPLL;XPO5;PTBP3;PCBP4;YTHDF3;PARN;CPEB2;CCT5;SAMD4B;RBM4;LARP4B;ZC3H11A;THOC5;RPL7;PUM1;IREB2;CARHSP1;UNK;RPS26;DCP1A;HNRNPK;HNRNPL;RPS13;CALR;LUC7L2
prerank,transcription coactivator binding (GO:0001223),0.3683486468449312,1.0216442351910964,0.4428822495606327,0.8855287344902975,1.0,3/20,3.05%,SMAD3;PPARD;CDK9
prerank,histone demethylase activity (GO:0032452),0.34134214627934006,1.019012526067533,0.42592592592592593,0.8893981018568026,1.0,13/27,25.37%,KDM5B;JMJD6;UTY;KDM3A;KDM4A;HR;KDM1A;KDM8;KDM7A;KDM2A;KDM5A;KDM2B;PHF8
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.3477721139189109,-1.0181513538961127,0.40632054176072235,0.7979248535030714,1.0,4/20,7.75%,DLG2;CASK;AK6;AK3
prerank,chloride channel regulator activity (GO:0017081),0.398261823003936,1.0178505240116011,0.4354243542435424,0.8883752877348049,1.0,5/14,22.41%,STX1A;WNK1;WNK3;WNK2;STX8
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.41939156665881316,1.016265910679782,0.4376237623762376,0.883994398443518,1.0,5/11,26.47%,HSPH1;BAG4;GRPEL1;SIL1;BAG5
prerank,adenyl nucleotide binding (GO:0030554),0.41939156665881316,1.016265910679782,0.4376237623762376,0.883994398443518,1.0,5/11,26.47%,HSPH1;BAG4;GRPEL1;SIL1;BAG5
prerank,ubiquitin protein ligase activity (GO:0061630),0.23510625940793145,1.0157901376415908,0.4132231404958678,0.8808264634908852,1.0,58/228,23.84%,HERC2;RNF38;RNF216;TRIM69;SMURF1;ITCH;TRIM11;TRIM5;NEURL1B;NEURL3;RNF41;RNF138;TRIM44;RFFL;HLTF;TRIM72;DTX4;RNF8;BFAR;MSL2;RNF166;AREL1;MYLIP;RNF25;DTX1;UHRF2;RNFT2;TRIM62;RNF187;ZNRF3;WWP2;UBE3A;RNF144B;DTX3;MKRN3;RNF7;FBXL22;RNF11;PELI2;ANAPC11;XIAP;DTX3L;UBE4A;STUB1;MGRN1;RNF2;TRIM3;TOPORS;SYVN1;RNF121;RNF34;GID4;RFWD3;RC3H2;RING1;LTN1;ZNRF1;RNF180
prerank,magnesium ion binding (GO:0000287),-0.22890755517421504,-1.0145409038543376,0.4228571428571429,0.8035700982073036,1.0,33/135,18.88%,LRRK2;NLRC4;TPPP;ADCY2;PAPOLA;GSS;ERN1;LATS1;TOP2A;PPA1;SIK3;STK26;RAN;YDJC;CDC42BPA;NLK;SIK1;NUDT3;GNAI1;SRR;TESC;GEN1;FIGNL1;PDE2A;CDC42BPG;EYA2;SNCA;IDH2;SRPK2;MSH6;PIF1;IRAK3;NIM1K
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.30903879681851004,-1.0105789406515975,0.44110854503464203,0.8102608363395255,1.0,10/33,20.23%,SCAF8;WAC;GTF2B;CDC73;CCAR2;SMYD2;ESRRB;ZNF326;SUPT4H1;DRAP1
prerank,deoxyribonuclease activity (GO:0004536),-0.3700263949988357,-1.0101868692415352,0.42596810933940776,0.806599554889935,1.0,2/14,5.18%,RPS3;ZRANB3
prerank,hexosyltransferase activity (GO:0016758),0.2563201528774269,1.0095960999520124,0.4265402843601896,0.8956808927751395,1.0,19/101,11.74%,HEXB;LARGE1;MGAT4A;B3GNT2;DPY19L4;ALG12;POMGNT1;PIGV;HEXA;ALG6;GCNT2;RFNG;B3GNT4;FUT7;CHPF;POMT1;CHPF2;POFUT1;B4GALNT1
prerank,phosphate ion binding (GO:0042301),-0.41214459886829913,-1.008288042753857,0.42857142857142855,0.8071854672368622,1.0,6/10,29.25%,PDE2A;ADSS2;MTHFD2;CHST14;RELA;G6PC1
prerank,NAD+ binding (GO:0070403),0.40130143236116006,1.0082598911149923,0.44981412639405205,0.89555660240131,1.0,3/12,14.69%,SIRT2;HPGD;CRYL1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2723706148457175,1.007593306035542,0.43709677419354837,0.8927998954977061,1.0,20/74,17.99%,HK2;PI4KB;PIK3CG;DGKK;PANK4;PIK3C3;DGKD;GK5;CHKB;PIK3CD;PIK3CB;PANK2;XYLB;PAPSS1;FCSK;NADK2;FAM20B;DCAKD;KHK;GNE
prerank,calcium-release channel activity (GO:0015278),-0.35882212683468795,-1.0075808229334815,0.41496598639455784,0.8043401548610409,1.0,4/17,6.61%,ITPR1;RYR3;RYR2;PKD2
prerank,manganese ion binding (GO:0030145),0.29660518689682025,1.0065115591400275,0.455,0.8917106692191317,1.0,11/48,14.57%,LARGE1;XXYLT1;PRIMPOL;POMGNT1;GALNT1;MGAT2;MGAT5;MGAT1;GALNT3;ABL1;IMPA1
prerank,sialyltransferase activity (GO:0008373),-0.34482571304053145,-1.0057383837141376,0.4423963133640553,0.8049140694183525,1.0,5/20,8.35%,ST3GAL1;ST3GAL4;ST8SIA4;ST8SIA1;ST8SIA2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.41985725690731945,-1.0051867098292262,0.460352422907489,0.8016513663217891,1.0,4/10,25.61%,USP15;DNAJC2;DNAJB2;ANKRD13A
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.31169044434793564,-1.0040865429417236,0.4272930648769575,0.7999206629454748,1.0,12/28,23.34%,LRRK2;MAPK10;PAK3;MAPKAPK5;AURKB;TTK;MAP2K6;RPS6KA2;SBK2;MAP2K5;RPS6KB1;PRKCG
prerank,histone deacetylase binding (GO:0042826),0.2588839289300132,1.0033667292751096,0.45746388443017655,0.8966607183888756,1.0,17/88,14.80%,MEF2C;AKAP8;SIRT2;MTA1;AKAP8L;HDAC10;MEF2D;SUDS3;BCOR;MEF2A;PRDM1;TOP2B;ANKRA2;BRMS1L;MAPK8;HDAC5;TAL1
prerank,ribosome binding (GO:0043022),0.29757287931690496,1.0032979055280495,0.42287694974003465,0.8922439926149819,1.0,14/46,21.87%,BAG6;SRP72;GTPBP6;ETF1;EIF2S1;EIF2A;C1QBP;SHFL;SEC61A1;SBDS;MAIP1;EFL1;ZC3H12A;CPEB1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.3156625456991025,-1.0030461738205418,0.4485981308411215,0.7981134886229903,1.0,4/26,3.91%,B3GALT1;CHSY3;EXTL2;B3GALNT2
prerank,symporter activity (GO:0015293),-0.41357817341860476,-1.0030119702730864,0.4309623430962343,0.7936021552210499,1.0,4/10,22.96%,SLC28A2;MFSD2A;SLC5A6;SLC5A5
prerank,tau protein binding (GO:0048156),0.30245961822711503,1.0024376304838136,0.45293072824156305,0.8904721800170468,1.0,12/40,22.05%,BIN1;PICALM;CLU;LGMN;MARK2;TAOK2;PIN1;DYRK1A;ROCK2;STUB1;MARK4;TTBK2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.2815966412015739,1.0011743441516558,0.44,0.8898828001496498,1.0,11/60,12.31%,MERTK;TGFBR2;CSF1R;IGF1R;RYK;MET;EPHA8;AXL;DDR2;PDGFRB;MUSK
prerank,G protein-coupled receptor activity (GO:0004930),-0.21228929371165908,-1.0009385352868534,0.43934426229508194,0.7948956542260881,1.0,86/239,31.61%,ADGRB3;ADGRL3;GRM8;ADGRE5;GRM5;ADRA1A;GRM1;GPR141;GPR176;HRH1;ADGRG6;RORB;GABBR1;GABBR2;GPR35;GPR45;OPRM1;HCRTR2;GPR173;OPRD1;LGR5;GALR1;ADRA2A;GPR161;P2RY1;PTAFR;XPR1;FFAR1;LGR4;GPR171;CNR2;ADGRG5;GPR174;TSHR;LPAR4;LPAR2;FFAR4;APLNR;ADCYAP1R1;RXFP2;FPR3;ADGRL4;S1PR2;NTSR1;RRH;AVPR2;ADRA1B;MC4R;PAX8;P2RY10;FPR2;GPR83;NPR3;S1PR5;GPR15;TM2D1;PTH1R;CXCR6;GPR65;TPRA1;GPR156;GPR37L1;S1PR4;LANCL1;OXTR;ADGRG4;NMUR1;OPN1MW3;OPN1MW;OPN5;GPR151;CRHR2;OPN4;AVPR1A;BDKRB1;ADGRD1;GPR143;CYSLTR2;DRD1;LGR6;GPR12;GPR3;FPR1;TAS1R3;AGTR1;ADRA2C
prerank,single-stranded RNA binding (GO:0003727),0.29855203413978465,1.0005152035368041,0.45,0.8874705434068135,1.0,8/43,10.19%,TLR7;POLR2D;U2AF2;SNRPC;DHX9;JMJD6;CNBP;EIF4H
prerank,endodeoxyribonuclease activity (GO:0004520),-0.3336918006595234,-1.0002884452248293,0.44798301486199577,0.7922699841542766,1.0,8/20,27.36%,RPS3;ZRANB3;RBBP8;MRE11;SETMAR;FEN1;ENDOV;ERCC1
prerank,chloride channel inhibitor activity (GO:0019869),0.4221413579093706,0.996983522730861,0.4670433145009416,0.8936069280753477,1.0,5/10,22.41%,STX1A;WNK1;WNK3;WNK2;STX8
prerank,adenyl ribonucleotide binding (GO:0032559),0.22179405795912674,0.9954692321337182,0.4762569832402235,0.8935230808062982,1.0,67/291,18.97%,TGFBR1;TWF2;ABCD2;MYO1B;GUK1;MAP4K4;MYO1F;TRNT1;ABCF3;UBA2;TBCK;PFKL;NEK6;MYH9;MKNK1;MAP4K3;AARS2;TAP2;EIF4G1;CHD8;FICD;CARS2;RPS6KA5;KSR1;ABCB8;DHX9;HSPA4;ABCE1;PGK1;SARS2;TSSK6;TSSK4;WNK1;PDK2;NUAK2;SMARCA5;PEX6;MAP4K2;PINK1;UHMK1;CDK11B;MARK2;BLM;AGAP2;PRPS1;PRPS1L1;ABL1;GCLC;PXK;ABCF1;LATS2;NDUFA13;AKT1;NVL;CDC42BPB;HSPA13;DARS2;RPS6KA4;ATP5F1D;TRIB1;NME1;SLC19A1;MAP4K5;ACSS2;VPS4A;P2RX5;PEX1
prerank,adenylyltransferase activity (GO:0070566),-0.33528292817288385,-0.994999954230508,0.46794871794871795,0.8027485587134622,1.0,10/21,25.06%,GPHN;OAS2;PAPOLA;OAS3;TENT2;TUT1;COASY;PAPOLG;PAPOLB;OASL
prerank,phospholipase C activity (GO:0004629),-0.3246134132879363,-0.9947628445253984,0.4617067833698031,0.7988937898440704,1.0,8/25,15.96%,PLCB1;CCR1;PLCH1;CHRM3;PLCB4;PLCH2;CCL5;PLCD1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2044424059200539,0.9944939499703879,0.4857142857142857,0.8921096376682978,1.0,160/831,20.15%,ZFHX3;SALL1;IKZF1;ETV5;ZSCAN26;MLXIPL;RREB1;SALL3;SMAD3;ZNF697;DNMT3A;BACH2;ETS1;NFE2L2;HEYL;HIVEP3;HOXD9;MEF2C;DDIT3;LYL1;SOX8;SKI;FOXJ2;UBP1;PPARD;ZFP90;MLXIP;FOXE1;MTA1;KLF11;ZNF83;DEAF1;NKX2-8;EGR1;MEF2D;PAX6;ELK1;KLF3;SKIL;ZNF568;CUX1;HBP1;HOXB8;MEIS3;TFE3;NFATC1;ZIM3;ELK3;MYCL;RBL2;CALCOCO1;MLX;GTF2IRD1;FOXK2;ATF3;ZBTB18;EGR3;ZBTB24;DHX9;THAP1;EGR2;ZNF569;JUN;SARS1;PKNOX1;TAL2;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;FOXO6;DMRTB1;SOX17;NEUROD6;NEUROD4;UTY;TWIST2;POU4F1;HMX2;ZNF319;KLF12;PATZ1;NPAS1;RXRB;MEF2A;NR2F1;PRDM1;IRF8;E2F2;ZSCAN21;NFE2L1;NRF1;NFYA;PAX2;RUNX1;MYNN;TBX6;ZNF367;TAF1;TEF;ARNT;SMAD9;E4F1;CEBPG;MXI1;RELB;SP9;ZIC1;ZNF3;HDAC5;ZBTB48;OLIG2;SAFB;PRDM2;TAL1;ZBTB8B;PROX1;MXD1;NRIP1;POU2F2;ZBTB39;TCF7L1;TCF3;IRF3;ZEB1;TGIF1;STAT6;MYPOP;MAFG;ZBTB2;CCAR1;HES6;ZFP62;POU2F1;GATA3;IRF9;PROX2;CUX2;ZBTB11;MITF;IRF2;ZNF740;ZNF260;ZKSCAN1;ZSCAN22;E2F3;NR1H2;DMTF1;RBMX;ZFP82;BHLHA9;ZNF585B;ZNF585A;KCNIP3;MGA
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4166023800440361,0.9926960696564174,0.45454545454545453,0.8933095747460119,1.0,4/10,17.97%,DCLRE1B;EXO1;DCLRE1C;DCLRE1A
prerank,growth factor receptor binding (GO:0070851),-0.23946183213996622,-0.9919320240302962,0.45308310991957107,0.8022286292028763,1.0,24/95,21.57%,HIP1;FGF10;LINGO1;ERN1;JAK2;PDGFD;TRIP6;CD300LF;ERBB4;SDCBP;VEGFD;CCDC88A;FGF7;FGF9;FER;IL1RAP;FAM83B;FGF5;ATXN2;SNX2;TSLP;FYN;KL;NCSTN
prerank,purinergic nucleotide receptor activity (GO:0001614),0.3810449428250754,0.991802832887132,0.46617915904936014,0.8915121585182683,1.0,2/15,4.42%,P2RY12;GPR34
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.29993140507169574,0.9916562619279804,0.48408710217755446,0.8875653703287124,1.0,20/40,30.55%,DNMT3A;COMT;PRMT8;ASMT;ARMT1;CARNMT1;GAMT;SETD3;FBL;METTL8;THUMPD3;HNMT;RRP8;ICMT;METTL4;LCMT1;LRTOMT;METTL2B;METTL2A;PEMT
prerank,ion gated channel activity (GO:0022839),-0.32302070253575615,-0.9894952809826343,0.46325167037861914,0.8046560396917193,1.0,7/24,16.72%,KCNT2;TMEM63C;ANO3;ANO6;ANO5;ANO10;KCNT1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.23489426846038608,-0.9890613466039093,0.47745358090185674,0.8012991245518808,1.0,16/100,9.54%,IQGAP2;HIP1;IQGAP1;CLVS2;SESTD1;KCNH1;DENND1B;RACGAP1;PLEKHA5;MYO1G;DENND1A;GOLPH3;PLEKHA3;BTK;PLEKHB2;RUBCN
prerank,calcium:sodium antiporter activity (GO:0005432),-0.40861571258193696,-0.9889836072605475,0.48366013071895425,0.7970900643198158,1.0,3/10,4.81%,SLC8A3;SLC24A2;SLC8B1
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3310743638303314,0.988891627730558,0.47686832740213525,0.8913929130565993,1.0,8/25,24.43%,CH25H;CYP46A1;NOS2;AKR1D1;FMO5;NOS1;POR;MICAL1
prerank,diacylglycerol kinase activity (GO:0004143),-0.40320648901359046,-0.9876933114848508,0.48,0.7963733781474248,1.0,3/11,12.07%,DGKB;DGKI;DGKH
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.4035027971232916,-0.987191464657341,0.4656652360515021,0.7934288424589483,1.0,2/10,4.59%,SHISA6;SHANK3
prerank,lysine-acetylated histone binding (GO:0070577),0.35225914001459285,0.9871345229870755,0.4759259259259259,0.8881740561865601,1.0,10/20,31.04%,DPF2;TAF1;BRD9;PSME4;CARM1;BRD3;SMARCA4;KMT2A;ATAD2B;BRD7
prerank,acetylation-dependent protein binding (GO:0140033),0.35225914001459285,0.9871345229870755,0.4759259259259259,0.8881740561865601,1.0,10/20,31.04%,DPF2;TAF1;BRD9;PSME4;CARM1;BRD3;SMARCA4;KMT2A;ATAD2B;BRD7
prerank,endopeptidase activator activity (GO:0061133),-0.4106038676592113,-0.9844308692888869,0.47216494845360824,0.7966394900051744,1.0,3/10,7.99%,NLRC4;PSMD14;PSME2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.38132646692736666,-0.9833234381523124,0.470954356846473,0.7952633041659035,1.0,3/13,6.90%,ERN1;PDGFD;VEGFD
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4144476015984517,0.9792616279749187,0.4740740740740741,0.9077625901333839,1.0,6/10,31.49%,OTUD5;STAMBPL1;OTUD4;STAMBP;CYLD;TNFAIP3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.26916379897541504,0.9782573911672097,0.49755301794453505,0.9062743560162041,1.0,30/69,31.07%,LPCAT4;DGAT1;CERS3;PLA2G4A;PLA2G15;PORCN;ZDHHC5;PNPLA1;MOGAT1;MOGAT2;ZDHHC13;ZDHHC7;CERS2;ASPG;ZDHHC12;DBT;KAT6B;ELP3;SCP2;CERS4;HHAT;NMT1;ZDHHC2;ZDHHC6;AWAT2;PLA2G4E;ZDHHC8;KAT2B;EP300;NAA10
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.2709796656152327,0.9777796193034141,0.48739495798319327,0.9033831787469986,1.0,11/60,12.31%,MERTK;CSF1R;EFEMP1;IGF1R;RYK;MET;EPHA8;AXL;DDR2;PDGFRB;MUSK
prerank,four-way junction DNA binding (GO:0000400),0.36622666801658105,0.977191084574792,0.5177304964539007,0.9007322580138828,1.0,7/17,24.17%,FANCM;RAD51B;BLM;ABL1;HMGB2;YY1;RAD51C
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.2825583083100663,0.9743724340162306,0.5238095238095238,0.9051482347987396,1.0,8/53,13.12%,SLC7A8;SLC1A3;SLC7A5;SLC36A1;SLC15A4;SLC22A2;SLC17A8;SLC6A9
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.38614355483531043,-0.9728448839140487,0.4968944099378882,0.8205374495237039,1.0,4/12,16.55%,TRIM37;TRAP1;BABAM2;TRAF1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.40385300803711355,0.9718826470963973,0.5121951219512195,0.9085514314678461,1.0,6/11,24.31%,NAA11;NAA25;NAA50;NAA20;NAA40;NAA60
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.38913680120992217,-0.9710492418995926,0.49473684210526314,0.820847339643858,1.0,4/11,30.49%,CHRNA4;CHRNB2;CHRNA9;CHRNB4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.28475057976253065,-0.9691485333186913,0.5,0.8215184779497685,1.0,13/33,28.28%,DCUN1D2;RPS3;ZMYM2;RNF19A;PRKN;DCUN1D3;RNF19B;RNF217;SIAH2;ANKIB1;PPARA;UBE3D;RNF14
prerank,zinc ion binding (GO:0008270),0.21740847675320416,0.9673136850757464,0.5463215258855586,0.917863374198724,1.0,51/293,14.78%,ARHGEF2;SLC30A5;SMAD3;SKI;SIRT2;PRIMPOL;HPF1;HDAC10;EGR1;PLA2G15;MT1B;MT1A;MT1H;MT1X;MT1G;MT1M;MT1F;MT1E;SNRPC;ATAD3A;PITRM1;MDM4;KDM5B;TET3;SHH;THAP1;ZMYND11;ACER3;SLC30A8;ZBTB32;PAPPA2;MT2A;TAB2;LIMS1;TIMM8B;CHD3;RNF8;DPEP1;MBD1;CXXC5;PTPN1;RNPEP;BAZ1B;SORD;KDM4A;BLM;ZNF3;SLU7;SOD1;UBA5;PRDM2
prerank,ankyrin binding (GO:0030506),-0.3398350762988767,-0.9669948631311418,0.49551569506726456,0.8230670777314518,1.0,4/19,13.41%,SPTBN1;NRCAM;SPTBN4;CDH1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.20283983023729185,0.9667309944046655,0.5767790262172284,0.915425774051161,1.0,85/597,14.80%,ETV5;BASP1;SMAD3;BACH2;ETS1;NFE2L2;HOXD9;MEF2C;DDIT3;SOX8;FLI1;FOXJ2;UBP1;PPARD;FOXE1;KMT2D;KLF11;CRY2;NKX2-8;EGR1;MEF2D;PAX6;ELK1;ATMIN;KLF3;ZNF568;CUX1;HOXB8;MEIS3;TFE3;NFATC1;CREB3L2;ELK3;CALCOCO1;MLX;FOXK2;ATF3;BCOR;ZBTB18;EGR3;KDM5B;MCM2;DHX9;EGR2;JUN;BRCA1;PKNOX1;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;SOX17;POU4F1;HMX2;KLF12;CHD3;RXRB;NR2F1;PRDM1;IRF8;LBX1;E2F2;NFYA;PAX2;RUNX1;SMARCA2;TBX6;DPF1;ETV3;TEF;ARNT;CEBPG;ABL1;SP9;ZIC1;HDAC5;ZBTB48;OLIG2;TSPYL2;TAL1
prerank,protein tyrosine kinase activity (GO:0004713),0.24430539863820133,0.9662601958168084,0.5279106858054227,0.9126901538260144,1.0,22/108,15.85%,MERTK;CSF1R;CLK1;LYN;IGF1R;SRC;RYK;PTK2B;CSK;CAMKK2;MET;EPHA8;AXL;DDR2;PDGFRB;PKDCC;MUSK;BAZ1B;ABL1;BMX;DYRK1A;TEC
prerank,sterol binding (GO:0032934),0.2748515472941993,0.961751012894642,0.520618556701031,0.9218086440100182,1.0,20/56,31.77%,GRAMD1A;OSBPL11;OSBPL3;NPC1;NPC2;OSBPL5;TSPO;VDAC1;OSBP;SCAP;VDAC2;PTCH1;SCP2;ABCA1;ANXA6;INSIG2;ERLIN2;STARD5;ABCG1;NR1H3
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.2939505551308037,-0.9613282704561893,0.5092592592592593,0.8343002241114061,1.0,9/33,18.77%,SCAF8;WAC;GTF2B;CDC73;CCAR2;SMYD2;ESRRB;ZNF326;SUPT4H1
prerank,CXCR chemokine receptor binding (GO:0045236),0.40070276122240167,0.9577462455461134,0.5341959334565619,0.9296303116648785,1.0,2/11,8.89%,ITCH;CXCL1
prerank,DNA polymerase binding (GO:0070182),0.3451577073191899,0.9575423063966023,0.5187265917602997,0.9259138779176112,1.0,8/18,27.86%,PCNA;CDK2AP1;FANCI;POLG2;ACD;SMARCA4;LONP1;RTEL1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.4039656002200841,-0.9542206512821857,0.5173824130879345,0.8491126695004334,1.0,5/10,17.04%,SUV39H1;SETD5;PRDM16;SETDB2;SUV39H2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.3791183493307332,-0.9538318705837042,0.5286624203821656,0.8457935083105762,1.0,6/11,18.74%,ATP11A;ATP11C;ABCA4;ATP10B;ATP8B2;ATP10A
prerank,phosphatidylcholine transporter activity (GO:0008525),0.35352444113108816,0.9532091726606056,0.5231053604436229,0.9343548634901294,1.0,8/17,25.40%,PCTP;PITPNC1;PITPNM1;ABCB4;MTTP;PITPNM2;PITPNB;ABCA1
prerank,double-stranded DNA binding (GO:0003690),0.2019009373090438,0.9531452362732851,0.6121134020618557,0.9303196766467895,1.0,94/531,19.04%,ETV5;BACH2;HOXD9;MEF2C;SOX8;FLI1;FOXJ2;UBP1;PPARD;FOXE1;KLF11;RAD51AP2;MAU2;NKX2-8;ZCCHC3;EGR1;MEF2D;PAX6;ELK1;KLF3;REXO4;CUX1;HOXB8;MEIS3;TFE3;NFATC1;WDR48;ELK3;MLX;ATF3;ZBTB18;EGR3;RAD51B;KDM5B;DHX9;CGAS;EGR2;ZMYND11;JUN;PKNOX1;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;POU4F1;HMX2;KLF12;RXRB;NR2F1;MBD1;PRDM1;IRF8;LBX1;E2F2;PAX2;APTX;TBX6;DPF1;TARDBP;ETV3;TEF;ARNT;CEBPG;TERF1;ABL1;SP9;ZIC1;ZBTB48;OLIG2;SAFB;PROX1;POU2F2;TCF7L1;IRF3;POLG2;TGIF1;AIM2;MAFG;ZBTB2;HES6;GATA3;IRF9;HMGB2;CUX2;NTHL1;FBH1;IRF2;ZNF740;E2F3
prerank,actin monomer binding (GO:0003785),0.33361564324801923,0.9528391093991041,0.5185840707964602,0.9270065037719629,1.0,5/22,14.23%,TWF2;ABITRAM;MYL3;ABL1;PFN4
prerank,transcription corepressor binding (GO:0001222),-0.2945763830841683,-0.9517501260011471,0.54,0.8469313606447153,1.0,6/27,14.74%,ZBTB16;MTF2;PER2;WIZ;LCOR;PER1
prerank,MHC class I protein binding (GO:0042288),0.3824179144014964,0.9510749332792133,0.5339805825242718,0.9280144796537199,1.0,3/13,5.35%,PILRA;TAP2;TUBB
prerank,Tat protein binding (GO:0030957),-0.396145312313992,-0.9494957017784562,0.5085836909871244,0.8485980931606186,1.0,3/10,17.22%,MDFIC;ACTB;NPM1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.3468059976739301,0.949100763476432,0.522140221402214,0.9293182512541078,1.0,4/18,16.74%,RPS6KA1;CD27;DPEP1;XIAP
prerank,C-C chemokine receptor activity (GO:0016493),0.3311630243683528,0.9487447849146587,0.5368782161234992,0.9262490129422289,1.0,3/21,13.98%,CX3CR1;CCR7;CCR5
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.2894627487261985,-0.9487037129566988,0.535632183908046,0.8462964835979906,1.0,7/31,11.43%,UBE2J2;UBE2E2;UBE2W;UBE2N;UBE2K;UBE2Q2;UBE2C
prerank,nuclear import signal receptor activity (GO:0061608),0.35984801784952675,0.9485438368403052,0.5564053537284895,0.92278839614482,1.0,7/15,26.83%,TNPO1;IPO4;TNPO3;KPNA3;IPO5;IPO9;HIKESHI
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.21375527185353316,0.9482956880943318,0.6195804195804195,0.9195087989584901,1.0,35/254,13.22%,ETV5;RREB1;SMAD3;ETS1;MEF2C;DDIT3;FOXJ2;UBP1;MLXIP;NKX2-8;EGR1;ELK1;ATMIN;MEIS3;NFATC1;ELK3;FOXK2;ATF3;MDM4;EGR2;JUN;ALX4;SOX17;POU4F1;ZNF319;RXRB;MEF2A;E2F2;ZSCAN21;SMARCD3;NRF1;RUNX1;RLF;E4F1;CEBPG
prerank,Hsp90 protein binding (GO:0051879),0.2994671900813455,0.9480850541261907,0.5127737226277372,0.9159800229049423,1.0,13/33,28.01%,CSNK2A1;USP19;PPID;HDAC8;STUB1;NOD2;MAPT;TELO2;HIF1A;CHORDC1;HDAC6;PPP5C;PPEF2
prerank,mechanosensitive ion channel activity (GO:0008381),0.3903928701826974,0.948041707422571,0.53584229390681,0.9121116420961884,1.0,5/12,26.28%,TMEM63A;PIEZO1;TMEM63B;TMC6;TMC4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.34233171295882003,-0.9479232456259654,0.5233853006681515,0.8441667027891363,1.0,7/15,23.00%,GPAT3;AGPAT4;AGPAT1;ABHD5;AGPAT3;PNPLA3;GPAT2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.36157647235055007,-0.9467505100818213,0.5277777777777778,0.843049505092828,1.0,7/13,24.17%,RYR2;PKIA;GSK3B;KCNQ1;PRKAR1A;EZR;PRKAR2B
prerank,C-C chemokine binding (GO:0019957),0.324002819995505,0.945829323766354,0.5287162162162162,0.9143200416407805,1.0,1/22,0.04%,CX3CR1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.3976368689617267,0.9456307753509121,0.5283018867924528,0.9108851864795056,1.0,4/11,32.47%,SLC25A45;SLC25A20;SLC25A29;SLC25A47
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3075561030562471,-0.9442625553772968,0.5424107142857143,0.8457667944064221,1.0,12/24,35.10%,RPS7;RPL41;RPL26;RPS14;SHMT1;SYNCRIP;UTP23;MYH10;GNL3;RPL5;DHX36;FMR1
prerank,ferrous iron binding (GO:0008198),0.3309758147568418,0.9439993476699531,0.5195729537366548,0.911654624946037,1.0,4/21,6.66%,FECH;EGLN1;PHYH;ISCU
prerank,regulatory RNA binding (GO:0061980),0.2884352658084638,0.9427041609136655,0.5348432055749129,0.9112495748563254,1.0,11/38,27.12%,TLR7;DHX9;PIWIL1;HNRNPA2B1;ZC3H12A;ELAVL1;AGO1;HNRNPA1;RBM4;PUM1;TLR9
prerank,guanyl ribonucleotide binding (GO:0032561),0.2170703495578152,0.9424921596707846,0.615727002967359,0.9079679848937137,1.0,65/196,28.17%,DNM2;TUBA4A;RAC1;RND1;TGM2;ARL5C;RHOQ;RHOB;RHOBTB1;CNGB3;TUBB;TUBB1;RND2;TUBG1;RHOH;ARFIP2;RAB4A;RRAS2;RAB39A;TUBA8;GBP6;TUBA1A;RAB35;RRAD;NMUR2;AGAP2;DIRAS2;SCG5;RRAGA;RAB32;ARL3;GBP5;RAB27A;MRAS;RAB13;NME1;SLC19A1;ARL11;GNL1;GBP7;RAB8B;NUDT16;TUBD1;RAC3;ARHGEF5;ARF1;NRAS;ARF4;RAB9A;RALB;TUBB3;SEPHS1;EIF2B2;RHOC;RAP2B;RAP1B;ARL6;NOA1;ANXA6;ARL8B;RANBP17;RRAS;MMAA;RAB2A;PIP4K2B
prerank,chemorepellent activity (GO:0045499),-0.3100438077099336,-0.9421130829171227,0.532051282051282,0.8473087937241922,1.0,4/25,4.74%,NRG3;DPP4;SEMA5A;SEMA4A
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.22017589325377487,0.9402016464119514,0.5981735159817352,0.9102465063975242,1.0,45/181,18.72%,SMAD3;NFE2L2;PPARD;MTA1;ELK1;TACC1;NFATC1;RBL2;FIZ1;TAF6;DHX9;MTDH;SIN3A;EGR2;JUN;ANKRD2;MEF2A;RNF25;SMARCD3;DLL1;COMMD6;TBX6;BBS2;TAF1;ARNT;TAF4;WWP2;HDAC5;GABARAPL1;PIAS3;RERE;TAL1;GTF2I;MAPK14;NCOA3;PROX1;PIAS2;NRIP1;TCF3;COMMD7;DTX3L;HES6;KDM1A;ARID1A;MIER3
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.3838742226412739,-0.938985904720595,0.5120350109409191,0.8513846465055123,1.0,2/11,2.50%,SGMS1;SGMS2
prerank,protein homodimerization activity (GO:0042803),-0.18291882129909226,-0.9383472290560065,0.7747747747747747,0.8488175755858783,1.0,169/589,25.29%,HIP1;DPYD;ZBTB16;TENM3;LRRK2;XDH;NLRC4;KCNN2;SLIT2;PTPRT;MKLN1;DPP4;LILRB1;CPQ;ABCB7;TPPP;GSS;MME;SLK;EXT1;B2M;MTUS2;ERN1;LRRFIP1;CENPF;CRPPA;TENM2;TOP2A;NTRK2;PEX11A;SYNE1;LRP6;EEA1;USF1;CACYBP;MID2;APOE;GBP3;STK26;SLC8B1;S100A11;DNM1L;CEBPB;MIGA1;BARD1;IKZF3;XPNPEP3;JAML;XPA;ERBB4;PKD2;PSMF1;TRIM37;ZBTB7B;GGCT;TAP1;TPD52L1;NECTIN1;AXIN1;SYNDIG1;SNX9;GBP4;TENM4;MTCL1;ATG7;CCDC88A;MFF;BAK1;ADRA2A;MTMR1;SRR;ADCY8;AHR;CR2;TESC;GBP2;CEBPA;KIT;MAP3K13;GYG1;PDLIM4;GEN1;ALDH3A2;SHMT1;JCHAIN;GLA;ACHE;HMOX1;PDE2A;PECAM1;CCL5;HMGCS1;RBPMS2;INPP5F;TIMM10;NAGA;S100A1;FOXP2;SLC39A13;MVD;NACC2;DROSHA;BCL2;SRF;EXT2;GNPTG;BANF1;PPCS;WDR54;ADD2;GLDC;TFRC;NPM1;S100A10;MSH6;FOXP3;BOK;CDA;IRAK3;SETMAR;GUCY2D;MYOM3;GRHPR;TERT;MTHFD1L;ABCB9;CAT;SMIM1;KYAT1;PAXX;TMEM266;KNSTRN;SNX2;YARS2;BHLHE40;SOX6;CAV2;DSCAML1;SLC4A1;NR0B2;HSD11B1;MSH2;INHBB;GLIPR2;NPR3;BST2;CASQ2;ATP2A1;GSTZ1;FLNA;MCL1;CUBN;RBM44;CNOT9;EPHX2;RACK1;ACSL6;CD4;PTH1R;CBY1;ANO1;UGT1A7;UGT1A4;UGT1A8;UGT1A1;XPNPEP1;LHPP;HSP90AB1;NDP
prerank,cytokine activity (GO:0005125),0.23205217778877743,0.9363910984731326,0.5920852359208524,0.916902536802053,1.0,25/131,24.85%,IL18;SLURP1;CCL3;WNT2B;WNT10B;CNTF;LEFTY1;IL12B;CTF1;CXCL1;INHA;WNT7B;IL33;IL34;CSF1;OSM;CCL24;IL1A;CXCL10;CCL25;IL36G;BMP2;TGFB1;CKLF;AIMP1
prerank,transcription cis-regulatory region binding (GO:0000976),0.20197458053978068,0.9345868536260242,0.6819371727748691,0.9181692302336886,1.0,64/406,15.88%,ETV5;BASP1;RREB1;SMAD3;ETS1;NFE2L2;HOXD9;MEF2C;DDIT3;FLI1;ZFP90;MLXIP;KMT2D;KLF11;CRY2;DEAF1;EGR1;MEF2D;PAX6;ELK1;ATMIN;ZNF568;CUX1;HOXB8;TFE3;CREB3L2;ELK3;RBL2;CALCOCO1;MLX;FOXK2;ATF3;BCOR;EGR2;FOXN3;JUN;BRCA1;BARHL1;ALX4;SOX17;TWIST2;HMX2;CHD3;NPAS1;RXRB;MEF2A;E2F2;NFYA;PAX2;RUNX1;SMARCA2;ARNT;E4F1;MXI1;TAF4;ZNF3;HDAC5;ZBTB48;PRDM2;TAL1;ZBTB8B;PROX1;POU2F2;TCF3
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3750275539137983,-0.933208851124133,0.5304347826086957,0.8583460429587005,1.0,2/11,12.05%,EGFR;MAP3K13
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.25200116488685975,-0.9318559013410942,0.5746268656716418,0.8576063541001827,1.0,7/53,8.16%,DPYD;CYBB;XDH;MICAL3;SDHA;KDM1B;KMO
prerank,SH3 domain binding (GO:0017124),0.25879895811214615,0.9304313337309134,0.572347266881029,0.9259690257121959,1.0,6/62,6.29%,ELMO1;DNM2;ABI3;ARHGAP27;AKAP5;AFAP1L2
prerank,alkali metal ion binding (GO:0031420),0.36532310991295064,0.9286153984339625,0.5456140350877193,0.927089052107062,1.0,3/13,16.54%,CAPN3;IMPA1;ADPRH
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3474802294876954,-0.9278831356709146,0.5572687224669604,0.8637100543329163,1.0,4/13,10.34%,PIK3C2A;PIK3C2B;PIP5K1B;PIK3C2G
prerank,mannosyltransferase activity (GO:0000030),0.3244594186548379,0.9257528191349871,0.5726643598615917,0.9310968127146408,1.0,6/21,15.37%,DPY19L4;ALG12;PIGV;POMT1;ALG2;ALG8
prerank,gated channel activity (GO:0022836),0.3648502767107848,0.9230061144407501,0.5793226381461676,0.9343590206817278,1.0,6/14,26.28%,TMEM63A;PACC1;PIEZO1;TMEM63B;TMC6;TMC4
prerank,cation:chloride symporter activity (GO:0015377),-0.3741447581572991,-0.919241051115293,0.5386313465783664,0.8815311886101566,1.0,6/10,22.99%,SLC12A8;SLC12A4;SLC12A5;SLC12A1;SLC6A1;SLC12A3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2248522588567963,0.9183082001902221,0.6620583717357911,0.9432717830224499,1.0,25/134,18.08%,SLCO2B1;SLC7A8;SLC1A3;SLC25A42;SLC7A5;SLC36A1;SLC25A25;SLC15A4;SLC52A3;SLC22A6;SLC17A8;MPC1;SLC52A2;SLC35A1;SLC52A1;SLC16A7;SLC6A9;GJA1;LRRC8A;SLC17A9;SLC38A1;SLC35B4;SLC23A2;SLC23A1;SLC19A1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.36481434542964053,0.9158166434705125,0.5760869565217391,0.9460955604837179,1.0,4/14,14.82%,CASP1;APAF1;RPS27L;PYCARD
prerank,acetylcholine receptor activity (GO:0015464),0.3133238233432706,0.9138471492896657,0.5553571428571429,0.9474494079881866,1.0,4/22,15.21%,CHRM1;CHRNB3;CHRNA3;ANXA9
prerank,RNA polymerase II complex binding (GO:0000993),-0.28187529909468473,-0.9111776011912749,0.5901639344262295,0.8980703306587744,1.0,9/32,18.77%,SCAF8;WAC;GTF2B;CDC73;CCAR2;SMYD2;ESRRB;ZNF326;SUPT4H1
prerank,sequence-specific DNA binding (GO:0043565),0.1920051138411998,0.911123308732689,0.7980049875311721,0.9507383782965934,1.0,96/590,18.12%,ETV5;SMAD3;BACH2;NFE2L2;HOXD9;MEF2C;SOX8;FLI1;FOXJ2;UBP1;PPARD;FOXE1;KLF11;NKX2-8;EGR1;MEF2D;ERF;PAX6;ELK1;KLF3;CUX1;HOXB8;MEIS3;CTC1;TFE3;NFATC1;ZBTB21;ELK3;CALCOCO1;MLX;FOXK2;ATF3;ZBTB18;EGR3;KDM5B;TET3;THAP1;CXXC1;EGR2;SLTM;NLRP3;JUN;PKNOX1;OVOL2;GATA2;HOXA6;BCL6B;BARHL1;BHLHE22;ALX4;ZBTB32;PAX1;POU4F1;HMX2;KLF12;PRMT1;RXRB;MEF2A;NR2F1;MBD1;PRDM1;IRF8;CXXC5;LBX1;E2F2;PAX2;TBX6;TAF1;DPF1;ETV3;ERH;TEF;ARNT;CEBPG;TERF1;ABL1;SP9;ZIC1;OLIG2;SAFB;PRDM2;CSRNP2;PROX1;POU2F2;TCF7L1;TEN1;IRF3;TGIF1;MAFG;ZBTB2;HES6;KDM1A;POU2F1;GATA3;IRF9;CUX2
prerank,cation transmembrane transporter activity (GO:0008324),0.2629446934283706,0.9108840927310906,0.6067019400352733,0.9475078692954401,1.0,6/48,8.82%,SLC7A8;SLC7A5;SLC36A1;SLC15A4;SLC22A2;SLC29A4
prerank,metalloendopeptidase activity (GO:0004222),-0.22650935751960588,-0.9105522712742766,0.6062992125984252,0.8954374121616131,1.0,31/76,31.92%,MMP16;MME;ADAMTS17;THSD4;TRABD2B;ADAMTS19;ADAM33;MMP12;MMP15;ADAMTSL1;ADAMTSL5;MMP19;MMP8;PHEX;MMP14;SPG7;ADAMTSL4;ADAMTS10;ADAMTS14;ADAMTS12;ECEL1;ADAM19;MMP9;ADAMTS15;ADAMTS9;ADAMTS7;ADAMTS8;ADAMTS13;MEP1B;MMEL1;MMP13
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.3353614898780155,-0.9097824016764304,0.5960264900662252,0.8931343411317114,1.0,6/15,18.05%,SLC1A6;SLC1A5;SLC25A12;SLC25A18;SLC1A1;SLC1A4
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.39691741879914544,0.9097104985817019,0.599624060150376,0.9466761574991697,1.0,6/10,25.37%,KDM4A;KDM8;KDM7A;KDM2A;KDM2B;PHF8
prerank,nuclear receptor binding (GO:0016922),0.22780689811290766,0.9094390054620397,0.67601246105919,0.9436415874337996,1.0,25/111,18.27%,SMAD3;BRD8;PRMT2;YWHAH;DDX5;TGFB1I1;CNOT1;PHB2;TACC1;PADI2;PPID;KDM3A;PRKCB;MMS19;SMARCD3;TAF1;CCDC62;DDX54;MED4;NCOA3;PROX1;NRIP1;MED25;KDM1A;ARID1A
prerank,sulfuric ester hydrolase activity (GO:0008484),0.37691861535619153,0.9091124185353913,0.5722120658135283,0.9406941426081438,1.0,6/12,25.61%,ARSB;ARSK;ARSA;GNS;ARSI;SULF1
prerank,peptidase activator activity (GO:0016504),-0.30782606475668517,-0.9087832180362496,0.5855855855855856,0.8912507829703723,1.0,5/22,12.58%,NLRC4;PSMD14;CLPX;PSME2;MAL
prerank,mRNA 3'-UTR binding (GO:0003730),0.24198667024421225,0.908704996723305,0.6446280991735537,0.9380043768471282,1.0,32/79,27.71%,SECISBP2;DDX5;HNRNPC;CELF2;ZFP36L1;ZFP36L2;RBM24;RNF20;CPSF1;CSDC2;TARDBP;IGF2BP2;FXR2;ELAVL3;EXOSC8;HNRNPA2B1;BOLL;ZC3H12A;CPEB1;LARP1;ELAVL1;DAZAP1;TP53;PCBP4;PARN;CPEB2;CCT5;RBM4;LARP4B;PUM1;ILF3;CARHSP1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.25935309529444156,-0.9085806698968467,0.6363636363636364,0.8875457109785015,1.0,7/42,9.02%,STAP1;NCK2;SHC3;IRS1;YWHAE;PTPN3;SHF
prerank,MHC protein binding (GO:0042287),-0.3044922658152879,-0.908432266119028,0.5882352941176471,0.8837330395874647,1.0,3/20,7.51%,CD74;LILRB1;TAP1
prerank,phosphotyrosine residue binding (GO:0001784),0.2793695857835742,0.904037994264033,0.6093489148580968,0.9458941453890818,1.0,11/37,20.19%,VAV2;PIK3R1;SHB;PLCG2;PTPN11;LDLRAP1;ABL1;PIK3R3;PTPN5;SHE;CRKL
prerank,kinesin binding (GO:0019894),-0.28311442076391563,-0.9032404509205836,0.609375,0.8927649101513772,1.0,8/27,14.97%,KIF1B;TOR1A;ACTB;PRC1;NEFH;KIF18B;FAM83D;SNCA
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2693035594640595,-0.9029443205524781,0.6332518337408313,0.8892804180193937,1.0,15/35,28.65%,TBPL1;FOXP1;GTF2B;MMP12;H3-3A;NR3C1;NPM1;KLF10;PIH1D1;DRAP1;HDAC1;FOS;AGO2;RRN3;RELA
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.28685450838968385,0.9017378521936488,0.6370106761565836,0.9481845027910871,1.0,3/32,2.43%,SLC7A8;SLC7A5;SLC36A1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.24787919235745207,0.9011898181550576,0.6716417910447762,0.9458207410519842,1.0,18/72,20.87%,ADAP2;TWF2;MYO1B;FLII;PICALM;SNX18;CGAS;AVIL;PLEKHA4;RAB35;HIP1R;LDLRAP1;ANXA9;KCNJ2;GRAMD2A;KRIT1;EXOC1;SDCBP2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.32932831868428136,0.9010281103146287,0.5946902654867257,0.9424815147062051,1.0,10/17,34.82%,NME4;CMPK1;NME6;NME1;AK8;DTYMK;AK1;CLP1;AK7;CMPK2
prerank,calcium activated cation channel activity (GO:0005227),-0.3256812434359943,-0.8994868003854392,0.6058558558558559,0.8934272544550934,1.0,6/17,13.64%,KCNN2;TMEM63C;KCNMB2;ANO6;KCNMB4;ANO10
prerank,phosphatase activity (GO:0016791),-0.22517917235493218,-0.8991551384932872,0.6819338422391857,0.8900976695574723,1.0,27/73,26.18%,PLPPR4;PLPP5;PTPN22;PLPP4;HDDC2;PLPPR1;DUSP10;DUSP26;ACP5;PXYLP1;DUSP16;OCRL;ENOPH1;PLPP3;DUSP28;PLPPR3;MDP1;SACM1L;PRUNE1;ALPL;NOCT;HDHD2;BPNT2;LPIN3;EPHX2;LHPP;DUSP4
prerank,aspartic-type endopeptidase activity (GO:0004190),0.36227478680153835,0.8976825893153841,0.5942307692307692,0.9472586989216678,1.0,2/12,15.27%,SPPL2B;CTSE
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.3357206206731905,-0.8967809320595668,0.5831485587583148,0.891683242866615,1.0,5/14,17.16%,KCNJ3;KCND3;KCNQ1;KCNIP2;KCNE3
prerank,phosphatidate phosphatase activity (GO:0008195),-0.35244432842315665,-0.8951773262258199,0.6095444685466378,0.8913161738396568,1.0,6/13,17.87%,PLPPR4;PLPP5;PLPP4;PLPPR1;PLPP3;PLPPR3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.290696444518249,0.8948404260380359,0.636518771331058,0.9505626808141041,1.0,5/29,9.69%,PKIG;INCA1;SPRY2;RPTOR;INKA1
prerank,neuropeptide receptor binding (GO:0071855),0.34451677849650475,0.8939509000880513,0.5770609318996416,0.9490649127449985,1.0,2/14,7.27%,NPY;PPY
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.34813322123465285,0.893833922499597,0.6119402985074627,0.9456252245130958,1.0,3/14,12.36%,MTMR10;MTMR14;MTMR4
prerank,CARD domain binding (GO:0050700),0.3444718583914711,0.8920275902682903,0.6,0.9466311727403185,1.0,4/14,20.24%,RIPK2;CASP1;MAVS;NOD2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.36496200080257596,-0.892002018782785,0.5962343096234309,0.8950203352934027,1.0,1/10,1.64%,DPYSL5
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.2883889218447171,-0.8918198034141365,0.6013363028953229,0.8914028984141807,1.0,7/24,17.31%,SESTD1;PLEKHA5;GOLPH3;PLEKHA3;OSBPL8;CERT1;PLEKHF1
prerank,Toll-like receptor binding (GO:0035325),0.3692713788031648,0.8911555450872584,0.6077348066298343,0.9451884298913888,1.0,1/11,0.51%,UNC93B1
prerank,5'-nucleotidase activity (GO:0008253),-0.34393786373369917,-0.890534419738877,0.6008583690987125,0.8905417888810222,1.0,1/13,3.48%,NT5C3B
prerank,heme binding (GO:0020037),-0.23216458248527752,-0.8899283879448889,0.7095959595959596,0.8880016585607408,1.0,19/65,23.11%,CYBB;SDHC;GUCY1B1;JAK2;CYP2U1;FLVCR1;THAP4;PGRMC2;SDHD;HMOX1;FLVCR2;STEAP4;CYCS;CYB5B;CAT;NOX4;CYP51A1;BACH1;CYP2S1
prerank,RNA cap binding (GO:0000339),0.33845355262353294,0.8889692390049969,0.6299638989169675,0.9472416116807456,1.0,6/16,22.24%,NCBP1;CYFIP1;DCPS;SNUPN;EIF3D;LARP1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.26649406078915505,-0.8879506262784055,0.634032634032634,0.8887633258827757,1.0,7/34,11.43%,UBE2J2;UBE2E2;UBE2W;UBE2N;UBE2K;UBE2Q2;UBE2C
prerank,mRNA methyltransferase activity (GO:0008174),0.35564494516700185,0.886568929641547,0.6038394415357766,0.949606487694902,1.0,5/12,23.27%,RNMT;METTL14;TRMT61A;PCIF1;METTL8
prerank,Hsp70 protein binding (GO:0030544),-0.26886767478266416,-0.8845432807924477,0.6357615894039735,0.8926799289368973,1.0,10/31,20.59%,ERN1;RPS3;PRKN;SPN;METTL21A;SNCA;MVD;DNAJC2;TSC1;DNAJB2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.23844140705004116,0.8835012734556433,0.6903633491311216,0.9533951648976128,1.0,21/75,24.54%,HSD3B2;HPGD;CBR1;DHRS4;IMPDH1;SORD;KCNAB3;CRYL1;HADHB;HSD17B10;PTGR1;MDH1;LDHAL6B;KCNAB1;AKR1B10;RDH11;NSDHL;GLYR1;LDHA;ME2;SPR
prerank,secondary active transmembrane transporter activity (GO:0015291),0.2513227905823806,0.8805910739181397,0.6998313659359191,0.9569002503456993,1.0,4/51,3.22%,SLCO2B1;SLC7A8;SLC7A5;SLC20A2
prerank,kinase inhibitor activity (GO:0019210),-0.2670323218415197,-0.8798022310356246,0.6610978520286396,0.9000383500219143,1.0,12/33,23.22%,SH3BP5;LRP6;SMCR8;DNAJC3;SPRY4;CDKN1A;SNCA;DUS2;NPM1;CDKN1C;GMFG;SH3BP5L
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.33780379668119026,0.8766291171371907,0.6044776119402985,0.9629868277593246,1.0,3/14,6.84%,CIAO3;ISCU;ACO2
prerank,phosphatidylinositol binding (GO:0035091),0.22923107470922974,0.8762238143246245,0.7169517884914464,0.9603753396097244,1.0,29/91,23.12%,PITPNC1;ITPR2;PICALM;MYO1E;SNX22;NUMA1;C2CD2L;PIGK;APPL1;DPEP1;SNX31;PARD3B;HIP1R;SNX5;DENND1C;PITPNM1;SNX13;PASK;SCARB1;ZFYVE16;FES;PIGU;GRAMD2A;GAP43;MAPT;RNF34;ANKFY1;EXOC8;PITPNM2
prerank,protein phosphatase 1 binding (GO:0008157),0.3106860022178593,0.8754990692929183,0.6469565217391304,0.9584807946487074,1.0,2/21,2.52%,PPP1R3E;PPP1R9B
prerank,mannose binding (GO:0005537),0.34740863114940757,0.8705703934883201,0.6051660516605166,0.966682630256387,1.0,2/12,8.41%,COLEC11;LMAN1L
prerank,E-box binding (GO:0070888),-0.26244673458607964,-0.8694990615960169,0.6884422110552764,0.9201475337985906,1.0,14/34,34.04%,PPARG;CLOCK;AHR;SCX;PER1;SNAI2;BHLHE40;SCRT2;NEUROD2;NEUROG2;TCF15;SNAI1;NEUROD1;HES1
prerank,SUMO transferase activity (GO:0019789),0.33373128175715416,0.8689586405805181,0.6518518518518519,0.9666955638653003,1.0,5/16,20.86%,RANBP2;EGR2;PIAS3;PIAS2;TOPORS
prerank,solute:sodium symporter activity (GO:0015370),-0.2735484326051076,-0.8666669081539093,0.6792873051224945,0.9227843361548925,1.0,6/27,18.96%,SLC5A7;SLC4A10;SLC28A2;SLC4A8;SLC13A5;SLC5A6
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.23202944032541353,0.8662570276362092,0.7355371900826446,0.9696109308516629,1.0,8/73,9.97%,CX3CR1;HCRTR1;MC2R;RXFP3;CALCR;FSHR;LHCGR;INPP5K
prerank,peptide N-acetyltransferase activity (GO:0034212),0.36994535461462724,0.8657791797672916,0.6462715105162524,0.9671851232047992,1.0,5/10,24.31%,NAA11;NAA25;NAA50;NAA20;NAA60
prerank,endonuclease activity (GO:0004519),0.2513825939594694,0.8655545830925219,0.6878306878306878,0.964207446709473,1.0,16/49,23.84%,YBEY;INTS11;REXO4;PIWIL1;RCL1;KHNYN;ERCC4;ZC3H12C;ZC3H12B;DIS3;NTHL1;TSNAX;SND1;ZC3H12A;EXOG;AGO1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.24535566094537342,0.8647790084461997,0.7014446227929374,0.9623763074919869,1.0,15/55,24.89%,SLC7A8;SLC16A6;SLC7A5;SLC36A1;SLC16A7;SLC38A10;SLC38A1;SLC23A2;SLC23A1;SLC19A1;SLC25A10;SLC16A4;SLC38A7;SLC38A11;SLC38A6
prerank,anion:anion antiporter activity (GO:0015301),-0.2993679312300732,-0.8636815040450447,0.6528384279475983,0.9254985447153421,1.0,6/17,22.21%,SLC26A7;SLC26A2;SLC26A8;SLC26A3;SLC4A1;SLC26A4
prerank,endopeptidase inhibitor activity (GO:0004866),0.23024774857113428,0.8616663878840966,0.7278382581648523,0.9658944071555954,1.0,13/82,17.12%,BIN1;CST3;UCHL5;PROS1;SLPI;LXN;GAPDH;SERPINE1;SERPINE2;SERPINF1;SPINT2;SPINK5;AGT
prerank,3'-5' exonuclease activity (GO:0008408),0.2467887996368554,0.8613345792187208,0.6962025316455697,0.9630958129370256,1.0,9/45,16.65%,REXO4;DIS3L2;REXO2;RAD1;EXOSC5;EXOSC10;ERI3;DIS3;ISG20
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3029472672802878,0.8591729442476749,0.673721340388007,0.964382150570847,1.0,11/22,27.56%,ZFP36L1;ZFP36L2;RBM24;CPSF1;ELAVL3;EXOSC8;ZC3H12A;CPEB1;ELAVL1;CPEB2;ILF3
prerank,methyltransferase activity (GO:0008168),0.25123804996533977,0.8586415486564984,0.7048092868988391,0.9620913566391832,1.0,16/46,25.61%,BUD23;COMT;MGMT;PRMT8;PRMT1;ASMT;ARMT1;BCDIN3D;CARNMT1;FTSJ3;GAMT;NSUN3;NSUN4;FTSJ1;RRP8;NDUFAF7
prerank,cholesterol binding (GO:0015485),0.2549482289500337,0.8585057323446688,0.7196428571428571,0.9589616757698197,1.0,16/47,31.77%,GRAMD1A;OSBPL3;NPC1;NPC2;OSBPL5;TSPO;VDAC1;VDAC2;PTCH1;SCP2;ABCA1;ANXA6;ERLIN2;STARD5;ABCG1;NR1H3
prerank,poly(U) RNA binding (GO:0008266),0.30684556234945815,0.8582692043895422,0.6728280961182994,0.9560990371981428,1.0,4/20,6.79%,SSB;HNRNPC;DIS3L2;HNRNPH1
prerank,chemokine receptor activity (GO:0004950),0.29181140194521576,0.8580600865745858,0.6953528399311532,0.9531107292319585,1.0,1/24,0.04%,CX3CR1
prerank,carbohydrate kinase activity (GO:0019200),0.3565133524708994,0.85714018524619,0.6378676470588235,0.9517981385358221,1.0,5/11,23.25%,HK2;XYLB;KHK;GNE;HK3
prerank,beta-tubulin binding (GO:0048487),0.2703755828233133,0.8539508279702523,0.6903914590747331,0.9554507122535916,1.0,8/31,18.40%,FGF13;APPL1;TRPV4;GABARAPL1;VAPB;LRPPRC;UXT;EML4
prerank,neuropeptide binding (GO:0042923),-0.30278158896232554,-0.8518723517412756,0.6717724288840262,0.9477637064915415,1.0,6/18,37.59%,OPRM1;OPRD1;MC4R;NMUR1;GPR37;SORL1
prerank,phosphatidic acid binding (GO:0070300),-0.3027002137113498,-0.8510363119569917,0.6623376623376623,0.9454433350131596,1.0,3/19,4.03%,SESTD1;RAPGEF2;PLTP
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.2206088792233602,-0.8503497459061982,0.7894736842105263,0.9427277804407194,1.0,9/71,7.84%,PTPRG;PTPRD;PTPRN2;PTPRT;PTPN22;PTPN12;PTPN3;TNS2;PTPN2
prerank,RNA stem-loop binding (GO:0035613),0.3509857583628928,0.8495609476839743,0.6535008976660682,0.9618977614950388,1.0,5/12,22.27%,DHX9;EPRS1;DDX3X;ZC3H12A;RC3H2
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.2631167665922162,-0.8481736739359307,0.7006960556844548,0.9433757009765911,1.0,10/27,24.00%,ITPR1;ATP2B1;TMEM165;ATP2A3;SLC4A8;MMGT1;MAGT1;AQP1;SLC12A3;KCNA1
prerank,endopeptidase activity (GO:0004175),0.19116463637904646,0.8476891190486588,0.8779803646563815,0.9625205700765963,1.0,55/257,22.37%,USP35;KLK2;UCHL1;USP8;USP12;PRSS36;ADAMTS1;CASP1;F12;CTSS;MMP2;LGMN;PITRM1;KLK8;USP28;MBTPS1;USP25;ADAM28;PRSS38;RCE1;MBTPS2;ADAMTS4;USP36;USP5;PSMB3;PSEN2;JMJD7;CTSF;USP9Y;PSMA7;PDIA3;NRDC;MIPEP;HPN;CTSE;KLK9;RHBDD3;PLG;ADAM10;PSMB9;MMP28;KDM8;HTRA2;AFG3L2;PIDD1;PSMB5;ADAMTS20;ADAM17;ADAMTS18;FURIN;PSMB7;TYSND1;MMP24;MMP25;PSMB8
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.25005302943260815,-0.8471362954155309,0.7206982543640897,0.9416324001446227,1.0,14/38,30.96%,SPOCK1;APP;SERPING1;SERPINI1;SERPINH1;ANXA2;SERPINB2;SERPINE3;TFPI2;SERPINA2;SERPINB5;HRG;SERPINA10;WFDC3
prerank,serine-type peptidase activity (GO:0008236),0.21602079512809946,0.8467669987152611,0.7938311688311688,0.9611420417839065,1.0,10/96,8.73%,KLK2;PRSS36;ST14;NAALAD2;F12;MMP2;KLK8;MBTPS1;PRSS38;KLK11
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3464191406795638,-0.8454090247120741,0.6470588235294118,0.9413970426621974,1.0,2/10,3.40%,PKIA;PRKAG2
prerank,chemokine binding (GO:0019956),0.2723796857659051,0.8452867956944558,0.7005163511187608,0.9610305321609254,1.0,3/30,8.12%,CX3CR1;ITGAV;CCR7
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3327757597398229,-0.844595091287281,0.6571428571428571,0.9391135212516825,1.0,6/12,28.65%,TBPL1;GTF2B;H3-3A;HDAC1;FOS;RELA
prerank,nuclear export signal receptor activity (GO:0005049),0.34712978773322756,0.8434713323670889,0.6579925650557621,0.9616532355800593,1.0,7/11,32.13%,NUP42;CSE1L;XPO5;XPO1;RANBP17;XPO6;NUP214
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3359011251354245,-0.8401877998209493,0.6878850102669405,0.9443435932419317,1.0,2/11,4.31%,IQGAP1;SH3RF1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3443882083457139,0.8380740351999459,0.6815642458100558,0.9697055736318593,1.0,3/12,12.09%,NCBP1;CYFIP1;DCPS
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.32848498748027294,0.8378018276019243,0.6666666666666666,0.9669016550876037,1.0,4/14,17.60%,POP1;TSEN2;RPP21;ELAC2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.23215613681457115,0.837007883465831,0.7693631669535284,0.9651487457613795,1.0,10/60,14.21%,LRRC39;PPM1H;PPM1L;RPAP2;PP2D1;ILKAP;LRRK1;CDC14B;TIMM50;PPP1CB
prerank,cytokine receptor binding (GO:0005126),0.2217464917711923,0.8360758011179639,0.7993630573248408,0.9638365577220518,1.0,20/83,22.98%,IL18;SMAD3;VEGFB;IL6ST;CNTF;IL12B;DDT;IL6R;IL34;TIMM50;PYCARD;CSF1;OSM;TYK2;CCRL2;SPRED2;ADAM17;ERAP1;CCL25;PXDN
prerank,protein phosphatase binding (GO:0019903),0.21041749726883985,0.8323982235688414,0.8292682926829268,0.9682466437141738,1.0,21/117,16.73%,SIRPA;CTTNBP2NL;PPP1R3E;PIK3R1;PPP6R3;PPP1R9B;AKAP5;MET;PPP6R1;VRK3;FBXL2;CEACAM1;DLG4;MTMR4;CD33;SOD1;MAPK14;KIF3A;SNX3;STAT6;MASTL
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.3472513515851933,-0.8322090569824081,0.6792873051224945,0.9570225468700267,1.0,5/10,18.50%,NSD3;NSD1;SETD5;SMYD2;SETMAR
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.26766683305736166,0.829417395319843,0.7250437828371279,0.9707907078279722,1.0,4/30,10.20%,CST3;RPS6KA1;CD27;DPEP1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.34100858664712597,0.8284149260851037,0.7106690777576854,0.9694130400713002,1.0,2/12,4.73%,GREM1;VEGFB
prerank,amino acid:sodium symporter activity (GO:0005283),0.34759536727204876,0.8280051030031876,0.6842105263157895,0.9669414990824545,1.0,1/11,0.82%,SLC1A3
prerank,CCR chemokine receptor binding (GO:0048020),-0.25713782344572544,-0.8247612763884875,0.7453703703703703,0.9678769817645442,1.0,11/28,34.79%,CCR2;CCL5;CCL14;CX3CL1;CCL7;NES;CCL19;CCL8;MSMP;CCL4;DEFB130A
prerank,glutathione transferase activity (GO:0004364),-0.2681187198610993,-0.8243836102889434,0.7632183908045977,0.9645432604112749,1.0,11/23,32.05%,MGST1;ALOX5AP;GSTT1;PTGES;GSTP1;MGST3;GSTZ1;GSTK1;LANCL1;MGST2;GSTA2
prerank,inward rectifier potassium channel activity (GO:0005242),0.2784331900179164,0.8238091835034949,0.730072463768116,0.971956108145555,1.0,3/24,6.36%,KCNK6;KCNN1;ABCC9
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3564546667488837,0.8232281749465405,0.7013232514177694,0.9698010715144771,1.0,4/10,15.92%,ECHS1;ECI1;ECHDC2;HADHB
prerank,bHLH transcription factor binding (GO:0043425),0.2958442358004009,0.8203317533946994,0.7300380228136882,0.9723101515591184,1.0,7/19,26.10%,SMAD3;MAP3K10;TCF3;KDM1A;TWIST1;LMO2;ISL1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.24857420631255717,0.8187968413453365,0.7686832740213523,0.9718662207255414,1.0,7/33,16.65%,DIS3L2;REXO2;EXOSC5;EXOSC10;ERI3;DIS3;ISG20
prerank,retinoic acid receptor binding (GO:0042974),0.30283017938022555,0.818701643133967,0.7058823529411765,0.96881070559751,1.0,3/17,4.39%,PRMT2;CNOT1;TACC1
prerank,protein phosphatase activator activity (GO:0072542),0.31839312278233345,0.8186628313390952,0.720226843100189,0.9656460779093451,1.0,4/13,23.48%,IGFBP3;PPP2R5B;PPP2R5A;CALM2
prerank,sterol transfer activity (GO:0120015),0.3043819638708039,0.8180187054017418,0.7282608695652174,0.9636349132126243,1.0,7/17,31.64%,GRAMD1A;NPC2;OSBP;MTTP;ABCA1;STARD5;ABCG1
prerank,phosphatase binding (GO:0019902),0.20887077664218684,0.8175956184280844,0.8411949685534591,0.9612286826046561,1.0,21/105,16.55%,SIRPA;SMAD3;PIK3R1;PPP6R3;CRY2;MET;PPP6R1;VRK3;WNK1;FBXL2;CEACAM1;SH2D4A;DLG4;MTMR4;CD33;CSRNP2;MAPK14;SFI1;KIF3A;SNX3;STAT6
prerank,ATP hydrolysis activity (GO:0140603),0.24319088184821738,0.8117110484823489,0.7697841726618705,0.9689213161788809,1.0,6/41,9.40%,ABCD2;MYO1E;CLU;DHX9;SWSAP1;CHD3
prerank,lipase activator activity (GO:0060229),0.34482175788158415,0.8108391462168287,0.7218934911242604,0.967315339411563,1.0,4/10,11.54%,SRC;CCL3;PDPK1;APOH
prerank,5'-3' RNA polymerase activity (GO:0034062),0.2673485193080395,0.807484080680525,0.7731958762886598,0.9700246614506154,1.0,8/27,23.17%,POLR2J;POLR2D;POLR3H;POLR1D;POLR1C;POLR2E;POLR2I;MED20
prerank,vitamin D receptor binding (GO:0042809),-0.30200767474123213,-0.8062877495773408,0.7155555555555555,0.9952526590923741,1.0,5/14,28.46%,TAF7;SNW1;MED14;MED16;MED1
prerank,carboxypeptidase activity (GO:0004180),0.2533106161069105,0.806004363482507,0.7767857142857143,0.9693490915978957,1.0,8/35,18.57%,NAALAD2;CPE;CPA4;CPB1;MINDY2;AGBL3;CTSA;CPA6
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2448610883031839,-0.8043829808830636,0.7814569536423841,0.9946147016845913,1.0,15/34,27.51%,SUV39H1;KMT2E;NSD3;EEF1AKMT1;TTLL12;EEF1AKMT2;SMYD2;METTL21A;CAMKMT;EEF1AKMT4;EHMT1;METTL21C;EEF1AKMT3;ETFBKMT;KMT5B
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.23428375700907222,-0.8038251362784757,0.8111380145278451,0.991595009779247,1.0,4/38,6.14%,HIP1;SESTD1;PLEKHA5;DENND1A
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.33837232288400176,-0.8020402409069394,0.7192622950819673,0.9906856570151806,1.0,1/10,1.00%,ATF2
prerank,wide pore channel activity (GO:0022829),-0.26170595516776557,-0.8015516446468154,0.7669683257918553,0.9874890515222563,1.0,5/23,21.71%,PANX2;PANX1;GJB2;GJD2;GJA5
prerank,TBP-class protein binding (GO:0017025),0.2775411830705011,0.8003551707841836,0.7571942446043165,0.9762412707935638,1.0,5/21,14.72%,TAF12;BRF2;TAF1;PSMC1;PSMC2
prerank,death domain binding (GO:0070513),0.33252416369597887,0.8000069090805758,0.7244701348747592,0.9736833357316889,1.0,2/11,5.58%,CRADD;TRADD
prerank,death receptor binding (GO:0005123),-0.29632223236293437,-0.7996225857554004,0.710691823899371,0.986872091795762,1.0,6/15,31.91%,BDNF;EDA;CASP8AP2;BID;NGF;NTF4
prerank,telomeric DNA binding (GO:0042162),0.25654437170298594,0.7958871761318468,0.7774030354131535,0.9776160899331572,1.0,14/32,27.90%,CTC1;BLM;TERF1;ZBTB48;TEN1;KDM1A;ACD;XRCC6;HNRNPA2B1;TELO2;STN1;UPF3A;HMBOX1;RPA1
prerank,phosphatidylglycerol binding (GO:1901611),0.31713476458306095,0.7957047424263233,0.7486437613019892,0.9748478049809872,1.0,2/13,6.05%,PITPNC1;NME4
prerank,gap junction channel activity (GO:0005243),-0.26423691371178626,-0.795058354476139,0.7511520737327189,0.9911088634907792,1.0,5/22,21.71%,PANX2;PANX1;GJB2;GJD2;GJA5
prerank,glucose transmembrane transporter activity (GO:0005355),-0.28618309672282094,-0.7943324543721755,0.7690631808278867,0.9884180672493484,1.0,8/17,35.01%,SLC2A8;SLC2A2;SLC2A4;SLC5A1;SLC5A10;SLC2A3;MFSD4A;SLC2A6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.26387501169217603,0.7936457795623926,0.7833622183708839,0.9752292624313229,1.0,3/27,5.47%,SLC9A9;SLC9A8;SLC8A1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.3195660506269361,-0.7917390811826897,0.7448132780082988,0.9888138120000268,1.0,2/11,8.94%,UBR5;UBE2K
prerank,ATPase regulator activity (GO:0060590),-0.2261287349878407,-0.788972968103067,0.8428246013667426,0.9897381268549664,1.0,7/38,14.00%,DNAJA2;DNAJC15;DNAJB4;BAG3;ATP1B3;TOR1AIP2;MYBPC3
prerank,antiporter activity (GO:0015297),-0.2642274704884489,-0.7881273100182882,0.8053097345132744,0.9872478958685625,1.0,4/20,16.79%,SLC25A30;SLC25A16;SLC35C2;SLC35E1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.3127090584697635,-0.7872703987231863,0.7395833333333334,0.9847402043086881,1.0,1/12,0.23%,B3GALT1
prerank,protein phosphatase 2A binding (GO:0051721),-0.25861882648067014,-0.7867863714195437,0.789598108747045,0.9816360732854966,1.0,5/23,11.19%,SMG7;STRN3;GRIN3A;SMG5;ADCY8
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.2987857864605264,-0.7864467972216175,0.7754237288135594,0.9783258225353907,1.0,3/14,13.00%,USP15;USP13;MINDY3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3314687222491687,0.7861800685438204,0.7642725598526704,0.9851825214011123,1.0,2/11,8.54%,PADI2;AGMAT
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.24628805620181307,-0.7854759438098519,0.803030303030303,0.9760514099175758,1.0,7/28,18.91%,TRIM37;EDA;TRAP1;BABAM2;TNFSF9;TRAF1;CASP8AP2
prerank,ATPase binding (GO:0051117),-0.2017582488649906,-0.7836216459531886,0.9008264462809917,0.9754996818378384,1.0,8/71,8.91%,ANK2;PDE4D;EGFR;SNU13;PTPN3;PKD2;ATP1B3;TMTC4
prerank,fibroblast growth factor binding (GO:0017134),0.28070793510545194,0.7819253473215524,0.7811387900355872,0.9890934331636992,1.0,9/21,27.44%,ITGAV;CEP57;API5;THBS1;FGFR4;FGFR2;ITGB3;FIBP;FGFRL1
prerank,NADPH binding (GO:0070402),-0.30496652362027643,-0.7809138741774965,0.7505773672055427,0.9762390833411008,1.0,9/13,35.55%,LBR;HMGCR;DUS2;GRHPR;CBR4;DHFR;CRYZ;DECR1;MTRR
prerank,G protein-coupled receptor binding (GO:0001664),0.19079834544862567,0.7781415793611376,0.9351851851851852,0.9924351126459422,1.0,24/132,20.37%,GNA15;GNA12;ARRB2;NPY;RYK;WNT2B;PPY;C1QBP;WNT10B;WNT7B;GRK2;INSL3;ZNRF3;PICK1;NPFF;USP4;GNAS;FZD1;ARRB1;STUB1;ITGB4;PENK;RSPO1;CCRL2
prerank,metallocarboxypeptidase activity (GO:0004181),-0.24446641957225668,-0.7778380904181498,0.8017817371937639,0.9772890959509118,1.0,10/26,31.08%,AGBL4;AGBL1;AEBP1;VASH2;AGBL2;CPXM2;CPA2;PEPD;CPA3;ACE2
prerank,nucleotidase activity (GO:0008252),-0.29084193781703493,-0.777721229331912,0.7825112107623319,0.9737167213900999,1.0,3/15,23.60%,NT5C3B;BPNT1;BPNT2
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3170917244852389,0.7760054917946032,0.7481343283582089,0.9928268006408933,1.0,5/12,19.13%,KDM3A;KDM4A;HR;KDM1A;KDM7A
prerank,nucleotide diphosphatase activity (GO:0004551),0.299733070330442,0.77463099857257,0.7651515151515151,0.9918146466213966,1.0,3/14,19.45%,FHIT;NUDT13;NUDT6
prerank,thyroid hormone receptor binding (GO:0046966),0.2551353138469122,0.7742030439780472,0.8077571669477235,0.989375174519801,1.0,3/28,4.39%,BRD8;PRMT2;TACC1
prerank,semaphorin receptor binding (GO:0030215),0.26116940584668735,0.7740211788635776,0.7830882352941176,0.9865693154670352,1.0,5/23,13.59%,SEMA3B;SEMA4C;SEMA4G;SEMA3G;SEMA4D
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2271812555331687,0.774001630805658,0.8464223385689355,0.9835070643200351,1.0,17/44,24.95%,KMT2D;ASH1L;CXXC1;EHMT2;KMT5C;SETD2;EZH2;EED;SETD4;PRDM9;SETD3;SETD7;SMYD1;KMT2B;KMT5A;SETDB1;WDR5
prerank,Notch binding (GO:0005112),0.2637066293948827,0.7698098165406152,0.8049645390070922,0.986870309211694,1.0,5/22,11.38%,JAG2;NOTCH4;DTX1;GALNT11;DLL1
prerank,metallopeptidase activity (GO:0008237),-0.18072540442838017,-0.7694351190301448,0.9567723342939481,0.9830594764769545,1.0,28/113,22.18%,MMP16;MME;PSMD14;ADAMTS17;THSD4;TRABD2B;ADAMTS19;ADAM33;MPND;MMP12;MMP15;ANPEP;ADAMTSL1;ADAM12;ADAMTSL5;MMP19;MMP8;PHEX;MMP14;SPG7;ADAM21;ADAMTSL4;LNPEP;ADAMTS10;ACE;ADAMTS14;ADAM2;ADAMTS12
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.29062788550556146,-0.7689214013222246,0.7672811059907834,0.9801178542758395,1.0,5/14,17.06%,SLC1A6;SLC25A12;SLC7A11;SLC25A18;SLC1A1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2208310395433402,0.7678459500634717,0.8782608695652174,0.9865308142966792,1.0,16/49,24.08%,BAG6;ZRANB1;TAB2;UFD1;MINDY2;ABRAXAS1;OPTN;TNIP2;UBQLN4;WDR81;PSMD4;TNIP1;ZBTB1;SPRTN;UBXN1;RAD23B
prerank,calcium-activated potassium channel activity (GO:0015269),0.3127353142346972,0.7677660396533674,0.7923076923076923,0.9835876900233854,1.0,3/11,10.04%,KCNMA1;KCNN1;KCNU1
prerank,ADP binding (GO:0043531),-0.24729704416794077,-0.7615853201742481,0.8240343347639485,0.9874910073574988,1.0,8/25,22.72%,ERN1;PRKAG2;TAP1;MYO6;ME1;MSH6;ACTA1;MSH2
prerank,frizzled binding (GO:0005109),-0.2236867909085475,-0.7609372033073679,0.8554502369668247,0.9846703251208645,1.0,9/34,21.74%,CCDC88C;LRP6;SDCBP;WNT4;WNT9A;SFRP1;WNT7A;WNT6;WNT8B
prerank,protein kinase activator activity (GO:0030295),0.21343474019237366,0.7601998887700335,0.8552412645590682,0.991699883434833,1.0,11/60,13.19%,FGF13;STRADA;SPRY2;AFAP1L2;GPRC5A;RPTOR;NCKAP1L;WNK1;MLST8;MARK2;AGAP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.30911375475645947,-0.758325069751447,0.7780172413793104,0.9806607824308219,1.0,6/10,32.98%,DUSP10;DUSP16;DUSP2;DUSP4;DUSP9;DUSP8
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.30911375475645947,-0.758325069751447,0.7780172413793104,0.9806607824308219,1.0,6/10,32.98%,DUSP10;DUSP16;DUSP2;DUSP4;DUSP9;DUSP8
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3227882094932067,0.7568860346574586,0.7890772128060264,0.993242909271671,1.0,3/10,19.24%,CACNB2;CACNA1A;CACNA1D
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2861679581169744,0.7559677963897157,0.7932960893854749,0.9914686555869142,1.0,3/16,12.36%,MTMR10;MTMR14;MTMR4
prerank,N-methyltransferase activity (GO:0008170),0.26774494304739305,0.75579846562686,0.801056338028169,0.9886656523384642,1.0,7/20,24.11%,METTL5;RNMT;PRMT1;SETD3;TFB1M;TRMT1L;HNMT
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.24485216707415738,-0.7551083745378133,0.7986577181208053,0.9815992942472158,1.0,7/24,23.30%,ZDHHC21;ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC18;ZDHHC24;ZDHHC19
prerank,phospholipase activator activity (GO:0016004),0.3221121947752501,0.7526764110757518,0.7775628626692457,0.9898058496716138,1.0,4/10,13.36%,SRC;CCL3;PDPK1;STX4
prerank,lipid phosphatase activity (GO:0042577),0.2940309366159929,0.7514616228173625,0.8102466793168881,0.988603077367395,1.0,4/14,13.95%,INPP5K;PLPP1;PLPP2;PLPPR2
prerank,DNA secondary structure binding (GO:0000217),0.24037803198874996,0.7508423886182035,0.8448566610455311,0.9865043866365596,1.0,10/31,24.17%,MEF2C;FANCM;RAD51B;BLM;ABL1;HMGB2;MAPT;LIN54;YY1;RAD51C
prerank,ephrin receptor activity (GO:0005003),-0.26854981752173723,-0.7482577712529582,0.8354978354978355,0.9838025832255363,1.0,8/17,29.23%,EPHA5;EPHA4;EPHB2;EPHA7;EPHA3;EPHB4;EPHA6;EFNA4
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.26854981752173723,-0.7482577712529582,0.8354978354978355,0.9838025832255363,1.0,8/17,29.23%,EPHA5;EPHA4;EPHB2;EPHA7;EPHA3;EPHB4;EPHA6;EFNA4
prerank,protein kinase inhibitor activity (GO:0004860),0.22265665575254082,0.7481678295501735,0.8848797250859106,0.9872464342709532,1.0,15/42,24.56%,PRKRIP1;SPRY2;RPTOR;ITPRIP;INKA1;MAPK8IP1;CIB1;QARS1;TRIB1;MBIP;CEP43;IBTK;SPRED2;CDKN1B;DUSP19
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.2768846078289231,-0.7473866569497959,0.8161925601750547,0.9814480155090853,1.0,4/15,17.75%,SESTD1;PLEKHA5;PLEKHF1;VEPH1
prerank,nucleosomal DNA binding (GO:0031492),-0.2518073806255403,-0.7472497965319291,0.7978021978021979,0.9779292573241812,1.0,4/21,12.01%,SMARCE1;MTA2;ACTB;H3-3A
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.25594913142013503,-0.7447583241798982,0.856492027334852,0.9776560887721463,1.0,7/18,28.07%,FAR2;ALDH3A2;ALDH9A1;ALDH2;ALDH6A1;FAR1;ALDH18A1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2184587210969089,0.7443523305723571,0.9003496503496503,0.9894450790156721,1.0,3/47,2.43%,SLC7A8;SLC7A5;SLC36A1
prerank,FAD binding (GO:0071949),-0.24143542696881126,-0.7412990352624752,0.8524590163934426,0.9785502599123178,1.0,8/24,23.84%,MICAL3;KDM1B;KMO;DAO;STEAP4;CYB5R2;CRY1;AGPS
prerank,protein kinase regulator activity (GO:0019887),-0.17931851818519198,-0.7408468691264184,0.9691516709511568,0.9754796481918495,1.0,28/95,24.17%,SH3BP5;PRKAG2;FAF1;CCND2;CCNF;CCNYL1;KIDINS220;TPX2;SMCR8;CCNJ;DNAJC3;SPRY4;CDKN1A;SNCA;RGCC;RPLP1;DUS2;NPM1;CCNB1;SPDYA;CDKN1C;GMFG;GPRC5C;PRKAR1A;CCNH;SH3BP5L;CAB39;PRKAR2B
prerank,NADP binding (GO:0050661),0.23571012001005515,0.7377112473901933,0.8591065292096219,0.9952517033320024,1.0,7/32,13.31%,QDPR;HSD17B1;DUOX1;NOS2;CRYM;CRYZL1;NNT
prerank,phosphatase activator activity (GO:0019211),0.2852228457060444,0.7376371959058338,0.8310679611650486,0.9923796105240867,1.0,5/14,23.48%,FRS2;PPP2R5B;PPP2R5A;BMP2;CALM2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.2864965481095608,0.7375886132570952,0.8119001919385797,0.9894578423466969,1.0,5/13,28.06%,SLC15A4;SLC38A7;SLC7A7;SLC66A1;SLC25A29
prerank,tau-protein kinase activity (GO:0050321),-0.25005215005018466,-0.737184931804343,0.860730593607306,0.9766119404169071,1.0,3/20,5.28%,MARK3;SIK3;GSK3B
prerank,lysine N-methyltransferase activity (GO:0016278),0.25714058012724594,0.7362406358644575,0.8509874326750448,0.9883682073922584,1.0,8/20,23.66%,EEF2KMT;EHMT2;ANTKMT;SETD2;SETD4;SETD3;SETD7;KMT5A
prerank,MAP kinase activity (GO:0004707),-0.27069956139078544,-0.7357482772046117,0.8344671201814059,0.9748375445958131,1.0,5/14,29.14%,MAPK10;NLK;MAPK1;MAPK15;MAPK13
prerank,telomerase RNA binding (GO:0070034),-0.2414909247162786,-0.7347352664725756,0.8675496688741722,0.9724394169935354,1.0,4/22,11.77%,SMG7;SMG6;SMG5;WRAP53
prerank,pseudouridine synthase activity (GO:0009982),-0.2796598701750759,-0.733707609022032,0.8038379530916845,0.9702173224098986,1.0,5/13,24.96%,PUS1;TRUB2;RPUSD1;RPUSD3;RPUSD4
prerank,chemokine activity (GO:0008009),-0.2252485318165957,-0.7328894941437353,0.858139534883721,0.9677479674915922,1.0,10/31,32.82%,PF4;CCL5;CCL14;CX3CL1;CCL7;CCL19;CCL8;CXCL9;CCL4;CXCL16
prerank,disordered domain specific binding (GO:0097718),-0.24015535592448423,-0.729540782333175,0.8318181818181818,0.9682654428252246,1.0,9/23,28.74%,FN1;CALM1;HSPA2;MDM2;FYN;KCNA1;HSP90AB1;CALM3;SMAD2
prerank,palmitoyltransferase activity (GO:0016409),-0.22438119687547664,-0.7282898629514268,0.8803611738148984,0.9661645175616359,1.0,6/28,14.54%,ZDHHC21;ZDHHC16;ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC18
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.19999940633851532,-0.7278304134405351,0.9399038461538461,0.963263564056394,1.0,15/49,26.18%,MPPED2;PTPN22;DUSP10;GDPD1;PXYLP1;DUSP16;SAMHD1;PLCXD2;DUSP28;SACM1L;PRUNE1;HDHD2;EPHX2;LHPP;DUSP4
prerank,intracellular chloride channel activity (GO:0061778),-0.2674950775613616,-0.7277479537349306,0.8195991091314031,0.9564741123929346,1.0,4/16,13.64%,ANO3;ANO6;ANO5;ANO10
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.2674950775613616,-0.7277479537349306,0.8195991091314031,0.9564741123929346,1.0,4/16,13.64%,ANO3;ANO6;ANO5;ANO10
prerank,gamma-tubulin binding (GO:0043015),-0.2423397922749428,-0.7266097645956558,0.8528138528138528,0.9542717339506159,1.0,4/21,15.06%,RACGAP1;CDK5RAP2;RAD51D;PAK1
prerank,cardiolipin binding (GO:1901612),-0.3013913732633622,-0.726524668406092,0.8148936170212766,0.9509988190462713,1.0,1/10,2.55%,MME
prerank,chemoattractant activity (GO:0042056),0.24808457214921933,0.7250546021711922,0.875886524822695,0.9991870583142863,1.0,4/26,8.24%,CCL3;VEGFB;PDGFB;GDNF
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.3111892410044684,0.7217445736711461,0.8397790055248618,1.0,1.0,1/10,2.35%,INCA1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.27970732701122647,-0.7196492619780129,0.8568281938325991,0.955767306716127,1.0,2/12,7.92%,XDH;ISCA2
prerank,serine-type endopeptidase activity (GO:0004252),-0.1793069029122765,-0.7196013269930425,0.9828850855745721,0.9524720333925404,1.0,26/80,30.48%,DPP4;PCSK2;PCSK5;CD5L;PARL;F7;MMP8;PLAT;PRSS12;HPR;HP;RHBDL3;MASP2;ACR;F11;PRSS53;RHBDD1;RHBDL2;GZMM;MMP9;PLAU;GZMB;GZMA;PRSS56;RHBDL1;TMPRSS3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2626895183318285,0.7179050389826194,0.8415300546448088,1.0,1.0,2/18,5.48%,HSD3B2;HSD17B1
prerank,transferrin receptor binding (GO:1990459),-0.2975891829765358,-0.7153645378528956,0.8553459119496856,0.9538508219806894,1.0,6/10,43.56%,SNX2;RGMA;CHUK;HFE;IKBKG;CD81
prerank,titin binding (GO:0031432),0.287278270573169,0.7146202705890959,0.8469945355191257,1.0,1.0,5/13,26.90%,CAPN3;MYBPC1;ANKRD23;CALM2;CAMK2D
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.21492591394531496,-0.7140627817739454,0.9086651053864169,0.9519347488407625,1.0,11/34,27.47%,IQGAP1;CALM1;IRGM;DBF4;CCNB1;CKS2;LTF;ETAA1;CAB39;CALM3;CCNT2
prerank,U6 snRNA binding (GO:0017070),0.26660661906834204,0.7093302405851876,0.8623853211009175,1.0,1.0,5/14,23.64%,SART3;PRPF4;LSM7;DDX39B;LSM8
prerank,histone acetyltransferase activity (GO:0004402),0.22725952411100625,0.7066633078847828,0.9045138888888888,1.0,1.0,14/30,30.35%,SRCAP;TAF1;NAA50;NCOA3;ARRB1;KAT5;NAA40;EPC1;TAF10;KAT6B;NAA60;EPC2;KAT2B;EP300
prerank,cholesterol transfer activity (GO:0120020),0.26722301870628673,0.7065061582920786,0.8935779816513761,1.0,1.0,6/16,31.64%,GRAMD1A;NPC2;MTTP;ABCA1;STARD5;ABCG1
prerank,alpha-tubulin binding (GO:0043014),0.22370270006155363,0.7054093125538565,0.9073426573426573,1.0,1.0,11/31,27.50%,DIP2B;TRIM36;SETD2;TRPV4;OFD1;EML4;EFHC2;TRAPPC14;HDAC6;TBCEL;ARL8B
prerank,potassium ion leak channel activity (GO:0022841),-0.25445735562647026,-0.7051757458998625,0.856492027334852,0.9576397083338016,1.0,1/15,0.85%,KCNK10
prerank,RNA methyltransferase activity (GO:0008173),0.255818489183539,0.7045497429768615,0.8790613718411552,0.9983367234180309,1.0,9/19,28.65%,TGS1;BCDIN3D;FTSJ3;FBL;METTL8;TRDMT1;FTSJ1;TRMT9B;METTL4
prerank,copper ion binding (GO:0005507),-0.20450171694218258,-0.7040351897106154,0.9516908212560387,0.9553249528203882,1.0,9/42,21.82%,PAM;ATP7A;SNCA;MOXD1;GPC1;CUTC;DCT;ACR;AOC2
prerank,DNA replication origin binding (GO:0003688),-0.2301691943260587,-0.7030704356632139,0.9075425790754258,0.9529294824621674,1.0,2/23,3.99%,POLA1;MCM9
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.2860843041911962,0.7028902885884732,0.8599290780141844,0.9972782697624032,1.0,3/13,23.22%,SRC;PYCARD;BMP2
prerank,exoribonuclease activity (GO:0004532),0.28258761579868774,0.6978522711257301,0.8494208494208494,0.9995322329192944,1.0,4/12,21.84%,EXOSC5;EXOSC10;EXOSC8;ZC3H12A
prerank,pyridoxal phosphate binding (GO:0030170),-0.23923389748831614,-0.6951898011631275,0.8765957446808511,0.957237632903586,1.0,5/20,17.04%,PSAT1;SRR;SHMT1;PYGM;GLDC
prerank,glucuronosyltransferase activity (GO:0015020),0.2513493284944631,0.6936425606227761,0.8826714801444043,1.0,1.0,4/19,16.01%,LARGE1;CHPF;CHSY1;UGT1A6
prerank,cAMP response element binding (GO:0035497),0.2943580626157388,0.6934987884613442,0.8314814814814815,0.9981857403532824,1.0,3/10,13.17%,CREB3L2;JUN;E4F1
prerank,WW domain binding (GO:0050699),0.23141953234553075,0.6926659265741322,0.9005424954792043,0.9961409048437284,1.0,3/26,11.86%,PMEPA1;NDFIP2;TCEAL1
prerank,methylated histone binding (GO:0035064),0.1949299214001835,0.691809006197025,0.96,0.9941105287369646,1.0,20/62,25.79%,CHD8;CXXC1;ZMYND11;DPF2;JMJD7;TAF1;KDM4A;MORC3;KDM8;KDM7A;KDM5A;CBX8;GLYR1;TDRD3;ZCWPW2;WDR5;RRP8;PHF8;SPIN1;ZCWPW1
prerank,transaminase activity (GO:0008483),-0.27818907815037786,-0.6868452806530366,0.8508403361344538,0.9616478536226484,1.0,2/11,12.40%,PSAT1;BCAT1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.21338238484669522,0.6846227175437292,0.9393414211438474,0.9980512441984588,1.0,13/35,28.62%,QTRT1;AARS2;PTRH1;BCDIN3D;ELAC2;DUS3L;QTRT2;DUS1L;TRDMT1;FTSJ1;ELAC1;GATC;TRMT9B
prerank,transcription coregulator binding (GO:0001221),-0.1863018266587612,-0.6828474691768528,0.9803439803439803,0.9620515695389759,1.0,9/50,14.74%,ZBTB16;THRB;MTF2;PER2;CTCF;AHR;WIZ;LCOR;PER1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2276050580022769,0.6826065217053392,0.8987783595113438,0.9970339624022367,1.0,11/24,34.82%,NME4;CMPK1;NME6;NME1;IP6K1;AK8;DTYMK;PPIP5K1;AK1;AK7;CMPK2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.23847412553611913,0.6822947347786171,0.8905380333951762,0.9916972760479855,1.0,2/21,3.05%,CDKL3;CDK9
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.23847412553611913,0.6822947347786171,0.8905380333951762,0.9916972760479855,1.0,2/21,3.05%,CDKL3;CDK9
prerank,BMP receptor binding (GO:0070700),0.28609887764936637,0.6822778675712068,0.900355871886121,0.9889147047910323,1.0,3/12,23.22%,SRC;PYCARD;BMP2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.22667276255674368,0.6808833688538086,0.9349005424954792,0.9873589380385753,1.0,2/25,3.25%,SIRT2;ART4
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.26520933036617717,-0.6777222198870707,0.8958333333333334,0.9629293556875229,1.0,5/12,30.36%,RRH;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.25480969215675126,-0.6772576912453974,0.8835616438356164,0.960077028615445,1.0,3/13,15.03%,ALDH1L1;ALDH3A2;ALDH9A1
prerank,general transcription initiation factor binding (GO:0140296),0.2261343209017905,0.6770635846846317,0.9113475177304965,0.9878738168357432,1.0,9/25,27.57%,TAF12;BRF2;TAF1;PSMC1;PSMC2;TBP;DR1;AR;YEATS2
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.2427828790038341,-0.6716169232922657,0.903370786516854,0.9614817710397765,1.0,3/15,15.03%,ALDH1L1;ALDH3A2;ALDH9A1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.2759715129294533,-0.6709575798776136,0.864693446088795,0.9587723997217946,1.0,2/10,8.34%,DSE;RENBP
prerank,miRNA binding (GO:0035198),-0.2055052790346908,-0.6687076438932288,0.9621749408983451,0.9574680692722619,1.0,30/30,79.49%,AGO4;TUT4;MATR3;AGO2;ZC3H7B;PNPT1;ZC3H10;FMR1;PUM2;AGO3;ZC3H7A;POU5F1;DND1;LIN28A;SOX2;RBM10;TRIM71;DDX21;RC3H1;TUT7;SPOUT1;YBX1;ZNF346;PUM1;RBM4;HNRNPA1;AGO1;ELAVL1;ZC3H12A;HNRNPA2B1
prerank,methylation-dependent protein binding (GO:0140034),0.19026822609205238,0.6648507802123959,0.9758203799654577,0.9949585109937827,1.0,18/57,25.79%,CHD8;CXXC1;ZMYND11;JMJD7;KDM4A;MORC3;KDM8;KDM7A;KDM5A;CBX8;GLYR1;TDRD3;ZCWPW2;WDR5;RRP8;PHF8;SPIN1;ZCWPW1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2250652685501118,0.6539266634106178,0.9404332129963899,1.0,1.0,7/22,23.63%,ZRANB1;TAB2;MINDY2;OPTN;WDR81;ZBTB1;SPRTN
prerank,signal sequence binding (GO:0005048),0.20003616039086475,0.6497065448828827,0.9476439790575916,1.0,1.0,16/35,33.97%,TOMM20L;TNPO1;IPO4;SEC61A1;TOMM20;KPNA3;KDELR2;NUP153;IPO5;TOMM70;CEMIP;SEC61A2;NUP214;KDELR1;KPNA1;KPNA7
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.25316932899755984,0.6487609124027577,0.9009174311926605,0.9983597377035639,1.0,2/13,10.43%,GDI2;RGS14
prerank,N-acyltransferase activity (GO:0016410),0.20367834912129718,0.6417898722566758,0.9551724137931035,1.0,1.0,12/32,31.07%,TGM2;CERS3;CERS2;NAA50;CERS4;NAT8L;GNPNAT1;NMT1;PLA2G4E;SIRT7;EP300;NAA10
prerank,CoA-ligase activity (GO:0016405),-0.24037166010576583,-0.6379054477929889,0.9272727272727272,0.9757562124244769,1.0,8/14,38.80%,ACSL1;ACSM3;AACS;SLC27A5;ACSBG2;ACSBG1;ACSF3;ACSS3
prerank,voltage-gated anion channel activity (GO:0008308),-0.2304510455605988,-0.6291795018712527,0.9285714285714286,0.9777164626951215,1.0,2/15,8.52%,CLCN5;ANO6
prerank,ribonuclease P RNA binding (GO:0033204),0.2701075164046123,0.6196175738257257,0.9184466019417475,1.0,1.0,2/10,12.42%,POP1;RPP21
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.1847864481423135,0.6171445386668675,0.9778911564625851,1.0,1.0,6/42,14.19%,INCA1;CCNG2;CCNL1;CKS1B;CCND3;CCNE1
prerank,acetyltransferase activity (GO:0016407),0.19594768071994526,0.6131712968344134,0.9753086419753086,1.0,1.0,12/31,31.07%,LCAT;PAFAH2;NAA50;DBT;KAT6B;ELP3;NAT8L;GNPNAT1;ACAT1;KAT2B;EP300;NAA10
prerank,platelet-derived growth factor binding (GO:0048407),-0.2450087732987168,-0.610566829702753,0.9278131634819533,0.9845176070997621,1.0,3/11,15.41%,COL4A1;COL1A1;COL5A1
prerank,ribonuclease P activity (GO:0004526),0.2588012216812217,0.6099889721060278,0.9258555133079848,1.0,1.0,2/11,12.42%,POP1;RPP21
prerank,CoA hydrolase activity (GO:0016289),-0.21882456360668093,-0.604548998321452,0.9554140127388535,0.984004906659379,1.0,16/16,78.15%,ACOT13;ACOT11;HIBCH;ACOT12;BAAT;ACSBG2;ACOT9;NUDT7;ACOT6;ACOT2;ACOT7;ACOT4;ACOT8;ACOT1;ABCD1;ACAA2
prerank,protein phosphatase regulator activity (GO:0019888),0.17219388573626837,0.6037621812623652,0.9950657894736842,1.0,1.0,8/53,17.11%,PPP6R3;PPP1R9B;PPP6R1;MGAT5;PPP2R5B;PPP4R2;EIF2AK2;PPP2R5A
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2384085195373991,0.6031467670553365,0.9484732824427481,1.0,1.0,2/13,12.64%,SLX4;EXO1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.22946887963934898,-0.6025050477040317,0.9638297872340426,0.9817546415307051,1.0,4/12,24.26%,CDK7;CDK4;MAPK1;CDK12
prerank,acid-thiol ligase activity (GO:0016878),0.22758691931389607,0.5805283473362494,0.9642184557438794,1.0,1.0,3/13,25.62%,ACSS1;ACSS2;AASDH
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.18830586252255138,0.5779500199579977,0.9814126394052045,1.0,1.0,6/28,20.93%,POP1;RPP21;EXO1;ELAC2;NUDT16;RNASEH1
prerank,proton transmembrane transporter activity (GO:0015078),0.17670581316567435,0.5749817042135815,0.9875886524822695,1.0,1.0,4/39,13.31%,COX7A2L;COX8A;COX5A;NNT
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.19581230983831147,0.5709366045299393,0.9743119266055046,1.0,1.0,8/22,26.80%,DUSP29;DUSP18;DUSP5;DUSP6;PPM1F;DUSP12;DUSP19;DUSP23
prerank,peptidoglycan binding (GO:0042834),0.23869717969731727,0.5647971065994929,0.9677996422182469,1.0,1.0,2/10,20.24%,NLRP3;NOD2
prerank,"DNA binding, bending (GO:0008301)",-0.2127622106172371,-0.564302773684477,0.9725158562367865,0.9926870567234309,1.0,3/14,19.16%,TOP2A;FOXC1;LEF1
prerank,N-acetyltransferase activity (GO:0008080),0.2018234957105359,0.5570819909815707,0.9819168173598554,1.0,1.0,10/19,37.13%,ATAT1;NAA50;NAT8L;GNPNAT1;KAT2B;EP300;NAA10;SAT2;NAA80;AANAT
prerank,phosphatase inhibitor activity (GO:0019212),0.20176065971048388,0.5570398334620669,0.9783783783783784,1.0,1.0,2/20,10.09%,PPP1R9B;MGAT5
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.1841079241146881,0.5565852288526236,0.9792027729636048,1.0,1.0,3/26,12.92%,SLC16A6;MPC1;SLC16A7
prerank,MAP kinase phosphatase activity (GO:0033549),0.2150456095065587,0.536088025716038,0.9707495429616088,1.0,1.0,3/12,16.85%,DUSP29;DUSP5;DUSP6
prerank,nuclear localization sequence binding (GO:0008139),0.19343442846940434,0.5342747419544307,0.9927536231884058,1.0,1.0,5/18,23.69%,TNPO1;IPO4;KPNA3;NUP153;IPO5
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.21481379977750117,-0.5318615731030916,0.9803063457330415,0.9978961610460498,1.0,3/11,18.63%,RDH13;DHRS13;RDH12
prerank,tRNA methyltransferase activity (GO:0008175),0.19733912141173998,0.5254404452775219,0.9921722113502935,1.0,1.0,8/16,29.93%,BCDIN3D;THUMPD3;TRDMT1;FTSJ1;ALKBH8;TRMT9B;METTL2B;METTL2A
prerank,hormone receptor binding (GO:0051427),-0.18529788626503674,-0.4893280804521562,0.9936575052854123,1.0,1.0,1/14,4.07%,JAK2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.20593773537534515,0.47757984368656137,0.9887640449438202,1.0,1.0,10/10,79.42%,ANKRD13B;FAN1;LAPTM5;ANKRD13D;FAAP20;DAXX;IDE;PML;ANKRD13A;DNAJB2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.18694899847132018,0.4731762296089093,0.9927140255009107,1.0,1.0,4/13,24.66%,TRMT10B;THUMPD3;TRMT1L;FTSJ1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.16025310764032158,0.46964388097355314,1.0,0.9993434489394384,1.0,2/26,10.09%,PPP1R9B;MGAT5
prerank,filamin binding (GO:0031005),-0.18969585102061565,-0.4662381660387193,0.9954337899543378,1.0,1.0,4/11,27.15%,NEBL;MICALL2;RFLNB;DPYSL4
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.1845673725360122,-0.4489268602974691,1.0,0.9981895418225953,1.0,4/11,28.89%,NUDT3;NUDT10;DCP2;NUDT11
prerank,ribosomal large subunit binding (GO:0043023),0.17224279706233137,0.40962985236300087,1.0,0.9994827455057177,1.0,11/11,82.79%,NEMF;LTN1;CPEB2;EIF6;MALSU1;CPSF6;NMD3;RBM3;MRRF;DHX33;NPM1
